{"parse":{"title":"Melanoma","pageid":716631,"revid":859587171,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Melanoma</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nMalignant melanoma</td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Melanoma.jpg\" class=\"image\"><img alt=\"Melanoma.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/300px-Melanoma.jpg\" width=\"300\" height=\"209\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/450px-Melanoma.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/600px-Melanoma.jpg 2x\" data-file-width=\"2450\" data-file-height=\"1705\" /></a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\nA melanoma of approximately 2.5&#160;cm (1&#160;in) by 1.5&#160;cm (0.6&#160;in)</td></tr><tr><th scope=\"row\">Pronunciation</th><td>\n<div class=\"plainlist\"><ul><li><span class=\"nowrap\"><span class=\"IPA nopopups noexcerpt\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/\u02cc/: secondary stress follows\">\u02cc</span><span title=\"&#39;m&#39; in &#39;my&#39;\">m</span><span title=\"/\u025b/: &#39;e&#39; in &#39;dress&#39;\">\u025b</span><span title=\"&#39;l&#39; in &#39;lie&#39;\">l</span><span title=\"/\u0259/: &#39;a&#39; in &#39;about&#39;\">\u0259</span><span title=\"/\u02c8/: primary stress follows\">\u02c8</span><span title=\"&#39;n&#39; in &#39;nigh&#39;\">n</span><span title=\"/o\u028a/: &#39;o&#39; in &#39;code&#39;\">o\u028a</span><span title=\"&#39;m&#39; in &#39;my&#39;\">m</span><span title=\"/\u0259/: &#39;a&#39; in &#39;about&#39;\">\u0259</span></span>/</a></span><small class=\"nowrap\">&#160;(<span class=\"unicode haudio\"><span class=\"fn\"><span style=\"white-space:nowrap\"><a href=\"/wiki/File:Melanoma-pronunciation.ogg\" title=\"About this sound\"><img alt=\"About this sound\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Loudspeaker.svg/11px-Loudspeaker.svg.png\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Loudspeaker.svg/17px-Loudspeaker.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Loudspeaker.svg/22px-Loudspeaker.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\" /></a>&#160;</span><a href=\"//upload.wikimedia.org/wikipedia/commons/b/bc/Melanoma-pronunciation.ogg\" class=\"internal\" title=\"Melanoma-pronunciation.ogg\">listen</a></span></span>)</small></span>&#x20;</li></ul></div></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a> and <a href=\"/wiki/Dermatology\" title=\"Dermatology\">dermatology</a></td></tr><tr><th scope=\"row\">Symptoms</th><td>\n<a href=\"/wiki/Nevus\" title=\"Nevus\">Mole</a> that is increasing in size, has irregular edges, change in color, itchiness, or <a href=\"/wiki/Ulcer_(dermatology)\" title=\"Ulcer (dermatology)\">skin breakdown</a>.<sup id=\"cite_ref-NCI2015_1-0\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Causes</th><td>\n<a href=\"/wiki/Ultraviolet_light\" class=\"mw-redirect\" title=\"Ultraviolet light\">Ultraviolet light</a> (Sun, <a href=\"/wiki/Tanning_lamp\" title=\"Tanning lamp\">tanning devices</a>)<sup id=\"cite_ref-WCR2014_2-0\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Risk_factor\" title=\"Risk factor\">Risk factors</a></th><td>\nFamily history, many moles, <a href=\"/wiki/Immunosuppression\" title=\"Immunosuppression\">poor immune function</a><sup id=\"cite_ref-NCI2015_1-1\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Diagnostic_method\" class=\"mw-redirect\" title=\"Diagnostic method\">Diagnostic method</a></th><td>\n<a href=\"/wiki/Tissue_biopsy\" class=\"mw-redirect\" title=\"Tissue biopsy\">Tissue biopsy</a><sup id=\"cite_ref-NCI2015_1-2\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Differential_diagnosis\" title=\"Differential diagnosis\">Differential diagnosis</a></th><td>\n<a href=\"/wiki/Seborrheic_keratosis\" title=\"Seborrheic keratosis\">Seborrheic keratosis</a>, <a href=\"/wiki/Lentigo\" title=\"Lentigo\">lentigo</a>, <a href=\"/wiki/Blue_nevus\" title=\"Blue nevus\">blue nevus</a>, <a href=\"/wiki/Dermatofibroma\" class=\"mw-redirect\" title=\"Dermatofibroma\">dermatofibroma</a><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup></td></tr><tr><th scope=\"row\">Prevention</th><td>\n<a href=\"/wiki/Sunscreen\" title=\"Sunscreen\">Sunscreen</a>, avoiding UV light<sup id=\"cite_ref-WCR2014_2-1\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Treatment</th><td>\nSurgery<sup id=\"cite_ref-NCI2015_1-3\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\">Prognosis</th><td>\n<a href=\"/wiki/Five-year_survival_rates\" class=\"mw-redirect\" title=\"Five-year survival rates\">Five-year survival rates</a> in USA 98% (localized), 17% (disseminated)<sup id=\"cite_ref-SEER2015_4-0\" class=\"reference\"><a href=\"#cite_note-SEER2015-4\">&#91;4&#93;</a></sup></td></tr><tr><th scope=\"row\">Frequency</th><td>\n3.1 million (2015)<sup id=\"cite_ref-GBD2015Pre_5-0\" class=\"reference\"><a href=\"#cite_note-GBD2015Pre-5\">&#91;5&#93;</a></sup></td></tr><tr><th scope=\"row\">Deaths</th><td>\n59,800 (2015)<sup id=\"cite_ref-GBD2015De_6-0\" class=\"reference\"><a href=\"#cite_note-GBD2015De-6\">&#91;6&#93;</a></sup></td></tr></tbody></table>\n<p><b>Melanoma</b>, also known as <b>malignant melanoma</b>, is a type of <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a> that develops from the pigment-containing cells known as <a href=\"/wiki/Melanocyte\" title=\"Melanocyte\">melanocytes</a>.<sup id=\"cite_ref-NCI2015_1-4\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup> Melanomas typically occur in the skin, but may rarely occur in the mouth, <a href=\"/wiki/Intestines\" class=\"mw-redirect\" title=\"Intestines\">intestines</a>, or <a href=\"/wiki/Uveal_melanoma\" title=\"Uveal melanoma\">eye</a>.<sup id=\"cite_ref-NCI2015_1-5\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-WCR2014_2-2\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> In women, they most commonly occur on the legs, while in men they are most common on the back.<sup id=\"cite_ref-WCR2014_2-3\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Sometimes they develop from a <a href=\"/wiki/Nevus\" title=\"Nevus\">mole</a> with changes such as an increase in size, irregular edges, change in color, itchiness, or <a href=\"/wiki/Ulcer_(dermatology)\" title=\"Ulcer (dermatology)\">skin breakdown</a>.<sup id=\"cite_ref-NCI2015_1-6\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup>\n</p><p>The primary cause of melanoma is <a href=\"/wiki/Ultraviolet_light\" class=\"mw-redirect\" title=\"Ultraviolet light\">ultraviolet light</a> (UV) exposure in those with low levels of <a href=\"/wiki/Human_skin_color\" title=\"Human skin color\">skin pigment</a>.<sup id=\"cite_ref-WCR2014_2-4\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> The UV light may be from either the sun or from other sources, such as <a href=\"/wiki/Tanning_lamp\" title=\"Tanning lamp\">tanning devices</a>.<sup id=\"cite_ref-WCR2014_2-5\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> About 25% develop from moles.<sup id=\"cite_ref-WCR2014_2-6\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Those with many moles, a history of affected family members, and who have <a href=\"/wiki/Immunosuppression\" title=\"Immunosuppression\">poor immune function</a> are at greater risk.<sup id=\"cite_ref-NCI2015_1-7\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup> A number of rare genetic defects such as <a href=\"/wiki/Xeroderma_pigmentosum\" title=\"Xeroderma pigmentosum\">xeroderma pigmentosum</a> also increase risk.<sup id=\"cite_ref-Az2014_8-0\" class=\"reference\"><a href=\"#cite_note-Az2014-8\">&#91;8&#93;</a></sup> Diagnosis is by <a href=\"/wiki/Biopsy\" title=\"Biopsy\">biopsy</a> and analysis of any skin lesion that has signs of being potentially cancerous.<sup id=\"cite_ref-NCI2015_1-8\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup>\n</p><p>Using <a href=\"/wiki/Sunscreen\" title=\"Sunscreen\">sunscreen</a> and avoiding UV light may prevent melanoma.<sup id=\"cite_ref-WCR2014_2-7\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Treatment is typically removal by surgery.<sup id=\"cite_ref-NCI2015_1-9\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup> In those with slightly larger cancers, nearby <a href=\"/wiki/Lymph_nodes\" class=\"mw-redirect\" title=\"Lymph nodes\">lymph nodes</a> may be tested for spread.<sup id=\"cite_ref-NCI2015_1-10\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup> Most people are cured if spread has not occurred.<sup id=\"cite_ref-NCI2015_1-11\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup> For those in whom melanoma has spread, <a href=\"/wiki/Cancer_immunotherapy\" title=\"Cancer immunotherapy\">immunotherapy</a>, <a href=\"/wiki/Biologic_therapy\" class=\"mw-redirect\" title=\"Biologic therapy\">biologic therapy</a>, <a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">radiation therapy</a>, or <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> may improve survival.<sup id=\"cite_ref-NCI2015_1-12\" class=\"reference\"><a href=\"#cite_note-NCI2015-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Syn2017_9-0\" class=\"reference\"><a href=\"#cite_note-Syn2017-9\">&#91;9&#93;</a></sup> With treatment the <a href=\"/wiki/Five-year_survival_rates\" class=\"mw-redirect\" title=\"Five-year survival rates\">five-year survival rates</a> in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred.<sup id=\"cite_ref-SEER2015_4-1\" class=\"reference\"><a href=\"#cite_note-SEER2015-4\">&#91;4&#93;</a></sup> The likelihood that it will come back or spread depends how <a href=\"/wiki/Breslow%27s_depth\" title=\"Breslow&#39;s depth\">thick the melanoma</a> is, how fast the cells are dividing, and whether or not the overlying skin has broken down.<sup id=\"cite_ref-WCR2014_2-8\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup>\n</p><p>Melanoma is the most dangerous type of skin cancer.<sup id=\"cite_ref-WCR2014_2-9\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Globally, in 2012, it newly occurred in 232,000 people.<sup id=\"cite_ref-WCR2014_2-10\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths.<sup id=\"cite_ref-GBD2015Pre_5-1\" class=\"reference\"><a href=\"#cite_note-GBD2015Pre-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-GBD2015De_6-1\" class=\"reference\"><a href=\"#cite_note-GBD2015De-6\">&#91;6&#93;</a></sup> Australia and New Zealand have the highest rates of melanoma in the world.<sup id=\"cite_ref-WCR2014_2-11\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America.<sup id=\"cite_ref-WCR2014_2-12\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Melanoma is more common in men than women.<sup id=\"cite_ref-Az2014_8-1\" class=\"reference\"><a href=\"#cite_note-Az2014-8\">&#91;8&#93;</a></sup> Melanoma has become more common since the 1960s in areas which are mostly populated with <a href=\"/wiki/White_people\" title=\"White people\">white people</a>.<sup id=\"cite_ref-WCR2014_2-13\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Az2014_8-2\" class=\"reference\"><a href=\"#cite_note-Az2014-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Cause\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Cause</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#UV_radiation\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">UV radiation</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Genetics\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Genetics</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Pathophysiology\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Pathophysiology</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Diagnosis</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#ABCDE\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">ABCDE</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Ugly_duckling\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Ugly duckling</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Biopsy\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Biopsy</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Classification\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Classification</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Laboratory\"><span class=\"tocnumber\">4.5</span> <span class=\"toctext\">Laboratory</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Staging\"><span class=\"tocnumber\">4.6</span> <span class=\"toctext\">Staging</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Prevention\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Prevention</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Avoiding_ultraviolet_radiation\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Avoiding ultraviolet radiation</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Sunscreen\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Sunscreen</span></a></li>\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Medications\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Medications</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Treatment\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#Surgery\"><span class=\"tocnumber\">6.1</span> <span class=\"toctext\">Surgery</span></a></li>\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#Add_on_treatment\"><span class=\"tocnumber\">6.2</span> <span class=\"toctext\">Add on treatment</span></a></li>\n<li class=\"toclevel-2 tocsection-20\"><a href=\"#Chemotherapy_and_immunotherapy\"><span class=\"tocnumber\">6.3</span> <span class=\"toctext\">Chemotherapy and immunotherapy</span></a></li>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#Lentigo_maligna\"><span class=\"tocnumber\">6.4</span> <span class=\"toctext\">Lentigo maligna</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Radiation_therapy\"><span class=\"tocnumber\">6.5</span> <span class=\"toctext\">Radiation therapy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-23\"><a href=\"#Prognosis\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-24\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Epidemiology</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#Australia\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Australia</span></a></li>\n<li class=\"toclevel-2 tocsection-26\"><a href=\"#United_States\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">United States</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#History\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-28\"><a href=\"#Terminology\"><span class=\"tocnumber\">9.1</span> <span class=\"toctext\">Terminology</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-29\"><a href=\"#Research\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-30\"><a href=\"#Targeted_therapies\"><span class=\"tocnumber\">10.1</span> <span class=\"toctext\">Targeted therapies</span></a></li>\n<li class=\"toclevel-2 tocsection-31\"><a href=\"#BRAF_inhibitors\"><span class=\"tocnumber\">10.2</span> <span class=\"toctext\">BRAF inhibitors</span></a></li>\n<li class=\"toclevel-2 tocsection-32\"><a href=\"#Ipilimumab\"><span class=\"tocnumber\">10.3</span> <span class=\"toctext\">Ipilimumab</span></a></li>\n<li class=\"toclevel-2 tocsection-33\"><a href=\"#Surveillance_methods\"><span class=\"tocnumber\">10.4</span> <span class=\"toctext\">Surveillance methods</span></a></li>\n<li class=\"toclevel-2 tocsection-34\"><a href=\"#Oncolytic_virotherapy\"><span class=\"tocnumber\">10.5</span> <span class=\"toctext\">Oncolytic virotherapy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-35\"><a href=\"#References\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-36\"><a href=\"#External_links\"><span class=\"tocnumber\">12</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Early signs of melanoma are changes to the shape or color of existing <a href=\"/wiki/Mole_(skin_marking)\" class=\"mw-redirect\" title=\"Mole (skin marking)\">moles</a> or, in the case of <a href=\"/wiki/Nodular_melanoma\" title=\"Nodular melanoma\">nodular melanoma</a>, the appearance of a new lump anywhere on the skin. At later stages, the mole may <a href=\"/wiki/Itch\" title=\"Itch\">itch</a>, <a href=\"/wiki/Ulcer_(dermatology)\" title=\"Ulcer (dermatology)\">ulcerate</a> or bleed.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>  Early signs of melanoma are summarized by the mnemonic \"ABCDE\":\n</p>\n<ul><li><b>A</b>symmetry</li>\n<li><b>B</b>orders (irregular with edges and corners)</li>\n<li><b>C</b>olor (variegated)</li>\n<li><b>D</b>iameter (greater than 6&#160;mm (0.24&#160;<a href=\"/wiki/Inch\" title=\"Inch\">in</a>), about the size of a pencil eraser)</li>\n<li><b>E</b>volving over time</li></ul>\n<p>These classifications do not, however, apply to the most dangerous form of melanoma, nodular melanoma, which has its own classifications:\n</p>\n<ul><li><b>E</b>levated above the skin surface</li>\n<li><b>F</b>irm to the touch</li>\n<li><b>G</b>rowing</li></ul>\n<p>Metastatic melanoma may cause nonspecific <a href=\"/wiki/Paraneoplastic_syndrome\" title=\"Paraneoplastic syndrome\">paraneoplastic symptoms</a>, including loss of appetite, <a href=\"/wiki/Nausea\" title=\"Nausea\">nausea</a>, vomiting and fatigue. <a href=\"/wiki/Metastasis\" title=\"Metastasis\">Metastasis</a> of early melanoma is possible, but relatively rare: less than a fifth of melanomas diagnosed early become metastatic. <a href=\"/wiki/Brain_metastasis\" title=\"Brain metastasis\">Brain metastases</a> are particularly common in patients with metastatic melanoma.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>  It can also spread to the liver, bones, abdomen or distant lymph nodes.\n</p>\n<h2><span class=\"mw-headline\" id=\"Cause\">Cause</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=2\" title=\"Edit section: Cause\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Melanomas are usually caused by DNA damage resulting from exposure to ultraviolet light from the sun. Genetics also plays a role.\n</p><p>Having more than fifty moles indicates an increased risk melanoma might arise. A weakened immune system makes it easier for cancer to arise due to the body\u2019s weakened ability to fight cancer cells.<sup id=\"cite_ref-Mayo2016_12-0\" class=\"reference\"><a href=\"#cite_note-Mayo2016-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"UV_radiation\">UV radiation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=3\" title=\"Edit section: UV radiation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The ultraviolet radiation from tanning beds increases the risk of melanoma.<sup id=\"cite_ref-pmid22833605_13-0\" class=\"reference\"><a href=\"#cite_note-pmid22833605-13\">&#91;13&#93;</a></sup> The <a href=\"/wiki/International_Agency_for_Research_on_Cancer\" title=\"International Agency for Research on Cancer\">International Agency for Research on Cancer</a> finds that tanning beds are \"carcinogenic to humans\" and that people who begin using tanning devices before the age of thirty years are 75% more likely to develop melanoma.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p><p>Those who work in airplanes also appear to have an increased risk, believed to be due to greater exposure to UV.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p><p><a href=\"/wiki/Ultraviolet\" title=\"Ultraviolet\">Ultraviolet UVB light</a> (wavelengths between 315\u2013280&#160;nm) from the sun is absorbed by skin cell DNA and results in a type of <a href=\"/wiki/Direct_DNA_damage\" title=\"Direct DNA damage\">direct DNA damage</a> called <a href=\"/wiki/Pyrimidine_dimers\" class=\"mw-redirect\" title=\"Pyrimidine dimers\">cyclobutane pyrimidine dimers (CPDs)</a>. <a href=\"/wiki/Thymine\" title=\"Thymine\">Thymine</a>-thymine, <a href=\"/wiki/Cytosine\" title=\"Cytosine\">cytosine</a>-cytosine or cytosine-thymine <a href=\"/wiki/Protein_dimer\" title=\"Protein dimer\">dimers</a> are formed by the joining of two adjacent <a href=\"/wiki/Pyrimidine\" title=\"Pyrimidine\">pyrimidine</a> bases within a DNA strand. Somewhat similarly to <a href=\"/wiki/UVB\" class=\"mw-redirect\" title=\"UVB\">UVB</a>, <a href=\"/wiki/Ultraviolet\" title=\"Ultraviolet\">UVA light</a> (longer wavelengths between 400\u2013315&#160;nm) from the sun or from tanning beds can also be directly absorbed by skin DNA (at about 100 to 1000 fold lower efficiency than UVB is absorbed).<sup id=\"cite_ref-pmid22005748_16-0\" class=\"reference\"><a href=\"#cite_note-pmid22005748-16\">&#91;16&#93;</a></sup>\n</p><p>Studies suggest that exposure to <a href=\"/wiki/Ultraviolet\" title=\"Ultraviolet\">ultraviolet</a> radiation (UVA<sup id=\"cite_ref-uva_17-0\" class=\"reference\"><a href=\"#cite_note-uva-17\">&#91;17&#93;</a></sup> and UVB) is one of the major contributors to the development of melanoma. Occasional extreme sun exposure (resulting in \"<a href=\"/wiki/Sunburn\" title=\"Sunburn\">sunburn</a>\") is causally related to melanoma.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> Melanoma is most common on the back in men and on legs in women (areas of intermittent sun exposure). The risk appears to be strongly influenced by socio-economic conditions rather than indoor versus outdoor occupations; it is more common in professional and administrative workers than unskilled workers.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> Other factors are <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> in or total loss of <a href=\"/wiki/Tumor_suppressor_gene\" class=\"mw-redirect\" title=\"Tumor suppressor gene\">tumor suppressor genes</a>. Use of <a href=\"/wiki/Sunbed\" class=\"mw-redirect\" title=\"Sunbed\">sunbeds</a> (with deeply penetrating UVA rays) has been linked to the development of skin cancers, including melanoma.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p><p>Possible significant elements in determining risk include the intensity and duration of sun exposure, the age at which sun exposure occurs, and the degree of <a href=\"/wiki/Skin_pigmentation\" class=\"mw-redirect\" title=\"Skin pigmentation\">skin pigmentation</a>. Melanoma rates tend to be highest in countries settled by migrants from <a href=\"/wiki/Northern_Europe\" title=\"Northern Europe\">northern Europe</a> that have a large amount of direct, intense sunlight that the skin of the settlers is not adapted to, most notably Australia. Exposure during childhood is a more important risk factor than exposure in adulthood. This is seen in migration studies in Australia.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p><p>Having multiple severe sunburns increases the likelihood that future sunburns develop into melanoma due to cumulative damage.<sup id=\"cite_ref-Mayo2016_12-1\" class=\"reference\"><a href=\"#cite_note-Mayo2016-12\">&#91;12&#93;</a></sup> The sun and tanning beds are the main sources of UV radiation that increase the risk for melanoma and living close to the equator increases exposure to UV radiation.<sup id=\"cite_ref-Mayo2016_12-2\" class=\"reference\"><a href=\"#cite_note-Mayo2016-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Genetics\">Genetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=4\" title=\"Edit section: Genetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A number of rare mutations, which often run in families, greatly increase melanoma susceptibility. Several <a href=\"/wiki/Genes\" class=\"mw-redirect\" title=\"Genes\">genes</a> increase risks. Some rare genes have a relatively high risk of causing melanoma; some more common genes, such as a gene called <a href=\"/wiki/Melanocortin_1_receptor\" title=\"Melanocortin 1 receptor\">MC1R</a> that causes red hair, have a relatively lower elevated risk. <a href=\"/wiki/Genetic_testing\" title=\"Genetic testing\">Genetic testing</a> can be used to search for the mutations.\n</p><p>One class of mutations affects the gene <a href=\"/wiki/P16_(gene)\" class=\"mw-redirect\" title=\"P16 (gene)\">CDKN2A</a>. An alternative <a href=\"/wiki/Reading_frame\" title=\"Reading frame\">reading frame</a> mutation in this gene leads to the destabilization of <a href=\"/wiki/P53\" title=\"P53\">p53</a>, a <a href=\"/wiki/Transcription_factor\" title=\"Transcription factor\">transcription factor</a> involved in <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a> and in fifty percent of human cancers. Another mutation in the same gene results in a nonfunctional inhibitor of <a href=\"/wiki/CDK4\" class=\"mw-redirect\" title=\"CDK4\">CDK4</a>, a <a href=\"/wiki/Cyclin\" title=\"Cyclin\">cyclin</a>-dependent <a href=\"/wiki/Kinase\" title=\"Kinase\">kinase</a> that promotes <a href=\"/wiki/Cell_division\" title=\"Cell division\">cell division</a>. Mutations that cause the skin condition <a href=\"/wiki/Xeroderma_pigmentosum\" title=\"Xeroderma pigmentosum\">xeroderma pigmentosum</a> (XP) also increase melanoma susceptibility. Scattered throughout the genome, these mutations reduce a cell's ability to repair DNA. Both CDKN2A and XP mutations are highly penetrant (the chances of a carrier to express the phenotype is high).\n</p><p>Familial melanoma is genetically heterogeneous,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> and loci for familial melanoma appear on the <a href=\"/wiki/Chromosome\" title=\"Chromosome\">chromosome</a> arms 1p, 9p and 12q. Multiple genetic events have been related to melanoma's <a href=\"/wiki/Pathogenesis\" title=\"Pathogenesis\">pathogenesis</a> (disease development).<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> The multiple <a href=\"/wiki/Tumor_suppressor_gene\" class=\"mw-redirect\" title=\"Tumor suppressor gene\">tumor suppressor</a> 1 (CDKN2A/MTS1) gene encodes p16INK4a \u2013 a low-<a href=\"/wiki/Molecular_weight\" class=\"mw-redirect\" title=\"Molecular weight\">molecular weight</a> protein inhibitor of <a href=\"/wiki/Cyclin-dependent_kinase\" title=\"Cyclin-dependent kinase\">cyclin-dependent protein kinases</a> (CDKs) \u2013 which has been localised to the p21 region of <a href=\"/wiki/Chromosome_9_(human)\" class=\"mw-redirect\" title=\"Chromosome 9 (human)\">human chromosome 9</a>.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p><p>Other mutations confer lower risk, but are more common in the population. People with mutations in the <a href=\"/wiki/MC1R\" class=\"mw-redirect\" title=\"MC1R\">MC1R</a> gene, for example, are two to four times more likely to develop melanoma than those with two wild-type (typical unaffected type) copies. MC1R mutations are very common; in fact, all red-haired people have a mutated copy. Mutation of the <a href=\"/wiki/MDM2\" class=\"mw-redirect\" title=\"MDM2\">MDM2</a> SNP309 gene is associated with increased risks for younger women.<sup id=\"cite_ref-pmid19318491_26-0\" class=\"reference\"><a href=\"#cite_note-pmid19318491-26\">&#91;26&#93;</a></sup>\n</p><p>Fair- and red-haired people, persons with multiple atypical <a href=\"/wiki/Nevi\" class=\"mw-redirect\" title=\"Nevi\">nevi</a> or <a href=\"/wiki/Dysplastic_nevus\" title=\"Dysplastic nevus\">dysplastic nevi</a> and persons born with giant <a href=\"/wiki/Congenital_melanocytic_nevi\" class=\"mw-redirect\" title=\"Congenital melanocytic nevi\">congenital melanocytic nevi</a> are at increased risk.<sup id=\"cite_ref-IMAGE_27-0\" class=\"reference\"><a href=\"#cite_note-IMAGE-27\">&#91;27&#93;</a></sup>\n</p><p>A family history of melanoma greatly increases a person's risk because mutations in several genes have been found in melanoma-prone families.<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> People with a history of one melanoma are at increased risk of developing a second primary tumor.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup>\n</p><p>Fair skin is the result of having less melanin in the skin, which means there is less protection from UV radiation.<sup id=\"cite_ref-Mayo2016_12-3\" class=\"reference\"><a href=\"#cite_note-Mayo2016-12\">&#91;12&#93;</a></sup> A family history could indicate a genetic predisposition to melanoma.<sup id=\"cite_ref-Mayo2016_12-4\" class=\"reference\"><a href=\"#cite_note-Mayo2016-12\">&#91;12&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Pathophysiology\">Pathophysiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=5\" title=\"Edit section: Pathophysiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg/220px-Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg.png\" width=\"220\" height=\"258\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/37/Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg/330px-Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg/440px-Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg.png 2x\" data-file-width=\"375\" data-file-height=\"440\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Where melanoma is most likely to develop</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/50/Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg/220px-Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg\" width=\"220\" height=\"220\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/50/Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg/330px-Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/50/Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg/440px-Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg 2x\" data-file-width=\"3000\" data-file-height=\"3000\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Molecular basis for melanoma cell motility: actin-rich <a href=\"/wiki/Podosome\" title=\"Podosome\">podosomes</a> (yellow), along with <a href=\"/wiki/Cell_nucleus\" title=\"Cell nucleus\">cell nuclei</a> (blue), actin (red), and an actin regulator (green).</div></div></div>\n<p>The earliest stage of melanoma starts when <a href=\"/wiki/Melanocytes\" class=\"mw-redirect\" title=\"Melanocytes\">melanocytes</a> begin out-of-control growth. Melanocytes are found between the outer layer of the skin (the <a href=\"/wiki/Epidermis_(skin)\" class=\"mw-redirect\" title=\"Epidermis (skin)\">epidermis</a>) and the next layer (the <a href=\"/wiki/Dermis\" title=\"Dermis\">dermis</a>). This early stage of the disease is called the radial growth phase, when the tumor is less than 1&#160;mm thick. Because the cancer cells have not yet reached the blood vessels deeper in the skin, it is very unlikely that this early-stage melanoma will spread to other parts of the body. If the melanoma is detected at this stage, then it can usually be completely removed with surgery.\n</p><p>When the tumor cells start to move in a different direction \u2013 vertically up into the epidermis and into the <a href=\"/wiki/Papillary_dermis\" class=\"mw-redirect\" title=\"Papillary dermis\">papillary dermis</a> \u2013 cell behaviour changes dramatically.<sup id=\"cite_ref-Hershkovitz10_30-0\" class=\"reference\"><a href=\"#cite_note-Hershkovitz10-30\">&#91;30&#93;</a></sup>\n</p><p>The next step in the evolution is the invasive radial growth phase, which is a confusing term; however, it explains the process of the radial growth, in which individual cells start to acquire invasive potential. From this point on the melanoma is capable of spreading. The <a href=\"/wiki/Breslow%27s_depth\" title=\"Breslow&#39;s depth\">Breslow's depth</a> of the lesion is usually less than 1&#160;mm (0.04&#160;<a href=\"/wiki/Inch\" title=\"Inch\">in</a>), while the <a href=\"/wiki/Clark_level\" class=\"mw-redirect\" title=\"Clark level\">Clark level</a> is usually 2.\n</p><p>The vertical growth phase (VGP) following is the invasive melanoma. The tumor becomes able to grow into the surrounding tissue and can spread around the body through blood or <a href=\"/wiki/Lymph_vessels\" class=\"mw-redirect\" title=\"Lymph vessels\">lymph vessels</a>. The tumor thickness is usually more than 1&#160;mm (0.04&#160;<a href=\"/wiki/Inch\" title=\"Inch\">in</a>), and the tumor involves the deeper parts of the dermis.\n</p><p>The host elicits an immunological reaction against the tumor during the VGP,<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> which is judged by the presence and activity of the <a href=\"/wiki/Tumor_infiltrating_lymphocyte\" class=\"mw-redirect\" title=\"Tumor infiltrating lymphocyte\">tumor infiltrating lymphocytes</a> (TILs). These cells sometimes completely destroy the primary tumor; this is called regression, which is the latest stage of development. In certain cases, the primary tumor is completely destroyed and only the metastatic tumor is discovered. About 40% of human melanomas contain activating mutations affecting the structure of the B-Raf <a href=\"/wiki/Protein\" title=\"Protein\">protein</a>, resulting in constitutive signaling through the Raf to <a href=\"/wiki/MAP_kinase\" class=\"mw-redirect\" title=\"MAP kinase\">MAP kinase</a> pathway.<sup id=\"cite_ref-pmid20697348_32-0\" class=\"reference\"><a href=\"#cite_note-pmid20697348-32\">&#91;32&#93;</a></sup>\n</p><p>In general, cancers are caused by damage to <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a>.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> UVA light mainly causes thymine-thymine dimers.<sup id=\"cite_ref-pmid21901217_34-0\" class=\"reference\"><a href=\"#cite_note-pmid21901217-34\">&#91;34&#93;</a></sup>  UVA also produces <a href=\"/wiki/Reactive_oxygen_species\" title=\"Reactive oxygen species\">reactive oxygen species</a> and these inflict other DNA damage, primarily single-strand breaks, oxidized <a href=\"/wiki/Pyrimidines\" class=\"mw-redirect\" title=\"Pyrimidines\">pyrimidines</a> and the oxidized <a href=\"/wiki/Purine\" title=\"Purine\">purine</a> <a href=\"/wiki/8-oxoguanine\" class=\"mw-redirect\" title=\"8-oxoguanine\">8-oxoguanine</a> (a mutagenic DNA change) at 1/10th, 1/10th and 1/3rd the frequencies of UVA-induced thymine-thymine dimers, respectively.\n</p><p>If unrepaired, CPD photoproducts can lead to mutations by inaccurate <a href=\"/wiki/Translesion_synthesis\" class=\"mw-redirect\" title=\"Translesion synthesis\">translesion synthesis</a> during DNA replication or repair. The most frequent mutations due to inaccurate synthesis past CPDs are cytosine to thymine (C&gt;T) or CC&gt;TT <a href=\"/wiki/Transition_(genetics)\" title=\"Transition (genetics)\">transition mutations</a>. These are commonly referred to as UV fingerprint <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a>, as they are the most specific mutation caused by UV, being frequently found in sun-exposed skin but rarely found in internal organs.<sup id=\"cite_ref-pmid23303275_35-0\" class=\"reference\"><a href=\"#cite_note-pmid23303275-35\">&#91;35&#93;</a></sup>  Errors in DNA repair of UV photoproducts, or inaccurate synthesis past these photoproducts, can also lead to deletions, insertions and <a href=\"/wiki/Chromosomal_translocation\" title=\"Chromosomal translocation\">chromosomal translocations</a>.\n</p><p>The entire genomes of 25 melanomas were sequenced.<sup id=\"cite_ref-pmid22622578_36-0\" class=\"reference\"><a href=\"#cite_note-pmid22622578-36\">&#91;36&#93;</a></sup> On average, about 80,000 mutated bases (mostly C&gt;T transitions) and about 100 structural rearragements were found per melanoma genome. This is much higher than the approximately 70 mutations across generations (parent to child).<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup>  Among the 25 melanomas, about 6,000 protein-coding genes had <a href=\"/wiki/Missense_mutation\" title=\"Missense mutation\">missense</a>, <a href=\"/wiki/Nonsense_mutation\" title=\"Nonsense mutation\">nonsense</a> or <a href=\"/wiki/Splice_site_mutation\" title=\"Splice site mutation\">splice site mutations</a>. The transcriptomes of over 100 melanomas has also been sequenced and analyzed. Almost 70% of all human protein coding genes are expressed in melanoma. Most of these genes are also expressed in other normal and cancer tissues, with some 200 genes showing a more specific expression pattern in melanoma compared to other forms of cancer. Examples of melanoma specific genes are <a href=\"/wiki/Tyrosinase\" title=\"Tyrosinase\">tyrosinase</a>, <a href=\"/wiki/MLANA\" title=\"MLANA\">MLANA</a> and <a href=\"/wiki/PMEL_(gene)\" title=\"PMEL (gene)\">PMEL</a>.<sup id=\"cite_ref-proteinatlas.org_39-0\" class=\"reference\"><a href=\"#cite_note-proteinatlas.org-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-Uhlen_eaan2507_40-0\" class=\"reference\"><a href=\"#cite_note-Uhlen_eaan2507-40\">&#91;40&#93;</a></sup>\n</p><p>UV radiation causes <a href=\"/wiki/DNA_damage\" class=\"mw-redirect\" title=\"DNA damage\">damage</a> to the <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> of cells, typically <a href=\"/wiki/Thymine\" title=\"Thymine\">thymine</a> dimerization, which when unrepaired can create <a href=\"/wiki/Mutation\" title=\"Mutation\">mutations</a> in the cell's <a href=\"/wiki/Gene\" title=\"Gene\">genes</a>. When the cell <a href=\"/wiki/Cell_division\" title=\"Cell division\">divides</a>, these mutations are propagated to new generations of cells. If the mutations occur in <a href=\"/wiki/Protooncogene\" class=\"mw-redirect\" title=\"Protooncogene\">protooncogenes</a> or <a href=\"/wiki/Tumor_suppressor_gene\" class=\"mw-redirect\" title=\"Tumor suppressor gene\">tumor suppressor genes</a>, the rate of <a href=\"/wiki/Mitosis\" title=\"Mitosis\">mitosis</a> in the mutation-bearing cells can become uncontrolled, leading to the formation of a <a href=\"/wiki/Tumor\" class=\"mw-redirect\" title=\"Tumor\">tumor</a>. Data from patients suggest that aberrant levels of activating transcription factor in the nucleus of melanoma cells are associated with increased metastatic activity of melanoma cells;<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> studies from mice on skin cancer tend to confirm a role for activating transcription factor-2 in cancer progression.<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup><sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup>\n</p><p><a href=\"/wiki/Cancer_stem_cells\" class=\"mw-redirect\" title=\"Cancer stem cells\">Cancer stem cells</a> may also be involved.<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=6\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/43/Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg/220px-Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg\" width=\"220\" height=\"293\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/43/Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg/330px-Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/43/Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg/440px-Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg 2x\" data-file-width=\"5400\" data-file-height=\"7200\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>ABCD rule illustration: On the left side from top to bottom: melanomas showing (A) Asymmetry, (B) a border that is uneven, ragged, or notched, (C) coloring of different shades of brown, black, or tan and (D) diameter that had changed in size. The normal moles on the right side do not have abnormal characteristics (no asymmetry, even border, even color, no change in diameter).</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Dermatoscope1.JPG\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Dermatoscope1.JPG/220px-Dermatoscope1.JPG\" width=\"220\" height=\"165\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Dermatoscope1.JPG/330px-Dermatoscope1.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e6/Dermatoscope1.JPG/440px-Dermatoscope1.JPG 2x\" data-file-width=\"1024\" data-file-height=\"768\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Dermatoscope1.JPG\" class=\"internal\" title=\"Enlarge\"></a></div>A <a href=\"/wiki/Dermatoscope\" class=\"mw-redirect\" title=\"Dermatoscope\">dermatoscope</a></div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Malignant_melanoma_(1)_at_thigh_Case_01.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6b/Malignant_melanoma_%281%29_at_thigh_Case_01.jpg/220px-Malignant_melanoma_%281%29_at_thigh_Case_01.jpg\" width=\"220\" height=\"166\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/6b/Malignant_melanoma_%281%29_at_thigh_Case_01.jpg/330px-Malignant_melanoma_%281%29_at_thigh_Case_01.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6b/Malignant_melanoma_%281%29_at_thigh_Case_01.jpg/440px-Malignant_melanoma_%281%29_at_thigh_Case_01.jpg 2x\" data-file-width=\"600\" data-file-height=\"452\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Malignant_melanoma_(1)_at_thigh_Case_01.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Melanoma in skin biopsy with <a href=\"/wiki/H%26E_stain\" title=\"H&amp;E stain\">H&amp;E stain</a> \u2013 this case may represent superficial spreading melanoma.</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg/220px-Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg\" width=\"220\" height=\"146\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg/330px-Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg/440px-Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg 2x\" data-file-width=\"12991\" data-file-height=\"8609\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Lymph node with almost complete replacement by metastatic melanoma. The brown pigment is focal deposition of melanin.</div></div></div>\n<p>Visual inspection is the most common diagnostic technique.<sup id=\"cite_ref-ap01_47-0\" class=\"reference\"><a href=\"#cite_note-ap01-47\">&#91;47&#93;</a></sup> Moles that are irregular in color or shape are typically treated as candidates. To detect melanomas (and increase survival rates), it is recommended to learn to recognize them (see \"ABCDE\" mnemonic above), to regularly examine <a href=\"/wiki/Melanocytic_nevus\" title=\"Melanocytic nevus\">moles</a> for changes (shape, size, color, itching or bleeding) and to consult a qualified physician when a candidate appears.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"ABCDE\">ABCDE</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=7\" title=\"Edit section: ABCDE\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A popular method for remembering the signs and symptoms of melanoma is the mnemonic \"ABCDE\":\n</p>\n<ul><li><b>A</b>symmetrical skin lesion.</li>\n<li><b>B</b>order of the lesion is irregular.</li>\n<li><b>C</b>olor: melanomas usually have multiple colors.</li>\n<li><b>D</b>iameter: moles greater than 6&#160;mm are more likely to be melanomas than smaller moles.</li>\n<li><b>E</b>nlarging: Enlarging or evolving</li></ul>\n<p>However, many melanomas present as lesions smaller than 6&#160;mm in diameter; and all melanomas are malignant when they first appear as a small dot. Physicians typically examine all moles, including those less than 6&#160;mm in diameter. <a href=\"/wiki/Seborrheic_keratosis\" title=\"Seborrheic keratosis\">Seborrheic keratosis</a> may meet some or all of the ABCD criteria, and can lead to <a href=\"/wiki/False_alarm\" title=\"False alarm\">false alarms</a>. Doctors can generally distinguish seborrheic keratosis from melanoma upon examination, or with <a href=\"/wiki/Dermatoscopy\" title=\"Dermatoscopy\">dermatoscopy</a>.\n</p><p>Some advocate replacing enlarging with evolution. Certainly moles that change and evolve will be a concern. Alternatively, some practitioners prefer elevation. Elevation can help identify a melanoma, but lack of elevation does not mean that the lesion is not a melanoma. Most melanomas in the US are detected before they become elevated. By the time elevation is visible, they may have progressed to the more dangerous invasive stage.\n</p><p><a href=\"/wiki/Nodular_melanoma\" title=\"Nodular melanoma\">Nodular melanomas</a> do not fulfill these criteria, having their own mnemonic, \"EFG\":\n</p>\n<ul><li><b>E</b>levated: the lesion is raised above the surrounding skin.</li>\n<li><b>F</b>irm: the nodule is solid to the touch.</li>\n<li><b>G</b>rowing: the nodule is increasing in size.</li></ul>\n<h3><span class=\"mw-headline\" id=\"Ugly_duckling\">Ugly duckling</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=8\" title=\"Edit section: Ugly duckling\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A recent and novel method is the \"ugly duckling sign\".<sup id=\"cite_ref-pmid9828892_50-0\" class=\"reference\"><a href=\"#cite_note-pmid9828892-50\">&#91;50&#93;</a></sup>  It is simple, easy to teach, and highly effective. Correlation of common lesion characteristics is made. Lesions that greatly deviate from the common characteristics are labeled an \"Ugly Duckling\", and a further professional exam is required. The \"Little Red Riding Hood\" sign<sup id=\"cite_ref-pmid9828892_50-1\" class=\"reference\"><a href=\"#cite_note-pmid9828892-50\">&#91;50&#93;</a></sup> suggests that individuals with fair skin and light-colored hair might have difficult-to-diagnose <a href=\"/wiki/Amelanotic_melanomas\" class=\"mw-redirect\" title=\"Amelanotic melanomas\">amelanotic melanomas</a>. Extra care is required when examining such individuals, as they might have multiple melanomas and severely <a href=\"/wiki/Dysplastic\" class=\"mw-redirect\" title=\"Dysplastic\">dysplastic</a> <a href=\"/wiki/Nevi\" class=\"mw-redirect\" title=\"Nevi\">nevi</a>. A dermatoscope must be used to detect \"ugly ducklings\", as many melanomas in these individuals resemble non-melanomas or are considered to be \"wolves in sheep's clothing\".<sup id=\"cite_ref-dermnetnz.org_51-0\" class=\"reference\"><a href=\"#cite_note-dermnetnz.org-51\">&#91;51&#93;</a></sup> These fair-skinned individuals often have lightly pigmented or amelanotic melanomas that do not present easy-to-observe color changes and variations. Their borders are often indistinct, complicating visual identification without a dermatoscope.\n</p><p>Amelanotic melanomas and melanomas arising in fair-skinned individuals are very difficult to detect, as they fail to show many of the characteristics in the ABCD rule, break the \"Ugly Duckling\" sign and are hard to distinguish from acne scarring, insect bites, <a href=\"/wiki/Benign_fibrous_histiocytoma\" title=\"Benign fibrous histiocytoma\">dermatofibromas</a>, or <a href=\"/wiki/Lentigo\" title=\"Lentigo\">lentigines</a>.\n</p>\n<h3><span class=\"mw-headline\" id=\"Biopsy\">Biopsy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=9\" title=\"Edit section: Biopsy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Following a visual examination and a dermatoscopic exam,<sup id=\"cite_ref-dermnetnz.org_51-1\" class=\"reference\"><a href=\"#cite_note-dermnetnz.org-51\">&#91;51&#93;</a></sup> or <i><a href=\"/wiki/In_vivo\" title=\"In vivo\">in vivo</a></i> diagnostic tools such as a confocal microscope, the doctor may <a href=\"/wiki/Biopsy\" title=\"Biopsy\">biopsy</a> the suspicious mole. A <a href=\"/wiki/Skin_biopsy\" title=\"Skin biopsy\">skin biopsy</a> performed under <a href=\"/wiki/Local_anesthesia\" title=\"Local anesthesia\">local anesthesia</a> is often required to assist in making or confirming the diagnosis and in defining severity. Elliptical excisional biopsies may remove the tumor, followed by <a href=\"/wiki/Histological\" class=\"mw-redirect\" title=\"Histological\">histological</a> analysis and Breslow scoring. Incisional biopsies such as <a href=\"/wiki/Skin_biopsy#Punch_biopsy\" title=\"Skin biopsy\">punch biopsies</a> are usually contraindicated in suspected melanomas, because of the possibility of sampling error<sup id=\"cite_ref-pmid19155361_52-0\" class=\"reference\"><a href=\"#cite_note-pmid19155361-52\">&#91;52&#93;</a></sup> or local implantation causing misestimation of tumour thickness.<sup id=\"cite_ref-pmid25827527_53-0\" class=\"reference\"><a href=\"#cite_note-pmid25827527-53\">&#91;53&#93;</a></sup><sup id=\"cite_ref-pmid22471244_54-0\" class=\"reference\"><a href=\"#cite_note-pmid22471244-54\">&#91;54&#93;</a></sup> However, fears that such biopsies may increase the risk of metastatic disease seem unfounded.<sup id=\"cite_ref-pmid16307945_55-0\" class=\"reference\"><a href=\"#cite_note-pmid16307945-55\">&#91;55&#93;</a></sup><sup id=\"cite_ref-pmid24665419_56-0\" class=\"reference\"><a href=\"#cite_note-pmid24665419-56\">&#91;56&#93;</a></sup>\n</p><p>Total body photography, which involves photographic documentation of as much body surface as possible, is often used during follow-up for high-risk patients. The technique has been reported to enable early detection and provides a cost-effective approach (with any digital camera), but its efficacy has been questioned due to its inability to detect macroscopic changes.<sup id=\"cite_ref-ap01_47-1\" class=\"reference\"><a href=\"#cite_note-ap01-47\">&#91;47&#93;</a></sup> The diagnosis method should be used in conjunction with (and not as a replacement for) dermoscopic imaging, with a combination of both methods appearing to give extremely high rates of detection.\n</p>\n<h3><span class=\"mw-headline\" id=\"Classification\">Classification</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=10\" title=\"Edit section: Classification\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Anal_Melanoma.JPG\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Anal_Melanoma.JPG/220px-Anal_Melanoma.JPG\" width=\"220\" height=\"146\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Anal_Melanoma.JPG/330px-Anal_Melanoma.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Anal_Melanoma.JPG/440px-Anal_Melanoma.JPG 2x\" data-file-width=\"3008\" data-file-height=\"2000\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Anal_Melanoma.JPG\" class=\"internal\" title=\"Enlarge\"></a></div>An anal melanoma</div></div></div>\n<p>Melanoma is divided into the following types:<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\n</p>\n<ul><li><a href=\"/wiki/Lentigo_maligna\" title=\"Lentigo maligna\">Lentigo maligna</a></li>\n<li><a href=\"/wiki/Lentigo_maligna_melanoma\" title=\"Lentigo maligna melanoma\">Lentigo maligna melanoma</a></li>\n<li><a href=\"/wiki/Superficial_spreading_melanoma\" title=\"Superficial spreading melanoma\">Superficial spreading melanoma</a></li>\n<li><a href=\"/wiki/Acral_lentiginous_melanoma\" title=\"Acral lentiginous melanoma\">Acral lentiginous melanoma</a></li>\n<li><a href=\"/wiki/Mucosal_melanoma\" title=\"Mucosal melanoma\">Mucosal melanoma</a></li>\n<li><a href=\"/wiki/Nodular_melanoma\" title=\"Nodular melanoma\">Nodular melanoma</a></li>\n<li><a href=\"/wiki/Polypoid_melanoma\" title=\"Polypoid melanoma\">Polypoid melanoma</a></li>\n<li><a href=\"/wiki/Desmoplastic_melanoma\" title=\"Desmoplastic melanoma\">Desmoplastic melanoma</a></li></ul>\n<p>See also:<sup id=\"cite_ref-Bolognia_58-0\" class=\"reference\"><a href=\"#cite_note-Bolognia-58\">&#91;58&#93;</a></sup>\n</p>\n<ul><li><a href=\"/wiki/Melanoma_with_small_nevus-like_cells\" class=\"mw-redirect\" title=\"Melanoma with small nevus-like cells\">Melanoma with small nevus-like cells</a></li>\n<li><a href=\"/wiki/Melanoma_with_features_of_a_Spitz_nevus\" title=\"Melanoma with features of a Spitz nevus\">Melanoma with features of a Spitz nevus</a></li>\n<li><a href=\"/wiki/Uveal_melanoma\" title=\"Uveal melanoma\">Uveal melanoma</a></li>\n<li><a href=\"/wiki/Vaginal_melanoma\" title=\"Vaginal melanoma\">Vaginal melanoma</a></li></ul>\n<h3><span class=\"mw-headline\" id=\"Laboratory\">Laboratory</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=11\" title=\"Edit section: Laboratory\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Lactate_dehydrogenase\" title=\"Lactate dehydrogenase\">Lactate dehydrogenase</a> (LDH) tests are often used to screen for <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastases</a>, although many patients with metastases (even end-stage) have a normal LDH; extraordinarily high LDH often indicates metastatic spread of the disease to the liver.\n</p><p>It is common for patients diagnosed with melanoma to have chest X-rays and an LDH test, and in some cases <a href=\"/wiki/Computed_tomography\" class=\"mw-redirect\" title=\"Computed tomography\">CT</a>, <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a>, <a href=\"/wiki/Positron_emission_tomography\" title=\"Positron emission tomography\">PET</a> and/or PET/CT scans. Although controversial, <a href=\"/wiki/Sentinel_lymph_node\" title=\"Sentinel lymph node\">sentinel lymph node</a> biopsies and examination of the <a href=\"/wiki/Lymph_node\" title=\"Lymph node\">lymph nodes</a> are also performed in patients to assess spread to the lymph nodes. A diagnosis of melanoma is supported by the presence of the <a href=\"/wiki/S-100_protein\" class=\"mw-redirect\" title=\"S-100 protein\">S-100 protein</a> marker.\n</p><p><a href=\"/wiki/HMB-45\" title=\"HMB-45\">HMB-45</a> is a monoclonal antibody that reacts against an antigen present in melanocytic tumors such as melanomas. It is used in anatomic pathology as a marker for such tumors.  The antibody was generated to an extract of melanoma. It reacts positively against melanocytic tumors but not other tumors, thus demonstrating specificity and sensitivity. The antibody also reacts positively against junctional nevus cells but not intradermal nevi, and against fetal melanocytes but not normal adult melanocytes.\n</p><p>HMB-45 is nonreactive with almost all non-melanoma human malignancies, with the exception of rare tumors showing evidence of melanogenesis (e.g., pigmented schwannoma, clear cell sarcoma) or tumors associated with tuberous sclerosis complex (angiomyolipoma and lymphangiomyoma).\n</p>\n<h3><span class=\"mw-headline\" id=\"Staging\">Staging</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=12\" title=\"Edit section: Staging\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><i>Further context on <a href=\"/wiki/Cancer_staging\" title=\"Cancer staging\">cancer staging</a> is available at <a href=\"/wiki/TNM_staging_system\" title=\"TNM staging system\">TNM</a>.</i>\n</p><p>Also of importance are the \"<a href=\"/wiki/Clark_level\" class=\"mw-redirect\" title=\"Clark level\">Clark level</a>\" and \"<a href=\"/wiki/Breslow%27s_depth\" title=\"Breslow&#39;s depth\">Breslow's depth</a>\", which refer to the microscopic depth of tumor invasion.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup>\n</p><p>Melanoma stages:<sup id=\"cite_ref-AJCC_60-0\" class=\"reference\"><a href=\"#cite_note-AJCC-60\">&#91;60&#93;</a></sup>\n5 year survival rates:\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg/220px-Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg.png\" width=\"220\" height=\"127\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg/330px-Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg/440px-Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg.png 2x\" data-file-width=\"375\" data-file-height=\"217\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg\" class=\"internal\" title=\"Enlarge\"></a></div>T stages of melanoma</div></div></div>\n<p><b>Stage 0</b>: Melanoma <i>in situ</i> (Clark Level I), 99.9% survival\n</p><p><b>Stage I / II</b>: Invasive melanoma, 89\u201395% survival\n</p>\n<ul><li>T1a: Less than 1.0&#160;mm primary tumor thickness, without ulceration, and mitosis &lt; 1/mm2</li>\n<li>T1b: Less than 1.0&#160;mm primary tumor thickness, with ulceration or mitoses \u2265 1/mm2</li>\n<li>T2a: 1.01\u20132.0&#160;mm primary tumor thickness, without ulceration</li></ul>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Malignes_Melanom.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Malignes_Melanom.jpg/220px-Malignes_Melanom.jpg\" width=\"220\" height=\"221\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Malignes_Melanom.jpg/330px-Malignes_Melanom.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Malignes_Melanom.jpg/440px-Malignes_Melanom.jpg 2x\" data-file-width=\"806\" data-file-height=\"808\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Malignes_Melanom.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>F18-FDG PET/CT in a melanoma patient showing multiple lesions, most likely metastases</div></div></div>\n<p><b>Stage II</b>: High risk melanoma, 45\u201379% survival\n</p>\n<ul><li>T2b: 1.01\u20132.0&#160;mm primary tumor thickness, with ulceration</li>\n<li>T3a: 2.01\u20134.0&#160;mm primary tumor thickness, without ulceration</li>\n<li>T3b: 2.01\u20134.0&#160;mm primary tumor thickness, with ulceration</li>\n<li>T4a: Greater than 4.0&#160;mm primary tumor thickness, without ulceration</li>\n<li>T4b: Greater than 4.0&#160;mm primary tumor thickness, with ulceration</li></ul>\n<p><b>Stage III</b>: Regional metastasis, 24\u201370% survival\n</p>\n<ul><li>N1: Single positive lymph node</li>\n<li>N2: Two to three positive lymph nodes <i>or</i> regional skin/in-transit metastasis</li>\n<li>N3: Four positive lymph nodes <i>or</i> one lymph node and regional skin/in-transit metastases</li></ul>\n<p><b>Stage IV</b>: Distant metastasis, 7\u201319% survival\n</p>\n<ul><li>M1a: Distant skin metastasis, normal <a href=\"/wiki/Lactate_dehydrogenase\" title=\"Lactate dehydrogenase\">LDH</a></li>\n<li>M1b: Lung metastasis, normal LDH</li>\n<li>M1c: Other distant metastasis <i>or</i> any distant metastasis with elevated LDH</li></ul>\n<p><i>Based upon AJCC five-year survival from initial melanoma diagnosis with proper treatment.</i>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevention\">Prevention</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=13\" title=\"Edit section: Prevention\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Avoiding_ultraviolet_radiation\">Avoiding ultraviolet radiation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=14\" title=\"Edit section: Avoiding ultraviolet radiation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Minimizing exposure to sources of ultraviolet radiation (the sun and sunbeds),<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup> following sun protection measures and wearing <a href=\"/wiki/Sun_protective_clothing\" title=\"Sun protective clothing\">sun protective clothing</a> (long-sleeved shirts, long trousers, and broad-brimmed hats) can offer protection.\n</p><p>Using artificial light for tanning was once believed to help prevent skin cancers, but it can actually lead to an increased incidence of melanomas.<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup>\n</p><p>The body uses UV light to generate <a href=\"/wiki/Vitamin_D\" title=\"Vitamin D\">vitamin D</a> so there is a need to balance getting enough sunlight to maintain healthy vitamin D levels and reducing the risk of melanoma; it takes around a half hour of sunlight for the body to generate its vitamin D for the day and this is about the same amount of time it takes for fair-skinned people to get a sunburn.  Exposure to sunlight can be intermittent instead of all at one time.<sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Sunscreen\">Sunscreen</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=15\" title=\"Edit section: Sunscreen\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Sunscreen\" title=\"Sunscreen\">Sunscreen</a> appears to be effective in preventing melanoma.<sup id=\"cite_ref-WCR2014_2-14\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-SunM_64-0\" class=\"reference\"><a href=\"#cite_note-SunM-64\">&#91;64&#93;</a></sup> In the past, use of sunscreens with a sun protection factor (SPF) rating of 50 or higher on exposed areas were recommended; as older sunscreens more effectively blocked UVA with higher SPF.<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup> Currently, newer sunscreen ingredients (<a href=\"/wiki/Avobenzone\" title=\"Avobenzone\">avobenzone</a>, <a href=\"/wiki/Zinc_oxide\" title=\"Zinc oxide\">zinc oxide</a>, and <a href=\"/wiki/Titanium_dioxide\" title=\"Titanium dioxide\">titanium dioxide</a>) effectively block both UVA and UVB even at lower SPFs. Sunscreen also protects against <a href=\"/wiki/Squamous_cell_carcinoma\" title=\"Squamous cell carcinoma\">squamous cell carcinoma</a>, another skin cancer.<sup id=\"cite_ref-SunS_66-0\" class=\"reference\"><a href=\"#cite_note-SunS-66\">&#91;66&#93;</a></sup>\n</p><p>Concerns have been raised that sunscreen might create a false sense of security against sun damage.<sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Medications\">Medications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=16\" title=\"Edit section: Medications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A 2005 review found tentative evidence that <a href=\"/wiki/Statin\" title=\"Statin\">statin</a> and <a href=\"/wiki/Fibrate\" title=\"Fibrate\">fibrate</a> medication may decrease the risk of melanoma.<sup id=\"cite_ref-Dell2005_68-0\" class=\"reference\"><a href=\"#cite_note-Dell2005-68\">&#91;68&#93;</a></sup> A 2006 review however did not support any benefit.<sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=17\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Malignant_melanoma_on_chest.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Malignant_melanoma_on_chest.jpg/220px-Malignant_melanoma_on_chest.jpg\" width=\"220\" height=\"184\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Malignant_melanoma_on_chest.jpg/330px-Malignant_melanoma_on_chest.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Malignant_melanoma_on_chest.jpg/440px-Malignant_melanoma_on_chest.jpg 2x\" data-file-width=\"700\" data-file-height=\"587\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Malignant_melanoma_on_chest.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Extensive malignant melanoma on a person's chest</div></div></div>\n<p>Confirmation of the clinical diagnosis is done with a <a href=\"/wiki/Skin_biopsy\" title=\"Skin biopsy\">skin biopsy</a>. This is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a <a href=\"/wiki/Sentinel_lymph_node\" title=\"Sentinel lymph node\">sentinel lymph node</a> biopsy may be performed. Controversy exists around trial evidence for sentinel lymph node biopsy;<sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup> with unclear evidence of benefit as of 2015.<sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup> Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.\n</p>\n<h3><span class=\"mw-headline\" id=\"Surgery\">Surgery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=18\" title=\"Edit section: Surgery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Excisional biopsies may remove the tumor, but further surgery is often necessary to reduce the risk of recurrence. Complete surgical excision with adequate <a href=\"/wiki/Surgical_margin\" class=\"mw-redirect\" title=\"Surgical margin\">surgical margins</a> and assessment for the presence of detectable metastatic disease along with short- and long-term followup is standard. Often this is done by a <a href=\"/wiki/Wide_local_excision\" title=\"Wide local excision\">wide local excision</a> (WLE) with 1\u20132&#160;cm (0.4\u20130.8&#160;in) margins. Melanoma-in-situ and lentigo malignas are treated with narrower surgical margins, usually 0.2\u20130.5&#160;cm (0.1\u20130.2&#160;in). Many surgeons consider 0.5&#160;cm (0.2&#160;in) the standard of care for standard excision of melanoma-in-situ,<sup id=\"cite_ref-72\" class=\"reference\"><a href=\"#cite_note-72\">&#91;72&#93;</a></sup> but 0.2&#160;cm (0.1&#160;in) margin might be acceptable for margin controlled surgery (<a href=\"/wiki/Mohs_surgery\" title=\"Mohs surgery\">Mohs surgery</a>, or the double-bladed technique with margin control). The wide excision aims to reduce the rate of tumor recurrence at the site of the original lesion. This is a common pattern of treatment failure in melanoma. Considerable research has aimed to elucidate appropriate margins for excision with a general trend toward less aggressive treatment during the last decades.<sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup> A 2009 meta-analysis of randomized controlled trials found a small difference in survival rates favoring wide excision of primary cutaneous melanomas, but these results were not statistically significant.<sup id=\"cite_ref-74\" class=\"reference\"><a href=\"#cite_note-74\">&#91;74&#93;</a></sup>\n</p><p>Mohs surgery has been reported with cure rate as low as 77%<sup id=\"cite_ref-Mikhail91_75-0\" class=\"reference\"><a href=\"#cite_note-Mikhail91-75\">&#91;75&#93;</a></sup> and as high as 98.0% for melanoma-in-situ.<sup id=\"cite_ref-Bene08_76-0\" class=\"reference\"><a href=\"#cite_note-Bene08-76\">&#91;76&#93;</a></sup>  <a href=\"/wiki/CCPDMA\" class=\"mw-redirect\" title=\"CCPDMA\">CCPDMA</a> and the \"double scalpel\" peripheral margin controlled surgery is equivalent to Mohs surgery in effectiveness on this \"intra-epithelial\" type of melanoma.\n</p><p>Melanomas that spread usually do so to the <a href=\"/wiki/Lymph_nodes\" class=\"mw-redirect\" title=\"Lymph nodes\">lymph nodes</a> in the area of the tumor before spreading elsewhere. Attempts to improve survival by removing lymph nodes surgically (<a href=\"/wiki/Lymphadenectomy\" title=\"Lymphadenectomy\">lymphadenectomy</a>) were associated with many complications, but no overall survival benefit. Recently, the technique of <a href=\"/wiki/Sentinel_lymph_node\" title=\"Sentinel lymph node\">sentinel lymph node</a> biopsy has been developed to reduce the complications of lymph node surgery while allowing assessment of the involvement of nodes with tumor.<sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;77&#93;</a></sup>\n</p><p>Biopsy of sentinel lymph nodes is a widely used procedure when treating cutaneous melanoma.<sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup><sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup>\n</p><p>Neither sentinel lymph node biopsy nor other diagnostic tests should be performed to evaluate early, thin melanoma, including melanoma in situ, T1a melanoma or T1b melanoma \u2264 0.5mm.<sup id=\"cite_ref-AADfive_80-0\" class=\"reference\"><a href=\"#cite_note-AADfive-80\">&#91;80&#93;</a></sup> People with these conditions are unlikely to have the cancer spread to their lymph nodes or anywhere else and already have a 97% 5-year survival rate.<sup id=\"cite_ref-AADfive_80-1\" class=\"reference\"><a href=\"#cite_note-AADfive-80\">&#91;80&#93;</a></sup> Because of these things, sentinel lymph node biopsy is <a href=\"/wiki/Unnecessary_health_care\" title=\"Unnecessary health care\">unnecessary health care</a> for them.<sup id=\"cite_ref-AADfive_80-2\" class=\"reference\"><a href=\"#cite_note-AADfive-80\">&#91;80&#93;</a></sup> Furthermore, baseline blood tests and radiographic studies should not be performed only based on identifying this kind of melanoma, as there are more accurate tests for detecting cancer and these tests have high false-positive rates.<sup id=\"cite_ref-AADfive_80-3\" class=\"reference\"><a href=\"#cite_note-AADfive-80\">&#91;80&#93;</a></sup> To potentially correct false positives, gene expression profiling may be used as auxiliary testing for ambiguous and small lesions.<sup id=\"cite_ref-:0_81-0\" class=\"reference\"><a href=\"#cite_note-:0-81\">&#91;81&#93;</a></sup><sup id=\"cite_ref-Brunner13_82-0\" class=\"reference\"><a href=\"#cite_note-Brunner13-82\">&#91;82&#93;</a></sup>\n</p><p>Sentinel lymph node biopsy is often performed, especially for T1b/T2+ tumors, mucosal tumors, ocular melanoma and tumors of the limbs.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (May 2013)\">citation needed</span></a></i>&#93;</sup> A process called <a href=\"/wiki/Lymphoscintigraphy\" class=\"mw-redirect\" title=\"Lymphoscintigraphy\">lymphoscintigraphy</a> is performed in which a radioactive tracer is injected at the tumor site to localize the sentinel node(s). Further precision is provided using a blue tracer <a href=\"/wiki/Dye\" title=\"Dye\">dye</a>, and surgery is performed to biopsy the node(s). Routine <a href=\"/wiki/H%26E_stain\" title=\"H&amp;E stain\">hematoxylin and eosin</a> (H&amp;E) and <a href=\"/wiki/Immunoperoxidase\" title=\"Immunoperoxidase\">immunoperoxidase</a> staining will be adequate to rule out node involvement. <a href=\"/wiki/Polymerase_chain_reaction\" title=\"Polymerase chain reaction\">Polymerase chain reaction</a> (PCR) tests on nodes, usually performed to test for entry into clinical trials, now demonstrate that many patients with a negative sentinel lymph node actually had a small number of positive cells in their nodes. Alternatively, a <a href=\"/wiki/Fine-needle_aspiration\" title=\"Fine-needle aspiration\">fine-needle aspiration</a> biopsy may be performed and is often used to test masses.\n</p><p>If a lymph node is positive, depending on the extent of lymph node spread, a radical lymph node dissection will often be performed. If the disease is completely resected, the patient will be considered for adjuvant therapy.\nExcisional <a href=\"/wiki/Skin_biopsy\" title=\"Skin biopsy\">skin biopsy</a> is the management of choice. Here, the suspect lesion is totally removed with an adequate (but minimal, usually 1 or 2&#160;mm) ellipse of surrounding skin and tissue.<sup id=\"cite_ref-83\" class=\"reference\"><a href=\"#cite_note-83\">&#91;83&#93;</a></sup>  To avoid disruption of the local lymphatic drainage, the preferred surgical margin for the initial biopsy should be narrow (1&#160;mm). The biopsy should include the epidermal, dermal, and subcutaneous layers of the skin. This enables the <a href=\"/wiki/Pathology\" title=\"Pathology\">histopathologist</a> to determine the thickness of the melanoma by microscopic examination. This is described by <a href=\"/wiki/Breslow%27s_thickness\" class=\"mw-redirect\" title=\"Breslow&#39;s thickness\">Breslow's thickness</a> (measured in millimeters). However, for large lesions, such as suspected lentigo maligna, or for lesions in surgically difficult areas (face, toes, fingers, eyelids), a small punch biopsy in representative areas will give adequate information and will not disrupt the final staging or depth determination. In no circumstances should the initial biopsy include the final surgical margin (0.5&#160;cm, 1.0&#160;cm, or 2&#160;cm), as a misdiagnosis can result in excessive scarring and <a href=\"/wiki/Morbidity\" class=\"mw-redirect\" title=\"Morbidity\">morbidity</a> from the procedure. A large initial excision will disrupt the local lymphatic drainage and can affect further lymphangiogram-directed lymphnode dissection. A small punch biopsy can be used at any time where for logistical and personal reasons a patient refuses more invasive excisional biopsy. Small punch biopsies are minimally invasive and heal quickly, usually without noticeable scarring.\n</p>\n<h3><span class=\"mw-headline\" id=\"Add_on_treatment\">Add on treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=19\" title=\"Edit section: Add on treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>High-risk melanomas may require <a href=\"/wiki/Adjuvant_therapy\" title=\"Adjuvant therapy\">adjuvant</a> treatment, although attitudes to this vary in different countries. In the United States, most patients in otherwise good health will begin up to a year of high-dose <a href=\"/wiki/Interferon\" title=\"Interferon\">interferon</a> treatment, which has severe side effects, but may improve the patient's prognosis slightly.<sup id=\"cite_ref-84\" class=\"reference\"><a href=\"#cite_note-84\">&#91;84&#93;</a></sup> However, the <a href=\"/wiki/British_Association_of_Dermatologists\" title=\"British Association of Dermatologists\">British Association of Dermatologists</a> guidelines on melanoma state that interferon is not recommended as a standard adjuvant treatment for melanoma.<sup id=\"cite_ref-Dermatologists&#39;_Management_Guidelines_85-0\" class=\"reference\"><a href=\"#cite_note-Dermatologists&#39;_Management_Guidelines-85\">&#91;85&#93;</a></sup> A 2013 meta-analysis suggested that the addition of interferon alpha increased disease-free and overall survival for people with AJCC TNM stage II-III cutaneous melanoma.<sup id=\"cite_ref-86\" class=\"reference\"><a href=\"#cite_note-86\">&#91;86&#93;</a></sup> A 2011 meta-analysis showed that interferon could lengthen the time before a melanoma comes back but increased survival by only 3% at 5 years. The unpleasant side effects also greatly decrease quality of life.<sup id=\"cite_ref-87\" class=\"reference\"><a href=\"#cite_note-87\">&#91;87&#93;</a></sup>\n</p><p>In Europe, interferon is usually not used outside the scope of clinical trials.<sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;88&#93;</a></sup><sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;89&#93;</a></sup>\n</p><p>Metastatic melanomas can be detected by X-rays, CT scans, MRIs, PET and PET/CTs, ultrasound, LDH testing and photoacoustic detection.<sup id=\"cite_ref-90\" class=\"reference\"><a href=\"#cite_note-90\">&#91;90&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Chemotherapy_and_immunotherapy\">Chemotherapy and immunotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=20\" title=\"Edit section: Chemotherapy and immunotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Various <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> agents, including <a href=\"/wiki/Temozolomide\" title=\"Temozolomide\">temozolomide</a>, <a href=\"/wiki/Dacarbazine\" title=\"Dacarbazine\">dacarbazine</a> (also termed DTIC), <a href=\"/wiki/Cancer_immunotherapy\" title=\"Cancer immunotherapy\">immunotherapy</a> (with <a href=\"/wiki/Interleukin-2\" class=\"mw-redirect\" title=\"Interleukin-2\">interleukin-2</a> (IL-2) or <a href=\"/wiki/Interferon\" title=\"Interferon\">interferon</a> (IFN)), as well as local perfusion, are used by different centers. The overall success in metastatic melanoma is quite limited.<sup id=\"cite_ref-91\" class=\"reference\"><a href=\"#cite_note-91\">&#91;91&#93;</a></sup>\n</p><p>IL-2 (<a href=\"/wiki/Proleukin\" class=\"mw-redirect\" title=\"Proleukin\">Proleukin</a>) was the first new therapy approved (1990 Europe, 1992 USA) for the treatment of metastatic melanoma in 20 years. Studies have demonstrated that IL-2 offers the possibility of a complete and long-lasting remission in this disease, although only in a small percentage of patients.<sup id=\"cite_ref-92\" class=\"reference\"><a href=\"#cite_note-92\">&#91;92&#93;</a></sup> Intralesional IL-2 for in-transit metastases has a high complete response rate ranging from 40 to 100%.<sup id=\"cite_ref-Current_Future_Melanoma_93-0\" class=\"reference\"><a href=\"#cite_note-Current_Future_Melanoma-93\">&#91;93&#93;</a></sup>\n</p><p>By 2005 a number of new agents and novel approaches were under evaluation and showed promise.<sup id=\"cite_ref-94\" class=\"reference\"><a href=\"#cite_note-94\">&#91;94&#93;</a></sup> In 2009 Clinical trial participation was considered the standard of care for metastatic melanoma.<sup id=\"cite_ref-95\" class=\"reference\"><a href=\"#cite_note-95\">&#91;95&#93;</a></sup>\n</p><p>Therapies for metastatic melanoma include biologic immunotherapy agents <a href=\"/wiki/Ipilimumab\" title=\"Ipilimumab\">ipilimumab</a>, <a href=\"/wiki/Pembrolizumab\" title=\"Pembrolizumab\">pembrolizumab</a>, and <a href=\"/wiki/Nivolumab\" title=\"Nivolumab\">nivolumab</a>;<sup id=\"cite_ref-Syn2017_9-1\" class=\"reference\"><a href=\"#cite_note-Syn2017-9\">&#91;9&#93;</a></sup> <a href=\"/wiki/BRAF_inhibitor\" class=\"mw-redirect\" title=\"BRAF inhibitor\">BRAF inhibitors</a>, such as <a href=\"/wiki/Vemurafenib\" title=\"Vemurafenib\">vemurafenib</a> and <a href=\"/wiki/Dabrafenib\" title=\"Dabrafenib\">dabrafenib</a>; and a <a href=\"/wiki/MEK_inhibitor\" title=\"MEK inhibitor\">MEK inhibitor</a> <a href=\"/wiki/Trametinib\" title=\"Trametinib\">trametinib</a>.<sup id=\"cite_ref-Current_Future_Melanoma_93-1\" class=\"reference\"><a href=\"#cite_note-Current_Future_Melanoma-93\">&#91;93&#93;</a></sup>\n</p><p>A number of treatments improve survival over traditional chemotherapy.<sup id=\"cite_ref-Pas2018_96-0\" class=\"reference\"><a href=\"#cite_note-Pas2018-96\">&#91;96&#93;</a></sup> Biochemotherapy (chemotherapy with cytokines IL-2 and IFN-\u03b1) combined with BRAF inhibitors improved survival for people with BRAF positive melanoma.<sup id=\"cite_ref-Pas2018_96-1\" class=\"reference\"><a href=\"#cite_note-Pas2018-96\">&#91;96&#93;</a></sup> Biochemotherapy alone did not improve overall survival and had higher toxicity than chemotherapy.<sup id=\"cite_ref-Pas2018_96-2\" class=\"reference\"><a href=\"#cite_note-Pas2018-96\">&#91;96&#93;</a></sup> Combining multiple chemotherapy agents (polychemotherapy) did not improve survival over monochemotherapy.<sup id=\"cite_ref-Pas2018_96-3\" class=\"reference\"><a href=\"#cite_note-Pas2018-96\">&#91;96&#93;</a></sup>\n</p><p>Anti-PD1 antibodies were found to be more effective than anti-CTLA4 antibodies with less systemic toxicity. However, the combination of anti-CTLA4 with anti-PD1 antibodies, or of BRAF inhibitors with MEK inhibitors, were found to increase overall survival more than each of these treatments alone.<sup id=\"cite_ref-Pas2018_96-4\" class=\"reference\"><a href=\"#cite_note-Pas2018-96\">&#91;96&#93;</a></sup>\n</p><p>Ongoing research is looking at treatment by <a href=\"/wiki/Adoptive_cell_transfer\" title=\"Adoptive cell transfer\">adoptive cell transfer</a>.<sup id=\"cite_ref-97\" class=\"reference\"><a href=\"#cite_note-97\">&#91;97&#93;</a></sup> For this purpose, application of prestimulated or modified <a href=\"/wiki/T_cells\" class=\"mw-redirect\" title=\"T cells\">T cells</a><sup id=\"cite_ref-98\" class=\"reference\"><a href=\"#cite_note-98\">&#91;98&#93;</a></sup> or <a href=\"/wiki/Dendritic_cells\" class=\"mw-redirect\" title=\"Dendritic cells\">dendritic cells</a> is possible.<sup id=\"cite_ref-99\" class=\"reference\"><a href=\"#cite_note-99\">&#91;99&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Lentigo_maligna\">Lentigo maligna</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=21\" title=\"Edit section: Lentigo maligna\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Standard excision is still being done by most surgeons. Unfortunately, the recurrence rate is exceedingly high (up to 50%). This is due to the ill-defined visible surgical margin, and the facial location of the lesions (often forcing the surgeon to use a narrow surgical margin). The narrow surgical margin used, combined with the limitation of the standard \"bread-loafing\" technique of fixed tissue histology \u2013 result in a high \"false negative\" error rate, and frequent recurrences. Margin control (peripheral margins) is necessary to eliminate the false negative errors. If <a href=\"/wiki/Bread_loafing\" title=\"Bread loafing\">bread loafing</a> is used, distances from sections should approach 0.1&#160;mm to assure that the method approaches complete margin control. A meta-analysis of the literature in 2014 found no randomized controlled trials of surgical interventions to treat lentigo maligna or melanoma in-situ, even though surgery is the most widely used treatment.<sup id=\"cite_ref-:1_100-0\" class=\"reference\"><a href=\"#cite_note-:1-100\">&#91;100&#93;</a></sup>\n</p><p><a href=\"/wiki/Mohs_surgery\" title=\"Mohs surgery\">Mohs surgery</a> has been done with cure rate reported to be as low as 77%,<sup id=\"cite_ref-Mikhail91_75-1\" class=\"reference\"><a href=\"#cite_note-Mikhail91-75\">&#91;75&#93;</a></sup> and as high as 95% by another author.<sup id=\"cite_ref-Bene08_76-1\" class=\"reference\"><a href=\"#cite_note-Bene08-76\">&#91;76&#93;</a></sup> The \"double scalpel\" peripheral margin controlled excision method approximates the Mohs method in margin control, but requires a pathologist intimately familiar with the complexity of managing the vertical margin on the thin peripheral sections and staining methods.<sup id=\"cite_ref-101\" class=\"reference\"><a href=\"#cite_note-101\">&#91;101&#93;</a></sup>\n</p><p>Some melanocytic nevi, and melanoma-in-situ (<a href=\"/wiki/Lentigo_maligna\" title=\"Lentigo maligna\">lentigo maligna</a>) have resolved with an experimental treatment,  <a href=\"/wiki/Imiquimod\" title=\"Imiquimod\">imiquimod</a> (Aldara) topical cream, an immune enhancing agent. Some dermasurgeons are combining the 2 methods: surgically excising the cancer and then treating the area with Aldara cream postoperatively for three months. While some studies have suggested the adjuvant use of topical tazarotene, the current evidence is insufficient to recommend it and suggests that it increases topical inflammation, leading to lower patient compliance.<sup id=\"cite_ref-:1_100-1\" class=\"reference\"><a href=\"#cite_note-:1-100\">&#91;100&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Radiation_therapy\">Radiation therapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=22\" title=\"Edit section: Radiation therapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Radiation_therapy\" title=\"Radiation therapy\">Radiation therapy</a> is often used after surgical resection for patients with locally or regionally advanced melanoma or for patients with unresectable distant metastases. Kilovoltage x-ray beams are often used for these treatments and have the property of the maximum radiation dose occurring close to the skin surface.<sup id=\"cite_ref-102\" class=\"reference\"><a href=\"#cite_note-102\">&#91;102&#93;</a></sup> It may reduce the rate of local recurrence but does not prolong survival.<sup id=\"cite_ref-103\" class=\"reference\"><a href=\"#cite_note-103\">&#91;103&#93;</a></sup> <a href=\"/wiki/Radioimmunotherapy\" title=\"Radioimmunotherapy\">Radioimmunotherapy</a> of metastatic melanoma is currently under investigation.\nRadiotherapy has a role in the palliation of metastatic melanoma.<sup id=\"cite_ref-104\" class=\"reference\"><a href=\"#cite_note-104\">&#91;104&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=23\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg/220px-Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg.png\" width=\"220\" height=\"254\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg/330px-Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg/440px-Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg.png 2x\" data-file-width=\"375\" data-file-height=\"433\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg\" class=\"internal\" title=\"Enlarge\"></a></div>A diagram showing the most common sites for melanoma to spread</div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:292px;\"><a href=\"/wiki/File:5YearSurvival2008to14.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/5YearSurvival2008to14.jpg/290px-5YearSurvival2008to14.jpg\" width=\"290\" height=\"194\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/e/ed/5YearSurvival2008to14.jpg 1.5x\" data-file-width=\"391\" data-file-height=\"261\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:5YearSurvival2008to14.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>5 year relative survival by stage at diagnosis for melanoma of the skin in the United States as of 2014</div></div></div>\n<p>Features that affect <a href=\"/wiki/Prognosis\" title=\"Prognosis\">prognosis</a> are <a href=\"/wiki/Tumor\" class=\"mw-redirect\" title=\"Tumor\">tumor</a> thickness in millimeters (<a href=\"/wiki/Breslow%27s_depth\" title=\"Breslow&#39;s depth\">Breslow's depth</a>), depth related to skin structures (<a href=\"/wiki/Clark_level\" class=\"mw-redirect\" title=\"Clark level\">Clark level</a>), type of melanoma, presence of ulceration, presence of lymphatic/<a href=\"/wiki/Perineural_invasion\" title=\"Perineural invasion\">perineural invasion</a>, presence of tumor-infiltrating <a href=\"/wiki/Lymphocyte\" title=\"Lymphocyte\">lymphocytes</a> (if present, prognosis is better), location of lesion, presence of satellite lesions, and presence of regional or distant <a href=\"/wiki/Metastasis\" title=\"Metastasis\">metastasis</a>.<sup id=\"cite_ref-105\" class=\"reference\"><a href=\"#cite_note-105\">&#91;105&#93;</a></sup> Certain types of melanoma have worse prognoses but this is explained by their <a href=\"/wiki/Breslow%27s_depth\" title=\"Breslow&#39;s depth\">thickness</a>. Less invasive melanomas even with lymph node metastases carry a better prognosis than deep melanomas without regional metastasis at time of staging. Local recurrences tend to behave similarly to a primary unless they are at the site of a <a href=\"/wiki/Wide_local_excision\" title=\"Wide local excision\">wide local excision</a> (as opposed to a staged excision or punch/shave excision) since these recurrences tend to indicate lymphatic invasion.\n</p><p>When melanomas have spread to the <a href=\"/wiki/Lymph_node\" title=\"Lymph node\">lymph nodes</a>, one of the most important factors is the number of nodes with malignancy. Extent of malignancy within a node is also important; micrometastases in which malignancy is only microscopic have a more favorable prognosis than macrometastases. In some cases micrometastases may only be detected by special staining, and if malignancy is only detectable by a rarely employed test known as the <a href=\"/wiki/Polymerase_chain_reaction\" title=\"Polymerase chain reaction\">polymerase chain reaction</a> (PCR), the prognosis is better. Macrometastases in which malignancy is clinically apparent (in some cases cancer completely replaces a node) have a far worse prognosis, and if nodes are matted or if there is extracapsular extension, the prognosis is worse still. In addition to these variables, expression levels and copy number variations of a number of relevant genes may be used to support assessment of malignant melanoma prognosis.<sup id=\"cite_ref-:0_81-1\" class=\"reference\"><a href=\"#cite_note-:0-81\">&#91;81&#93;</a></sup><sup id=\"cite_ref-Brunner13_82-1\" class=\"reference\"><a href=\"#cite_note-Brunner13-82\">&#91;82&#93;</a></sup>\n</p><p>When there is distant metastasis, the cancer is generally considered incurable. The five-year survival rate is less than 10%.<sup id=\"cite_ref-AJCC_60-1\" class=\"reference\"><a href=\"#cite_note-AJCC-60\">&#91;60&#93;</a></sup> The median survival is 6\u201312 months. Treatment is <a href=\"/wiki/Palliative_care\" title=\"Palliative care\">palliative</a>, focusing on life extension and <a href=\"/wiki/Quality_of_life\" title=\"Quality of life\">quality of life</a>. In some cases, patients may live many months or even years with metastatic melanoma (depending on the aggressiveness of the treatment). Metastases to skin and lungs have a better prognosis. Metastases to brain, bone and liver are associated with a worse prognosis. Survival is better with metastasis in which the location of the primary tumor is unknown.<sup id=\"cite_ref-106\" class=\"reference\"><a href=\"#cite_note-106\">&#91;106&#93;</a></sup>\n</p><p>There is not enough definitive evidence to adequately stage, and thus give a prognosis for, ocular melanoma and melanoma of soft parts, or mucosal melanoma (e.g. rectal melanoma), although these tend to metastasize more easily. Even though regression may increase survival, when a melanoma has regressed, it is impossible to know its original size and thus the original tumor is often worse than a <a href=\"/wiki/Pathology\" title=\"Pathology\">pathology report</a> might indicate.\n</p><p>About 200 genes are prognostic in melanoma, with both unfavorable genes where high expression is correlated to poor survival and favorable genes where high expression is associated with longer survival times. Examples of unfavorable genes are <a href=\"/wiki/MCM6\" title=\"MCM6\">MCM6</a> and <a href=\"/wiki/Timeless_(gene)\" title=\"Timeless (gene)\">TIMELESS</a> and an example of a favorable gene is <a href=\"/wiki/WIPI1\" title=\"WIPI1\">WIPI1</a>.<sup id=\"cite_ref-proteinatlas.org_39-1\" class=\"reference\"><a href=\"#cite_note-proteinatlas.org-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-Uhlen_eaan2507_40-1\" class=\"reference\"><a href=\"#cite_note-Uhlen_eaan2507-40\">&#91;40&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=24\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:292px;\"><a href=\"/wiki/File:Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg/290px-Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg.png\" width=\"290\" height=\"128\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg/435px-Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f4/Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg/580px-Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg.png 2x\" data-file-width=\"940\" data-file-height=\"415\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg\" class=\"internal\" title=\"Enlarge\"></a></div><a href=\"/wiki/Age_adjustment\" title=\"Age adjustment\">Age-standardized</a> <a href=\"/wiki/Incidence_(epidemiology)\" title=\"Incidence (epidemiology)\">new cases per year</a> of melanoma of the skin per 100,000 inhabitants in 2008.<sup id=\"cite_ref-107\" class=\"reference\"><a href=\"#cite_note-107\">&#91;107&#93;</a></sup><style data-mw-deduplicate=\"TemplateStyles:r853264625\">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class=\"refbegin columns references-column-count references-column-count-2\" style=\"-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;\"> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;no data</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;less than 1.75</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;1.76\u20133.50</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;3.51\u20135.25</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;5.26\u20137.00</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;7.01\u20138.75</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;8.76\u201310.50</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;10.51\u201312.25</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;12.26\u201314.00</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;14.01\u201315.75</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;15.76\u201317.50</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;17.76\u201319.25</div> <div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;more than 19.25</div> </div></div></div></div>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:292px;\"><a href=\"/wiki/File:Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg/290px-Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg.png\" width=\"290\" height=\"128\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg/435px-Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/69/Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg/580px-Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg.png 2x\" data-file-width=\"940\" data-file-height=\"415\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Deaths from melanoma and other skin cancers per million persons in 2012 <link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r853264625\"/><div class=\"refbegin columns references-column-count references-column-count-3\" style=\"-moz-column-count: 3; -webkit-column-count: 3; column-count: 3;\"><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff20; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;0\u20132</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffe820; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;3\u20135</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffd820; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;6-6</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc020; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;7\u20138</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffa020; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;9-9</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a20; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;10\u201313</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #f08015; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;14\u201318</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #e06815; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;19\u201337</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d85010; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;38\u201351</div><div class=\"legend\" style=\"-webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column\"><span class=\"legend-color\" style=\"display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d02010; color:black; font-size:100%; text-align:center;\">&#160;</span>&#160;52\u2013114</div></div></div></div></div>\n<p>Globally, in 2012, melanoma occurred in 232,000 people and resulted in 55,000 deaths.<sup id=\"cite_ref-WCR2014_2-15\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> Australia and New Zealand have the highest rates of melanoma in the world.<sup id=\"cite_ref-WCR2014_2-16\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup> It has become more common in the last 20 years in areas that are mostly <a href=\"/wiki/White_people\" title=\"White people\">Caucasian</a>.<sup id=\"cite_ref-WCR2014_2-17\" class=\"reference\"><a href=\"#cite_note-WCR2014-2\">&#91;2&#93;</a></sup>\n</p><p>The rate of melanoma has increased in the recent years, but it is not clear to what extent changes in behavior, in the environment, or in early detection are involved.<sup id=\"cite_ref-108\" class=\"reference\"><a href=\"#cite_note-108\">&#91;108&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Australia\">Australia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=25\" title=\"Edit section: Australia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Australia\" title=\"Australia\">Australia</a> has a very high \u2013 and increasing \u2013 rate of melanoma. In 2012, deaths from melanoma occurred in 7.3\u20139.8 per 100,000 population. In Australia, melanoma is the third most common cancer in either sex; indeed, its incidence is higher than for <a href=\"/wiki/Lung_cancer\" title=\"Lung cancer\">lung cancer</a>, although the latter accounts for more deaths. It is estimated that in 2012, more than 12,000 Australians were diagnosed with melanoma: given Australia's modest population, this is better expressed as 59.6 new cases per 100,000 population per year; &gt;1 in 10 of all new cancer cases were melanomas.<sup id=\"cite_ref-aihw2012_109-0\" class=\"reference\"><a href=\"#cite_note-aihw2012-109\">&#91;109&#93;</a></sup>  Melanoma incidence in Australia is matter of significance, for the following reasons: \n</p>\n<ul><li>Australian melanoma incidence has increased by more than 30 per cent between 1991 and 2009.</li>\n<li>Australian melanoma age-standardised incidence rates were, as of 2008, at least 12 times higher than the world average.</li>\n<li>Australian melanoma incidence is, by some margin, the highest in the world.</li>\n<li>Overall age-standardised cancer incidence in Australia is the highest in the world, and this is attributable to melanoma alone. Age-standardised overall cancer incidence is similar to New Zealand, but there is a statistically-significant difference between Australia and all other parts of the developed world including North America, Western Europe, and the Mediterranean.</li></ul>\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=26\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In the United States about 9,000 people die from melanoma a year.<sup id=\"cite_ref-Vital2015_110-0\" class=\"reference\"><a href=\"#cite_note-Vital2015-110\">&#91;110&#93;</a></sup> In 2011 it affected 19.7 per 100,000, and resulted in death in 2.7 per 100,000.<sup id=\"cite_ref-Vital2015_110-1\" class=\"reference\"><a href=\"#cite_note-Vital2015-110\">&#91;110&#93;</a></sup>\n</p><p>In 2013:\n</p>\n<ul><li>71,943 people in the United States were diagnosed with melanomas of the skin, including 42,430 men and 29,513 women.</li>\n<li>9,394 people in the United States died from melanomas of the skin, including 6,239 men and 3,155 women.<sup id=\"cite_ref-111\" class=\"reference\"><a href=\"#cite_note-111\">&#91;111&#93;</a></sup></li></ul>\n<p>The American Cancer Society\u2019s estimates for melanoma incidence in the United States for 2017 are:\n</p>\n<ul><li>About 87,110 new melanomas will be diagnosed (about 52,170 in men and 34,940 in women).</li>\n<li>About 9,730 people are expected to die of melanoma (about 6,380 men and 3,350 women).</li></ul>\n<p>Melanoma is more than 20 times more common in whites than in African Americans. Overall, the lifetime risk of getting melanoma is about 2.5% (1 in 40) for whites, 0.1% (1 in 1,000) for African Americans, and 0.5% (1 in 200) for Hispanics.\n</p><p>The risk of melanoma increases as people age. The average age of people when the disease is diagnosed is 63.<sup id=\"cite_ref-112\" class=\"reference\"><a href=\"#cite_note-112\">&#91;112&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=27\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/Timeline_of_melanoma\" title=\"Timeline of melanoma\">Timeline of melanoma</a></div>\n<p>Although melanoma is not a new disease, evidence for its occurrence in antiquity is rather scarce. However, one example lies in a 1960s examination of nine <a href=\"/wiki/Peru\" title=\"Peru\">Peruvian</a> mummies, <a href=\"/wiki/Radiocarbon\" class=\"mw-redirect\" title=\"Radiocarbon\">radiocarbon</a> dated to be approximately 2400 years old, which showed apparent signs of melanoma: melanotic masses in the skin and diffuse metastases to the bones.<sup id=\"cite_ref-urteaga_113-0\" class=\"reference\"><a href=\"#cite_note-urteaga-113\">&#91;113&#93;</a></sup>\n</p><p><a href=\"/wiki/John_Hunter_(surgeon)\" title=\"John Hunter (surgeon)\">John Hunter</a> is reported to be the first to operate on metastatic melanoma in 1787. Although not knowing precisely what it was, he described it as a \"cancerous fungous excrescence\". The excised tumor was preserved in the <a href=\"/wiki/Hunterian_and_Wellcome_Museums\" class=\"mw-redirect\" title=\"Hunterian and Wellcome Museums\">Hunterian Museum</a> of the <a href=\"/wiki/Royal_College_of_Surgeons_of_England\" title=\"Royal College of Surgeons of England\">Royal College of Surgeons of England</a>. It was not until 1968 that microscopic examination of the specimen revealed it to be an example of metastatic melanoma.<sup id=\"cite_ref-bodenham_114-0\" class=\"reference\"><a href=\"#cite_note-bodenham-114\">&#91;114&#93;</a></sup>\n</p><p>The French physician <a href=\"/wiki/Ren%C3%A9_Laennec\" title=\"Ren\u00e9 Laennec\">Ren\u00e9 Laennec</a> was the first to describe melanoma as a disease entity. His report was initially presented during a lecture for the Facult\u00e9 de M\u00e9decine de Paris in 1804 and then published as a bulletin in 1806.<sup id=\"cite_ref-laennec_115-0\" class=\"reference\"><a href=\"#cite_note-laennec-115\">&#91;115&#93;</a></sup>\nThe first English language report of melanoma was presented by an English general practitioner from Stourbridge, William Norris in 1820.<sup id=\"cite_ref-norris1_116-0\" class=\"reference\"><a href=\"#cite_note-norris1-116\">&#91;116&#93;</a></sup>  In his later work in 1857 he remarked that there is a familial predisposition for development of melanoma (<i>Eight Cases of <a href=\"/wiki/Melanosis\" title=\"Melanosis\">Melanosis</a> with Pathological and Therapeutical Remarks on That Disease</i>). Norris was also a pioneer in suggesting a link between nevi and melanoma and the possibility of a relationship between melanoma and environmental exposures, by observing that most of his patients had pale complexions.<sup id=\"cite_ref-117\" class=\"reference\"><a href=\"#cite_note-117\">&#91;117&#93;</a></sup> He also described that melanomas could be amelanotic and later showed the metastatic nature of melanoma by observing that they can disseminate to other visceral organs.\n</p><p>The first formal acknowledgment of advanced melanoma as untreatable came from <a href=\"/wiki/Samuel_Cooper_(surgeon)\" title=\"Samuel Cooper (surgeon)\">Samuel Cooper</a> in 1840. He stated that the only chance for a cure depends upon the early removal of the disease (i.e., early excision of the malignant mole) ...'<sup id=\"cite_ref-cooper_118-0\" class=\"reference\"><a href=\"#cite_note-cooper-118\">&#91;118&#93;</a></sup>\n</p><p>More than one and a half centuries later this situation remains largely unchanged.\n</p>\n<h3><span class=\"mw-headline\" id=\"Terminology\">Terminology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=28\" title=\"Edit section: Terminology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The word <i>melanoma</i> came to English from 19th-century <a href=\"/wiki/New_Latin\" title=\"New Latin\">New Latin</a><sup id=\"cite_ref-MW_Collegiate_119-0\" class=\"reference\"><a href=\"#cite_note-MW_Collegiate-119\">&#91;119&#93;</a></sup> and uses <a href=\"/wiki/Classical_compound\" title=\"Classical compound\">combining forms</a> derived from <a href=\"/wiki/Ancient_Greek\" title=\"Ancient Greek\">ancient Greek</a> roots: <i><a href=\"https://en.wiktionary.org/wiki/melano-#Prefix\" class=\"extiw\" title=\"wikt:melano-\">melano-</a></i> (denoting <a href=\"/wiki/Melanin\" title=\"Melanin\">melanin</a>) + <i><a href=\"https://en.wiktionary.org/wiki/-oma#Suffix\" class=\"extiw\" title=\"wikt:-oma\">-oma</a></i> (denoting a tissue mass and especially a <a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">neoplasm</a>), in turn from <a href=\"/wiki/Greek_language\" title=\"Greek language\">Greek</a> <a href=\"https://en.wiktionary.org/wiki/%CE%BC%CE%AD%CE%BB%CE%B1%CF%82\" class=\"extiw\" title=\"wikt:\u03bc\u03ad\u03bb\u03b1\u03c2\">\u03bc\u03ad\u03bb\u03b1\u03c2</a> <i>melas</i>, \"dark\",<sup id=\"cite_ref-120\" class=\"reference\"><a href=\"#cite_note-120\">&#91;120&#93;</a></sup> and <a href=\"https://en.wiktionary.org/wiki/-%CF%89%CE%BC%CE%B1\" class=\"extiw\" title=\"wikt:-\u03c9\u03bc\u03b1\">-\u03c9\u03bc\u03b1</a> <i>oma</i>, \"process\". The word <i>melanoma</i> has a long history of being used  <a href=\"/wiki/Word_sense\" title=\"Word sense\">in a broader sense</a> to refer to any <a href=\"/wiki/Melanocytic_tumor\" title=\"Melanocytic tumor\">melanocytic tumor</a>, benign or malignant but usually malignant,<sup id=\"cite_ref-Dorlands_121-0\" class=\"reference\"><a href=\"#cite_note-Dorlands-121\">&#91;121&#93;</a></sup><sup id=\"cite_ref-AHD_122-0\" class=\"reference\"><a href=\"#cite_note-AHD-122\">&#91;122&#93;</a></sup> but today the narrower sense referring only to malignant types has become so dominant that benign tumors are usually not called melanomas anymore and the word <i>melanoma</i> is now usually taken to mean malignant melanoma unless otherwise specified. Terms such as \"benign <a href=\"/wiki/Melanocytic_tumor\" title=\"Melanocytic tumor\">melanocytic tumor</a>\" unequivocally label the benign types, and modern histopathologic tumor classifications used in medicine do not use the word for benign tumors.\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=29\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Pharmacotherapy research for unresectable or metastatic malignant melanoma is ongoing.<sup id=\"cite_ref-melanoma2012_123-0\" class=\"reference\"><a href=\"#cite_note-melanoma2012-123\">&#91;123&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Targeted_therapies\">Targeted therapies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=30\" title=\"Edit section: Targeted therapies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In clinical research setting other therapies, such as adoptive cell therapy or <a href=\"/wiki/Gene_therapy\" title=\"Gene therapy\">gene therapy</a>, are being tested.<sup id=\"cite_ref-124\" class=\"reference\"><a href=\"#cite_note-124\">&#91;124&#93;</a></sup>\n</p><p>Two kinds of experimental treatments developed at the <a href=\"/wiki/National_Cancer_Institute\" title=\"National Cancer Institute\">National Cancer Institute</a> (NCI), have been used in metastatic melanoma with tentative success.<sup id=\"cite_ref-Hershkovitz10_30-1\" class=\"reference\"><a href=\"#cite_note-Hershkovitz10-30\">&#91;30&#93;</a></sup>\n</p><p>The first treatment involves adoptive cell therapy (ACT) using TILs immune cells (tumor infiltrating lymphocytes) isolated from a person's own melanoma tumor.<sup id=\"cite_ref-Current_Future_Melanoma_93-2\" class=\"reference\"><a href=\"#cite_note-Current_Future_Melanoma-93\">&#91;93&#93;</a></sup> These cells are grown in large numbers in a laboratory and returned to the patient after a treatment that temporarily reduces normal T cells in the patient's body. TIL therapy following lymphodepletion can result in durable complete response in a variety of setups.<sup id=\"cite_ref-125\" class=\"reference\"><a href=\"#cite_note-125\">&#91;125&#93;</a></sup><sup id=\"cite_ref-Besser10_126-0\" class=\"reference\"><a href=\"#cite_note-Besser10-126\">&#91;126&#93;</a></sup>\n</p><p>The second treatment, adoptive transfer of genetically altered autologous lymphocytes, depends on delivering genes that encode so called <a href=\"/wiki/T_cell_receptor\" class=\"mw-redirect\" title=\"T cell receptor\">T cell receptors</a> (TCRs), into patient's lymphocytes.<sup id=\"cite_ref-Current_Future_Melanoma_93-3\" class=\"reference\"><a href=\"#cite_note-Current_Future_Melanoma-93\">&#91;93&#93;</a></sup> After that manipulation lymphocytes recognize and bind to certain molecules found on the surface of melanoma cells and kill them.<sup id=\"cite_ref-nih_127-0\" class=\"reference\"><a href=\"#cite_note-nih-127\">&#91;127&#93;</a></sup>\n</p><p>A <a href=\"/wiki/Cancer_vaccine\" title=\"Cancer vaccine\">cancer vaccine</a> showed modest benefit in late-stage testing in 2009 against melanoma.<sup id=\"cite_ref-128\" class=\"reference\"><a href=\"#cite_note-128\">&#91;128&#93;</a></sup><sup id=\"cite_ref-129\" class=\"reference\"><a href=\"#cite_note-129\">&#91;129&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"BRAF_inhibitors\">BRAF inhibitors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=31\" title=\"Edit section: BRAF inhibitors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>About 60% of melanomas contain a mutation in the <a href=\"/wiki/BRAF_(gene)\" title=\"BRAF (gene)\">B-Raf gene</a>. Early clinical trials suggested that B-Raf inhibitors including Plexxicon's <a href=\"/wiki/Vemurafenib\" title=\"Vemurafenib\">vemurafenib</a> could lead to substantial tumor regression in a majority of patients if their tumor contain the B-Raf mutation.<sup id=\"cite_ref-130\" class=\"reference\"><a href=\"#cite_note-130\">&#91;130&#93;</a></sup>  In June 2011, a large <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trial</a> confirmed the positive findings from those earlier trials.<sup id=\"cite_ref-studies_131-0\" class=\"reference\"><a href=\"#cite_note-studies-131\">&#91;131&#93;</a></sup><sup id=\"cite_ref-pmid21639808_132-0\" class=\"reference\"><a href=\"#cite_note-pmid21639808-132\">&#91;132&#93;</a></sup>\n</p><p>In August 2011 Vemurafenib received FDA approval for the treatment of late-stage melanoma. In May 2013 the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">US FDA</a> approved dabrafenib as a single agent treatment for patients with BRAF V600E mutation-positive advanced melanoma.<sup id=\"cite_ref-r20150530_133-0\" class=\"reference\"><a href=\"#cite_note-r20150530-133\">&#91;133&#93;</a></sup>\n</p><p>Some researchers believe that combination therapies that simultaneously block multiple pathways may improve efficacy by making it more difficult for the tumor cells to mutate before being destroyed. In October 2012 a study reported that combining Dabrafenib with a <a href=\"/wiki/MEK_inhibitor\" title=\"MEK inhibitor\">MEK inhibitor</a> <a href=\"/wiki/Trametinib\" title=\"Trametinib\">trametinib</a> led to even better outcomes. Compared to Dabrafenib alone, progression-free survival was increased to 41% from 9%, and the median <a href=\"/wiki/Progression-free_survival\" title=\"Progression-free survival\">progression-free survival</a> increased to 9.4 months versus 5.8 months. Some side effects were, however, increased in the combined study.\n<sup id=\"cite_ref-134\" class=\"reference\"><a href=\"#cite_note-134\">&#91;134&#93;</a></sup><sup id=\"cite_ref-pmid23020132_135-0\" class=\"reference\"><a href=\"#cite_note-pmid23020132-135\">&#91;135&#93;</a></sup>\n</p><p>In January 2014, the FDA approved the combination of dabrafenib and trametinib for the treatment of patients with BRAF V600E/K-mutant metastatic melanoma.<sup id=\"cite_ref-136\" class=\"reference\"><a href=\"#cite_note-136\">&#91;136&#93;</a></sup>\n</p><p>Eventual resistance to BRAF and MEK inhibitors may be due to a cell surface protein known as <a href=\"/wiki/EPH_receptor_A2\" title=\"EPH receptor A2\">EphA2</a> which is now being investigated.<sup id=\"cite_ref-137\" class=\"reference\"><a href=\"#cite_note-137\">&#91;137&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Ipilimumab\">Ipilimumab</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=32\" title=\"Edit section: Ipilimumab\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>At the <a href=\"/wiki/American_Society_of_Clinical_Oncology\" title=\"American Society of Clinical Oncology\">American Society of Clinical Oncology</a> Conference in June 2010, the <a href=\"/wiki/Bristol-Myers_Squibb\" title=\"Bristol-Myers Squibb\">Bristol-Myers Squibb</a> pharmaceutical company reported the clinical findings of their drug <a href=\"/wiki/Ipilimumab\" title=\"Ipilimumab\">ipilimumab</a>. The study found an increase in median survival from 6.4 to 10 months in patients with advanced melanomas treated with the monoclonal ipilimumab, versus an experimental vaccine. It also found a one-year survival rate of 25% in the control group using the vaccine, 44% in the vaccine and ipilimumab group, and 46% in the group treated with ipilimumab alone.<sup id=\"cite_ref-138\" class=\"reference\"><a href=\"#cite_note-138\">&#91;138&#93;</a></sup> However, some have raised concerns about this study for its use of the unconventional control arm, rather than comparing the drug against a placebo or standard treatment.<sup id=\"cite_ref-139\" class=\"reference\"><a href=\"#cite_note-139\">&#91;139&#93;</a></sup><sup id=\"cite_ref-140\" class=\"reference\"><a href=\"#cite_note-140\">&#91;140&#93;</a></sup> The criticism was that although Ipilimumab performed better than the vaccine, the vaccine has not been tested before and may be causing toxicity, making the drug appear better by comparison.\n</p><p>Ipilimumab was approved by the FDA in March 2011 to treat patients with late-stage melanoma that has spread or cannot be removed by surgery.<sup id=\"cite_ref-141\" class=\"reference\"><a href=\"#cite_note-141\">&#91;141&#93;</a></sup><sup id=\"cite_ref-142\" class=\"reference\"><a href=\"#cite_note-142\">&#91;142&#93;</a></sup><sup id=\"cite_ref-Drugs.com_143-0\" class=\"reference\"><a href=\"#cite_note-Drugs.com-143\">&#91;143&#93;</a></sup>\n</p><p>In June 2011, a clinical trial of ipilimumab plus <a href=\"/wiki/Dacarbazine\" title=\"Dacarbazine\">dacarbazine</a> combined this immune system booster with the standard chemotherapy drug that targets cell division. It showed an increase in median survival for these late stage patients to 11 months instead of the 9 months normally seen. Researchers were also hopeful that perhaps 10\u201320% of patients could live a long time. Some serious side-effects of revving up the immune system were seen in some patients. A course of treatment costs $120,000. The drug's brandname is Yervoy.<sup id=\"cite_ref-studies_131-1\" class=\"reference\"><a href=\"#cite_note-studies-131\">&#91;131&#93;</a></sup><sup id=\"cite_ref-144\" class=\"reference\"><a href=\"#cite_note-144\">&#91;144&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Surveillance_methods\">Surveillance methods</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=33\" title=\"Edit section: Surveillance methods\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Advances in high resolution ultrasound scanning have enabled surveillance of metastatic burden to the sentinel lymph nodes.<sup id=\"cite_ref-145\" class=\"reference\"><a href=\"#cite_note-145\">&#91;145&#93;</a></sup> The Screening and Surveillance of Ultrasound in Melanoma trial (SUNMEL) is evaluating ultrasound as an alternative to invasive surgical methods.<sup id=\"cite_ref-146\" class=\"reference\"><a href=\"#cite_note-146\">&#91;146&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Oncolytic_virotherapy\">Oncolytic virotherapy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=34\" title=\"Edit section: Oncolytic virotherapy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In some countries oncolytic virotherapy methods are studied and used to treat melanoma. Oncolytic virotherapy is a promising branch of <a href=\"/wiki/Virotherapy\" title=\"Virotherapy\">virotherapy</a>, where <a href=\"/wiki/Oncolytic_viruses\" class=\"mw-redirect\" title=\"Oncolytic viruses\">oncolytic viruses</a> are used to treat diseases; viruses can increase metabolism, reduce anti-tumor immunity and disorganize vasculature.<sup id=\"cite_ref-147\" class=\"reference\"><a href=\"#cite_note-147\">&#91;147&#93;</a></sup> Talimogene laherparepvec (T-VEC) (which is a herpes simplex virus type 1\u2013derived oncolytic immunotherapy), was shown to be useful against metastatic melanoma in 2015 with an increased survival of 4.4 months.<sup id=\"cite_ref-148\" class=\"reference\"><a href=\"#cite_note-148\">&#91;148&#93;</a></sup><sup id=\"cite_ref-Syn2017_9-2\" class=\"reference\"><a href=\"#cite_note-Syn2017-9\">&#91;9&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=35\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-NCI2015-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NCI2015_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-NCI2015_1-12\"><sup><i><b>m</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq\">\"Melanoma Treatment\u2013for health professionals (PDQ\u00ae)\"</a>. <i>National Cancer Institute</i>. June 26, 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150704213842/http://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq\">Archived</a> from the original on 4 July 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">30 June</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=Melanoma+Treatment%E2%80%93for+health+professionals+%28PDQ%C2%AE%29&amp;rft.date=2015-06-26&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Ftypes%2Fskin%2Fhp%2Fmelanoma-treatment-pdq&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-WCR2014-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-WCR2014_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-WCR2014_2-17\"><sup><i><b>r</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf\"><i>World Cancer Report 2014</i></a> <span style=\"font-size:85%;\">(PDF)</span>. World Health Organization. 2014. pp.&#160;Chapter 5.14. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-9283204299\" title=\"Special:BookSources/978-9283204299\">978-9283204299</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140530232406/http://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf\">Archived</a> <span style=\"font-size:85%;\">(PDF)</span> from the original on 2014-05-30.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=World+Cancer+Report+2014&amp;rft.pages=Chapter+5.14&amp;rft.pub=World+Health+Organization&amp;rft.date=2014&amp;rft.isbn=978-9283204299&amp;rft_id=https%3A%2F%2Fwww.iarc.fr%2Fen%2Fpublications%2Fpdfs-online%2Fwcr%2F2003%2FWorldCancerReport.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Goldstein, BG; Goldstein, AO (1 April 2001). \"Diagnosis and management of malignant melanoma\". <i>American Family Physician</i>. <b>63</b> (7): 1359\u201368, 1374. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11310650\">11310650</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Family+Physician&amp;rft.atitle=Diagnosis+and+management+of+malignant+melanoma&amp;rft.volume=63&amp;rft.issue=7&amp;rft.pages=1359-68%2C+1374&amp;rft.date=2001-04-01&amp;rft_id=info%3Apmid%2F11310650&amp;rft.aulast=Goldstein&amp;rft.aufirst=BG&amp;rft.au=Goldstein%2C+AO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SEER2015-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SEER2015_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SEER2015_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://seer.cancer.gov/statfacts/html/melan.html\">\"SEER Stat Fact Sheets: Melanoma of the Skin\"</a>. <i>NCI</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140706134347/http://seer.cancer.gov/statfacts/html/melan.html\">Archived</a> from the original on 2014-07-06.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NCI&amp;rft.atitle=SEER+Stat+Fact+Sheets%3A+Melanoma+of+the+Skin&amp;rft_id=http%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fmelan.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-GBD2015Pre-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GBD2015Pre_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GBD2015Pre_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577\">\"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015\"</a>. <i>Lancet</i>. <b>388</b> (10053): 1545\u20131602. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2816%2931678-6\">10.1016/S0140-6736(16)31678-6</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577\">5055577</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27733282\">27733282</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Global%2C+regional%2C+and+national+incidence%2C+prevalence%2C+and+years+lived+with+disability+for+310+diseases+and+injuries%2C+1990%E2%80%932015%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2015&amp;rft.volume=388&amp;rft.issue=10053&amp;rft.pages=1545-1602&amp;rft.date=2016-10-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5055577&amp;rft_id=info%3Apmid%2F27733282&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2816%2931678-6&amp;rft.aulast=GBD+2015+Disease+and+Injury+Incidence+and+Prevalence&amp;rft.aufirst=Collaborators.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5055577&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-GBD2015De-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GBD2015De_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GBD2015De_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903\">\"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015\"</a>. <i>Lancet</i>. <b>388</b> (10053): 1459\u20131544. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s0140-6736%2816%2931012-1\">10.1016/s0140-6736(16)31012-1</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903\">5388903</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27733281\">27733281</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Global%2C+regional%2C+and+national+life+expectancy%2C+all-cause+mortality%2C+and+cause-specific+mortality+for+249+causes+of+death%2C+1980%E2%80%932015%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2015&amp;rft.volume=388&amp;rft.issue=10053&amp;rft.pages=1459-1544&amp;rft.date=2016-10-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5388903&amp;rft_id=info%3Apmid%2F27733281&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2816%2931012-1&amp;rft.aulast=GBD+2015+Mortality+and+Causes+of+Death&amp;rft.aufirst=Collaborators.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5388903&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kanavy HE, Gerstenblith MR (December 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S1085-5629(11)00130-1\">\"Ultraviolet radiation and melanoma\"</a>. <i>Semin Cutan Med Surg</i>. <b>30</b> (4): 222\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.sder.2011.08.003\">10.1016/j.sder.2011.08.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22123420\">22123420</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Cutan+Med+Surg&amp;rft.atitle=Ultraviolet+radiation+and+melanoma&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=222-28&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.sder.2011.08.003&amp;rft_id=info%3Apmid%2F22123420&amp;rft.aulast=Kanavy&amp;rft.aufirst=HE&amp;rft.au=Gerstenblith%2C+MR&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1085-5629%2811%2900130-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Az2014-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Az2014_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Az2014_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Az2014_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Azoury, SC; Lange, JR (October 2014). \"Epidemiology, risk factors, prevention, and early detection of melanoma\". <i>The Surgical Clinics of North America</i>. <b>94</b> (5): vii, 945\u201362. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.suc.2014.07.013\">10.1016/j.suc.2014.07.013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25245960\">25245960</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Surgical+Clinics+of+North+America&amp;rft.atitle=Epidemiology%2C+risk+factors%2C+prevention%2C+and+early+detection+of+melanoma&amp;rft.volume=94&amp;rft.issue=5&amp;rft.pages=vii%2C+945-62&amp;rft.date=2014-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.suc.2014.07.013&amp;rft_id=info%3Apmid%2F25245960&amp;rft.aulast=Azoury&amp;rft.aufirst=SC&amp;rft.au=Lange%2C+JR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Syn2017-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Syn2017_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Syn2017_9-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Syn2017_9-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Syn, Nicholas L; Teng, Michele W L; Mok, Tony S K; Soo, Ross A (2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S1470204517306071\">\"De-novo and acquired resistance to immune checkpoint targeting\"</a>. <i>The Lancet Oncology</i>. <b>18</b> (12): e731\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/s1470-2045%2817%2930607-1\">10.1016/s1470-2045(17)30607-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29208439\">29208439</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.atitle=De-novo+and+acquired+resistance+to+immune+checkpoint+targeting&amp;rft.volume=18&amp;rft.issue=12&amp;rft.pages=e731-41&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2Fs1470-2045%2817%2930607-1&amp;rft_id=info%3Apmid%2F29208439&amp;rft.aulast=Syn&amp;rft.aufirst=Nicholas+L&amp;rft.au=Teng%2C+Michele+W+L&amp;rft.au=Mok%2C+Tony+S+K&amp;rft.au=Soo%2C+Ross+A&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1470204517306071&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150801214405/http://melanomawarningsigns.com/\">\"MelanomaWarningSigns.com\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.melanomawarningsigns.com/\">the original</a> on 2015-08-01.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MelanomaWarningSigns.com&amp;rft_id=http%3A%2F%2Fwww.melanomawarningsigns.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fiddler IJ (October 1995). \"Melanoma metastasis\". <i>Cancer Control</i>. <b>2</b> (5): 398\u2013404. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/107327489500200503\">10.1177/107327489500200503</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10862180\">10862180</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Control&amp;rft.atitle=Melanoma+metastasis&amp;rft.volume=2&amp;rft.issue=5&amp;rft.pages=398-404&amp;rft.date=1995-10&amp;rft_id=info%3Adoi%2F10.1177%2F107327489500200503&amp;rft_id=info%3Apmid%2F10862180&amp;rft.au=Fiddler+IJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mayo2016-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mayo2016_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mayo2016_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Mayo2016_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Mayo2016_12-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Mayo2016_12-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.mayoclinic.org/diseases-conditions/melanoma/basics/risk-factors/con-20026009\">\"Melanoma Risk factors\"</a>. <i>Mayo Clinic</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170410133759/http://www.mayoclinic.org/diseases-conditions/melanoma/basics/risk-factors/con-20026009\">Archived</a> from the original on 2017-04-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-04-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mayo+Clinic&amp;rft.atitle=Melanoma+Risk+factors&amp;rft_id=http%3A%2F%2Fwww.mayoclinic.org%2Fdiseases-conditions%2Fmelanoma%2Fbasics%2Frisk-factors%2Fcon-20026009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22833605-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22833605_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Boniol, M; Autier, P; Boyle, P; Gandini, S (Jul 24, 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3404185\">\"Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis\"</a>. <i>BMJ (Clinical Research Ed.)</i>. <b>345</b>: e4757. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.e4757\">10.1136/bmj.e4757</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3404185\">3404185</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22833605\">22833605</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+%28Clinical+Research+Ed.%29&amp;rft.atitle=Cutaneous+melanoma+attributable+to+sunbed+use%3A+systematic+review+and+meta-analysis&amp;rft.volume=345&amp;rft.pages=e4757&amp;rft.date=2012-07-24&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3404185&amp;rft_id=info%3Apmid%2F22833605&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.e4757&amp;rft.aulast=Boniol&amp;rft.aufirst=M&amp;rft.au=Autier%2C+P&amp;rft.au=Boyle%2C+P&amp;rft.au=Gandini%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3404185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">WHO International Agency for Research on Cancer Monograph Working Group (August 2009). \"A Review of Human Carcinogens \u2013 Part D: Radiation\". <i><a href=\"/wiki/The_Lancet_Oncology\" class=\"mw-redirect\" title=\"The Lancet Oncology\">The Lancet Oncology</a></i>. <b>10</b> (8): 751\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1470-2045%2809%2970213-X\">10.1016/S1470-2045(09)70213-X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19655431\">19655431</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.atitle=A+Review+of+Human+Carcinogens+%E2%80%93+Part+D%3A+Radiation&amp;rft.volume=10&amp;rft.issue=8&amp;rft.pages=751-52&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2809%2970213-X&amp;rft_id=info%3Apmid%2F19655431&amp;rft.au=WHO+International+Agency+for+Research+on+Cancer+Monograph+Working+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sanlorenzo, Martina; Wehner, Mackenzie R.; Linos, Eleni; Kornak, John; Kainz, Wolfgang; Posch, Christian; Vujic, Igor; Johnston, Katia; Gho, Deborah; Monico, Gabriela; McGrath, James T.; Osella-Abate, Simona; Quaglino, Pietro; Cleaver, James E.; Ortiz-Urda, Susana (January 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4482339\">\"The Risk of Melanoma in Airline Pilots and Cabin Crew\"</a>. <i>JAMA Dermatology</i>. <b>151</b> (1): 51\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jamadermatol.2014.1077\">10.1001/jamadermatol.2014.1077</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4482339\">4482339</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25188246\">25188246</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Dermatology&amp;rft.atitle=The+Risk+of+Melanoma+in+Airline+Pilots+and+Cabin+Crew&amp;rft.volume=151&amp;rft.issue=1&amp;rft.pages=51-58&amp;rft.date=2015-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4482339&amp;rft_id=info%3Apmid%2F25188246&amp;rft_id=info%3Adoi%2F10.1001%2Fjamadermatol.2014.1077&amp;rft.aulast=Sanlorenzo&amp;rft.aufirst=Martina&amp;rft.au=Wehner%2C+Mackenzie+R.&amp;rft.au=Linos%2C+Eleni&amp;rft.au=Kornak%2C+John&amp;rft.au=Kainz%2C+Wolfgang&amp;rft.au=Posch%2C+Christian&amp;rft.au=Vujic%2C+Igor&amp;rft.au=Johnston%2C+Katia&amp;rft.au=Gho%2C+Deborah&amp;rft.au=Monico%2C+Gabriela&amp;rft.au=McGrath%2C+James+T.&amp;rft.au=Osella-Abate%2C+Simona&amp;rft.au=Quaglino%2C+Pietro&amp;rft.au=Cleaver%2C+James+E.&amp;rft.au=Ortiz-Urda%2C+Susana&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4482339&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22005748-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22005748_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">R\u00fcnger TM, Farahvash B, Hatvani Z, Rees A (January 2012). \"Comparison of DNA damage responses following equimutagenic doses of UVA and UVB: a less effective cell cycle arrest with UVA may render UVA-induced pyrimidine dimers more mutagenic than UVB-induced ones\". <i>Photochem. Photobiol. Sci</i>. <b>11</b> (1): 207\u201315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1039/c1pp05232b\">10.1039/c1pp05232b</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22005748\">22005748</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Photochem.+Photobiol.+Sci.&amp;rft.atitle=Comparison+of+DNA+damage+responses+following+equimutagenic+doses+of+UVA+and+UVB%3A+a+less+effective+cell+cycle+arrest+with+UVA+may+render+UVA-induced+pyrimidine+dimers+more+mutagenic+than+UVB-induced+ones&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=207-15&amp;rft.date=2012-01&amp;rft_id=info%3Adoi%2F10.1039%2Fc1pp05232b&amp;rft_id=info%3Apmid%2F22005748&amp;rft.aulast=R%C3%BCnger&amp;rft.aufirst=TM&amp;rft.au=Farahvash%2C+B&amp;rft.au=Hatvani%2C+Z&amp;rft.au=Rees%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-uva-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-uva_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wang S, Setlow R, Berwick M, Polsky D, Marghoob A, Kopf A, Bart R (2001). \"Ultraviolet A and melanoma: a review\". <i>J Am Acad Dermatol</i>. <b>44</b> (5): 837\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1067/mjd.2001.114594\">10.1067/mjd.2001.114594</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11312434\">11312434</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.atitle=Ultraviolet+A+and+melanoma%3A+a+review&amp;rft.volume=44&amp;rft.issue=5&amp;rft.pages=837-46&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1067%2Fmjd.2001.114594&amp;rft_id=info%3Apmid%2F11312434&amp;rft.aulast=Wang&amp;rft.aufirst=S&amp;rft.au=Setlow%2C+R&amp;rft.au=Berwick%2C+M&amp;rft.au=Polsky%2C+D&amp;rft.au=Marghoob%2C+A&amp;rft.au=Kopf%2C+A&amp;rft.au=Bart%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oliveria S, Saraiya M, Geller A, Heneghan M, Jorgensen C (2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2082713\">\"Sun exposure and risk of melanoma\"</a>. <i>Arch Dis Child</i>. <b>91</b> (2): 131\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/adc.2005.086918\">10.1136/adc.2005.086918</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2082713\">2082713</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16326797\">16326797</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch+Dis+Child&amp;rft.atitle=Sun+exposure+and+risk+of+melanoma&amp;rft.volume=91&amp;rft.issue=2&amp;rft.pages=131-38&amp;rft.date=2006&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2082713&amp;rft_id=info%3Apmid%2F16326797&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.2005.086918&amp;rft.aulast=Oliveria&amp;rft.aufirst=S&amp;rft.au=Saraiya%2C+M&amp;rft.au=Geller%2C+A&amp;rft.au=Heneghan%2C+M&amp;rft.au=Jorgensen%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2082713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lee J, Strickland D (1980). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2010319\">\"Malignant melanoma: social status and outdoor work\"</a>. <i>Br J Cancer</i>. <b>41</b> (5): 757\u201363. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/bjc.1980.138\">10.1038/bjc.1980.138</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2010319\">2010319</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7426301\">7426301</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+J+Cancer&amp;rft.atitle=Malignant+melanoma%3A+social+status+and+outdoor+work&amp;rft.volume=41&amp;rft.issue=5&amp;rft.pages=757-63&amp;rft.date=1980&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2010319&amp;rft_id=info%3Apmid%2F7426301&amp;rft_id=info%3Adoi%2F10.1038%2Fbjc.1980.138&amp;rft.aulast=Lee&amp;rft.aufirst=J&amp;rft.au=Strickland%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2010319&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW (January 1995). \"Occupation and the risk of malignant melanoma\". <i>Cancer</i>. <b>75</b> (2 Suppl): 637\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/1097-0142%2819950115%2975%3A2\">10.1002/1097-0142(19950115)75:2</a> (inactive 2018-09-10). <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7804988\">7804988</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=Occupation+and+the+risk+of+malignant+melanoma&amp;rft.volume=75&amp;rft.issue=2+Suppl&amp;rft.pages=637-44&amp;rft.date=1995-01&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%2819950115%2975%3A2&amp;rft_id=info%3Apmid%2F7804988&amp;rft.aulast=Pion&amp;rft.aufirst=IA&amp;rft.au=Rigel%2C+DS&amp;rft.au=Garfinkel%2C+L&amp;rft.au=Silverman%2C+MK&amp;rft.au=Kopf%2C+AW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/mediacentre/news/notes/2005/np07/en/\">The World Health Organization recommends that no person under 18 should use a sunbed</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090616124844/http://www.who.int/mediacentre/news/notes/2005/np07/en/\">Archived</a> 2009-06-16 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Khlat M, Vail A, Parkin M, Green A (1992). \"Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay\". <i>Am J Epidemiol</i>. <b>135</b> (10): 1103\u201313. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1632422\">1632422</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Epidemiol&amp;rft.atitle=Mortality+from+melanoma+in+migrants+to+Australia%3A+variation+by+age+at+arrival+and+duration+of+stay&amp;rft.volume=135&amp;rft.issue=10&amp;rft.pages=1103-13&amp;rft.date=1992&amp;rft_id=info%3Apmid%2F1632422&amp;rft.aulast=Khlat&amp;rft.aufirst=M&amp;rft.au=Vail%2C+A&amp;rft.au=Parkin%2C+M&amp;rft.au=Green%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greene MH. (1998). \"The genetics of hereditary melanoma and nevi\". <i>Cancer</i>. <b>86</b> (11): 2464\u201377. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/%28SICI%291097-0142%2819991201%2986%3A11\">10.1002/(SICI)1097-0142(19991201)86:11</a> (inactive 2018-09-10). <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10630172\">10630172</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=The+genetics+of+hereditary+melanoma+and+nevi&amp;rft.volume=86&amp;rft.issue=11&amp;rft.pages=2464-77&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0142%2819991201%2986%3A11&amp;rft_id=info%3Apmid%2F10630172&amp;rft.au=Greene+MH.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Halachmi S, Gilchrest BA (2001). \"Update on genetic events in the pathogenesis of melanoma\". <i>Current Opinion in Oncology</i>. <b>13</b> (2): 129\u201336. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00001622-200103000-00008\">10.1097/00001622-200103000-00008</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11224711\">11224711</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Oncology&amp;rft.atitle=Update+on+genetic+events+in+the+pathogenesis+of+melanoma&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=129-36&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1097%2F00001622-200103000-00008&amp;rft_id=info%3Apmid%2F11224711&amp;rft.aulast=Halachmi&amp;rft.aufirst=S&amp;rft.au=Gilchrest%2C+BA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;cmd=Retrieve&amp;dopt=full_report&amp;list_uids=1029\">CDKN2A cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20041117054925/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene\">Archived</a> 2004-11-17 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>. from Entrez Gene</span>\n</li>\n<li id=\"cite_note-pmid19318491-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19318491_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Firoz for Cancer Research, EF; Warycha, M; Zakrzewski, J; Pollens, D; Wang, G; Shapiro, R; Berman, R; Pavlick, A; Manga, P; Ostrer, H.; Celebi, J. T.; Kamino, H.; Darvishian, F.; Rolnitzky, L.; Goldberg, J. D.; Osman, I.; Polsky, D. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3881546\">\"Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma\"</a>. <i>Clinical Cancer Research</i>. <b>15</b> (7): 2573\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/1078-0432.CCR-08-2678\">10.1158/1078-0432.CCR-08-2678</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3881546\">3881546</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19318491\">19318491</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Association+of+MDM2+SNP309%2C+Age+of+Onset%2C+and+Gender+in+Cutaneous+Melanoma&amp;rft.volume=15&amp;rft.issue=7&amp;rft.pages=2573-80&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3881546&amp;rft_id=info%3Apmid%2F19318491&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-08-2678&amp;rft.aulast=Firoz+for+Cancer+Research&amp;rft.aufirst=EF&amp;rft.au=Warycha%2C+M&amp;rft.au=Zakrzewski%2C+J&amp;rft.au=Pollens%2C+D&amp;rft.au=Wang%2C+G&amp;rft.au=Shapiro%2C+R&amp;rft.au=Berman%2C+R&amp;rft.au=Pavlick%2C+A&amp;rft.au=Manga%2C+P&amp;rft.au=Ostrer%2C+H.&amp;rft.au=Celebi%2C+J.+T.&amp;rft.au=Kamino%2C+H.&amp;rft.au=Darvishian%2C+F.&amp;rft.au=Rolnitzky%2C+L.&amp;rft.au=Goldberg%2C+J.+D.&amp;rft.au=Osman%2C+I.&amp;rft.au=Polsky%2C+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3881546&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-IMAGE-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-IMAGE_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bliss J, Ford D, Swerdlow A, Armstrong B, Cristofolini M, Elwood J, Green A, Holly E, Mack T, MacKie R (1995). \"Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)\". <i>Int J Cancer</i>. <b>62</b> (4): 367\u201376. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/ijc.2910620402\">10.1002/ijc.2910620402</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7635560\">7635560</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Cancer&amp;rft.atitle=Risk+of+cutaneous+melanoma+associated+with+pigmentation+characteristics+and+freckling%3A+systematic+overview+of+10+case-control+studies.+The+International+Melanoma+Analysis+Group+%28IMAGE%29&amp;rft.volume=62&amp;rft.issue=4&amp;rft.pages=367-76&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.2910620402&amp;rft_id=info%3Apmid%2F7635560&amp;rft.aulast=Bliss&amp;rft.aufirst=J&amp;rft.au=Ford%2C+D&amp;rft.au=Swerdlow%2C+A&amp;rft.au=Armstrong%2C+B&amp;rft.au=Cristofolini%2C+M&amp;rft.au=Elwood%2C+J&amp;rft.au=Green%2C+A&amp;rft.au=Holly%2C+E&amp;rft.au=Mack%2C+T&amp;rft.au=MacKie%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Miller A, Mihm M (2006). \"Melanoma\". <i>N Engl J Med</i>. <b>355</b> (1): 51\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMra052166\">10.1056/NEJMra052166</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16822996\">16822996</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Melanoma&amp;rft.volume=355&amp;rft.issue=1&amp;rft.pages=51-65&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra052166&amp;rft_id=info%3Apmid%2F16822996&amp;rft.aulast=Miller&amp;rft.aufirst=A&amp;rft.au=Mihm%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rhodes A, Weinstock M, Fitzpatrick T, Mihm M, Sober A (1987). \"Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals\". <i>JAMA</i>. <b>258</b> (21): 3146\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.258.21.3146\">10.1001/jama.258.21.3146</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3312689\">3312689</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Risk+factors+for+cutaneous+melanoma.+A+practical+method+of+recognizing+predisposed+individuals&amp;rft.volume=258&amp;rft.issue=21&amp;rft.pages=3146-54&amp;rft.date=1987&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.258.21.3146&amp;rft_id=info%3Apmid%2F3312689&amp;rft.aulast=Rhodes&amp;rft.aufirst=A&amp;rft.au=Weinstock%2C+M&amp;rft.au=Fitzpatrick%2C+T&amp;rft.au=Mihm%2C+M&amp;rft.au=Sober%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hershkovitz10-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Hershkovitz10_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Hershkovitz10_30-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hershkovitz L, Schachter J, Treves AJ, Besser MJ (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3018069\">\"Focus on adoptive T cell transfer trials in melanoma\"</a>. <i>Clin. Dev. Immunol</i>. <b>2010</b>: 260267. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1155/2010/260267\">10.1155/2010/260267</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3018069\">3018069</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21234353\">21234353</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Dev.+Immunol.&amp;rft.atitle=Focus+on+adoptive+T+cell+transfer+trials+in+melanoma&amp;rft.volume=2010&amp;rft.pages=260267&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3018069&amp;rft_id=info%3Apmid%2F21234353&amp;rft_id=info%3Adoi%2F10.1155%2F2010%2F260267&amp;rft.aulast=Hershkovitz&amp;rft.aufirst=L&amp;rft.au=Schachter%2C+J&amp;rft.au=Treves%2C+AJ&amp;rft.au=Besser%2C+MJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3018069&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=34439\">\"ASCO Annual Meeting Proceedings Part I. Abstract: Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study\"</a>. <i>Journal of Clinical Oncology</i>. <b>25</b> (18S): 8519. 2007. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110725021007/http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=34439\">Archived</a> from the original on 2011-07-25.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=ASCO+Annual+Meeting+Proceedings+Part+I.+Abstract%3A+Protective+effect+of+a+brisk+tumor+infiltrating+lymphocyte+infiltrate+in+melanoma%3A+An+EORTC+melanoma+group+study&amp;rft.volume=25&amp;rft.issue=18S&amp;rft.pages=8519&amp;rft.date=2007&amp;rft_id=http%3A%2F%2Fwww.asco.org%2Fascov2%2FMeetings%2FAbstracts%3F%26vmview%3Dabst_detail_view%26confID%3D47%26abstractID%3D34439&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20697348-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20697348_32-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Davies, M A; Samuels, Y (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3169242\">\"Analysis of the genome to personalize therapy for melanoma\"</a>. <i>Oncogene</i>. <b>29</b> (41): 5545\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/onc.2010.323\">10.1038/onc.2010.323</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3169242\">3169242</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20697348\">20697348</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncogene&amp;rft.atitle=Analysis+of+the+genome+to+personalize+therapy+for+melanoma&amp;rft.volume=29&amp;rft.issue=41&amp;rft.pages=5545-55&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3169242&amp;rft_id=info%3Apmid%2F20697348&amp;rft_id=info%3Adoi%2F10.1038%2Fonc.2010.323&amp;rft.aulast=Davies&amp;rft.aufirst=M+A&amp;rft.au=Samuels%2C+Y&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3169242&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Bernstein C, Prasad AR, Nfonsam V, Bernstein H (2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.intechopen.com/books/new-research-directions-in-dna-repair/dna-damage-dna-repair-and-cancer\">\"DNA Damage, DNA Repair and Cancer\"</a>.  In Clark Chen. <i>New Research Directions in DNA Repair</i>. InTech. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-953-51-1114-6\" title=\"Special:BookSources/978-953-51-1114-6\">978-953-51-1114-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=DNA+Damage%2C+DNA+Repair+and+Cancer&amp;rft.btitle=New+Research+Directions+in+DNA+Repair&amp;rft.pub=InTech&amp;rft.date=2013&amp;rft.isbn=978-953-51-1114-6&amp;rft.aulast=Bernstein&amp;rft.aufirst=C&amp;rft.au=Prasad%2C+AR&amp;rft.au=Nfonsam%2C+V&amp;rft.au=Bernstein%2C+H&amp;rft_id=http%3A%2F%2Fwww.intechopen.com%2Fbooks%2Fnew-research-directions-in-dna-repair%2Fdna-damage-dna-repair-and-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21901217-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21901217_34-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sage E, Girard PM, Francesconi S (January 2012). \"Unravelling UVA-induced mutagenesis\". <i>Photochem. Photobiol. Sci</i>. <b>11</b> (1): 74\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1039/c1pp05219e\">10.1039/c1pp05219e</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21901217\">21901217</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Photochem.+Photobiol.+Sci.&amp;rft.atitle=Unravelling+UVA-induced+mutagenesis&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=74-80&amp;rft.date=2012-01&amp;rft_id=info%3Adoi%2F10.1039%2Fc1pp05219e&amp;rft_id=info%3Apmid%2F21901217&amp;rft.aulast=Sage&amp;rft.aufirst=E&amp;rft.au=Girard%2C+PM&amp;rft.au=Francesconi%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23303275-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23303275_35-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Budden T, Bowden NA (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3565312\">\"The Role of Altered Nucleotide Excision Repair and UVB-Induced DNA Damage in Melanomagenesis\"</a>. <i>Int J Mol Sci</i>. <b>14</b> (1): 1132\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/ijms14011132\">10.3390/ijms14011132</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3565312\">3565312</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23303275\">23303275</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Mol+Sci&amp;rft.atitle=The+Role+of+Altered+Nucleotide+Excision+Repair+and+UVB-Induced+DNA+Damage+in+Melanomagenesis&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=1132-51&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3565312&amp;rft_id=info%3Apmid%2F23303275&amp;rft_id=info%3Adoi%2F10.3390%2Fijms14011132&amp;rft.aulast=Budden&amp;rft.aufirst=T&amp;rft.au=Bowden%2C+NA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3565312&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22622578-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22622578_36-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E, Ghosh P, Zhang H, Zeid R, Ren X, Cibulskis K, Sivachenko AY, Wagle N, Sucker A, Sougnez C, Onofrio R, Ambrogio L, Auclair D, Fennell T, Carter SL, Drier Y, Stojanov P, Singer MA, Voet D, Jing R, Saksena G, Barretina J, Ramos AH, Pugh TJ, Stransky N, Parkin M, Winckler W, Mahan S, Ardlie K, Baldwin J, Wargo J, Schadendorf D, Meyerson M, Gabriel SB, Golub TR, Wagner SN, Lander ES, Getz G, Chin L, Garraway LA (May 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798\">\"Melanoma genome sequencing reveals frequent PREX2 mutations\"</a>. <i>Nature</i>. <b>485</b> (7399): 502\u201306. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature11071\">10.1038/nature11071</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798\">3367798</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22622578\">22622578</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Melanoma+genome+sequencing+reveals+frequent+PREX2+mutations&amp;rft.volume=485&amp;rft.issue=7399&amp;rft.pages=502-06&amp;rft.date=2012-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3367798&amp;rft_id=info%3Apmid%2F22622578&amp;rft_id=info%3Adoi%2F10.1038%2Fnature11071&amp;rft.aulast=Berger&amp;rft.aufirst=MF&amp;rft.au=Hodis%2C+E&amp;rft.au=Heffernan%2C+TP&amp;rft.au=Deribe%2C+YL&amp;rft.au=Lawrence%2C+MS&amp;rft.au=Protopopov%2C+A&amp;rft.au=Ivanova%2C+E&amp;rft.au=Watson%2C+IR&amp;rft.au=Nickerson%2C+E&amp;rft.au=Ghosh%2C+P&amp;rft.au=Zhang%2C+H&amp;rft.au=Zeid%2C+R&amp;rft.au=Ren%2C+X&amp;rft.au=Cibulskis%2C+K&amp;rft.au=Sivachenko%2C+AY&amp;rft.au=Wagle%2C+N&amp;rft.au=Sucker%2C+A&amp;rft.au=Sougnez%2C+C&amp;rft.au=Onofrio%2C+R&amp;rft.au=Ambrogio%2C+L&amp;rft.au=Auclair%2C+D&amp;rft.au=Fennell%2C+T&amp;rft.au=Carter%2C+SL&amp;rft.au=Drier%2C+Y&amp;rft.au=Stojanov%2C+P&amp;rft.au=Singer%2C+MA&amp;rft.au=Voet%2C+D&amp;rft.au=Jing%2C+R&amp;rft.au=Saksena%2C+G&amp;rft.au=Barretina%2C+J&amp;rft.au=Ramos%2C+AH&amp;rft.au=Pugh%2C+TJ&amp;rft.au=Stransky%2C+N&amp;rft.au=Parkin%2C+M&amp;rft.au=Winckler%2C+W&amp;rft.au=Mahan%2C+S&amp;rft.au=Ardlie%2C+K&amp;rft.au=Baldwin%2C+J&amp;rft.au=Wargo%2C+J&amp;rft.au=Schadendorf%2C+D&amp;rft.au=Meyerson%2C+M&amp;rft.au=Gabriel%2C+SB&amp;rft.au=Golub%2C+TR&amp;rft.au=Wagner%2C+SN&amp;rft.au=Lander%2C+ES&amp;rft.au=Getz%2C+G&amp;rft.au=Chin%2C+L&amp;rft.au=Garraway%2C+LA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3367798&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Roach JC, Glusman G, Smit AF,  et al. (April 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280\">\"Analysis of genetic inheritance in a family quartet by whole-genome sequencing\"</a>. <i>Science</i>. <b>328</b> (5978): 636\u201339. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1186802\">10.1126/science.1186802</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280\">3037280</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20220176\">20220176</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Analysis+of+genetic+inheritance+in+a+family+quartet+by+whole-genome+sequencing&amp;rft.volume=328&amp;rft.issue=5978&amp;rft.pages=636-39&amp;rft.date=2010-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3037280&amp;rft_id=info%3Apmid%2F20220176&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1186802&amp;rft.aulast=Roach&amp;rft.aufirst=JC&amp;rft.au=Glusman%2C+G&amp;rft.au=Smit%2C+AF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3037280&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Campbell CD, Chong JX, Malig M,  et al. (November 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3483378\">\"Estimating the human mutation rate using autozygosity in a founder population\"</a>. <i>Nat. Genet</i>. <b>44</b> (11): 1277\u201381. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ng.2418\">10.1038/ng.2418</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3483378\">3483378</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23001126\">23001126</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Genet.&amp;rft.atitle=Estimating+the+human+mutation+rate+using+autozygosity+in+a+founder+population&amp;rft.volume=44&amp;rft.issue=11&amp;rft.pages=1277-81&amp;rft.date=2012-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3483378&amp;rft_id=info%3Apmid%2F23001126&amp;rft_id=info%3Adoi%2F10.1038%2Fng.2418&amp;rft.aulast=Campbell&amp;rft.aufirst=CD&amp;rft.au=Chong%2C+JX&amp;rft.au=Malig%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3483378&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-proteinatlas.org-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-proteinatlas.org_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-proteinatlas.org_39-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.proteinatlas.org/humanpathology/melanoma\">\"The human pathology proteome in melanoma \u2013 The Human Protein Atlas\"</a>. <i>www.proteinatlas.org</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-10-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.proteinatlas.org&amp;rft.atitle=The+human+pathology+proteome+in+melanoma+%E2%80%93+The+Human+Protein+Atlas&amp;rft_id=https%3A%2F%2Fwww.proteinatlas.org%2Fhumanpathology%2Fmelanoma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Uhlen_eaan2507-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Uhlen_eaan2507_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Uhlen_eaan2507_40-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sj\u00f6stedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao (2017-08-18). <a rel=\"nofollow\" class=\"external text\" href=\"http://science.sciencemag.org/content/357/6352/eaan2507\">\"A pathology atlas of the human cancer transcriptome\"</a>. <i>Science</i>. <b>357</b> (6352): eaan2507. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.aan2507\">10.1126/science.aan2507</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28818916\">28818916</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+pathology+atlas+of+the+human+cancer+transcriptome&amp;rft.volume=357&amp;rft.issue=6352&amp;rft.pages=eaan2507&amp;rft.date=2017-08-18&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aan2507&amp;rft_id=info%3Apmid%2F28818916&amp;rft.aulast=Uhlen&amp;rft.aufirst=Mathias&amp;rft.au=Zhang%2C+Cheng&amp;rft.au=Lee%2C+Sunjae&amp;rft.au=Sj%C3%B6stedt%2C+Evelina&amp;rft.au=Fagerberg%2C+Linn&amp;rft.au=Bidkhori%2C+Gholamreza&amp;rft.au=Benfeitas%2C+Rui&amp;rft.au=Arif%2C+Muhammad&amp;rft.au=Liu%2C+Zhengtao&amp;rft_id=http%3A%2F%2Fscience.sciencemag.org%2Fcontent%2F357%2F6352%2Feaan2507&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Leslie MC, Bar-Eli M (January 2005). \"Regulation of gene expression in melanoma: new approaches for treatment\". <i>J. Cell. Biochem</i>. <b>94</b> (1): 25\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jcb.20296\">10.1002/jcb.20296</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15523674\">15523674</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell.+Biochem.&amp;rft.atitle=Regulation+of+gene+expression+in+melanoma%3A+new+approaches+for+treatment&amp;rft.volume=94&amp;rft.issue=1&amp;rft.pages=25-38&amp;rft.date=2005-01&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.20296&amp;rft_id=info%3Apmid%2F15523674&amp;rft.aulast=Leslie&amp;rft.aufirst=MC&amp;rft.au=Bar-Eli%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bhoumik A, Singha N, O'Connell MJ, Ronai ZA (June 2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2427333\">\"Regulation of TIP60 by ATF2 modulates ATM activation\"</a>. <i>J. Biol. Chem</i>. <b>283</b> (25): 17605\u201314. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1074/jbc.M802030200\">10.1074/jbc.M802030200</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2427333\">2427333</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18397884\">18397884</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.atitle=Regulation+of+TIP60+by+ATF2+modulates+ATM+activation&amp;rft.volume=283&amp;rft.issue=25&amp;rft.pages=17605-14&amp;rft.date=2008-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2427333&amp;rft_id=info%3Apmid%2F18397884&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.M802030200&amp;rft.aulast=Bhoumik&amp;rft.aufirst=A&amp;rft.au=Singha%2C+N&amp;rft.au=O%27Connell%2C+MJ&amp;rft.au=Ronai%2C+ZA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2427333&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bhoumik A, Jones N, Ronai Z (March 2004). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC384722\">\"Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>101</b> (12): 4222\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.0400195101\">10.1073/pnas.0400195101</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC384722\">384722</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15010535\">15010535</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Transcriptional+switch+by+activating+transcription+factor+2-derived+peptide+sensitizes+melanoma+cells+to+apoptosis+and+inhibits+their+tumorigenicity&amp;rft.volume=101&amp;rft.issue=12&amp;rft.pages=4222-27&amp;rft.date=2004-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC384722&amp;rft_id=info%3Apmid%2F15010535&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0400195101&amp;rft.aulast=Bhoumik&amp;rft.aufirst=A&amp;rft.au=Jones%2C+N&amp;rft.au=Ronai%2C+Z&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC384722&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). \"The role of ATF-2 in oncogenesis\". <i>BioEssays</i>. <b>30</b> (4): 314\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/bies.20734\">10.1002/bies.20734</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18348191\">18348191</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioEssays&amp;rft.atitle=The+role+of+ATF-2+in+oncogenesis&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=314-27&amp;rft.date=2008-04&amp;rft_id=info%3Adoi%2F10.1002%2Fbies.20734&amp;rft_id=info%3Apmid%2F18348191&amp;rft.aulast=Vlahopoulos&amp;rft.aufirst=SA&amp;rft.au=Logotheti%2C+S&amp;rft.au=Mikas%2C+D&amp;rft.au=Giarika%2C+A&amp;rft.au=Gorgoulis%2C+V&amp;rft.au=Zoumpourlis%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huang Y, Minigh J, Miles S, Niles RM (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265711\">\"Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition\"</a>. <i>J Mol Signal</i>. <b>3</b>: 3. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1750-2187-3-3\">10.1186/1750-2187-3-3</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265711\">2265711</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18269766\">18269766</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Mol+Signal&amp;rft.atitle=Retinoic+acid+decreases+ATF-2+phosphorylation+and+sensitizes+melanoma+cells+to+taxol-mediated+growth+inhibition&amp;rft.volume=3&amp;rft.pages=3&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2265711&amp;rft_id=info%3Apmid%2F18269766&amp;rft_id=info%3Adoi%2F10.1186%2F1750-2187-3-3&amp;rft.aulast=Huang&amp;rft.aufirst=Y&amp;rft.au=Minigh%2C+J&amp;rft.au=Miles%2C+S&amp;rft.au=Niles%2C+RM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2265711&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Parmiani, G (11 March 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4810118\">\"Melanoma Cancer Stem Cells: Markers and Functions\"</a>. <i>Cancers</i>. <b>8</b> (3): 34. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/cancers8030034\">10.3390/cancers8030034</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4810118\">4810118</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26978405\">26978405</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancers&amp;rft.atitle=Melanoma+Cancer+Stem+Cells%3A+Markers+and+Functions&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=34&amp;rft.date=2016-03-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4810118&amp;rft_id=info%3Apmid%2F26978405&amp;rft_id=info%3Adoi%2F10.3390%2Fcancers8030034&amp;rft.aulast=Parmiani&amp;rft.aufirst=G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4810118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ap01-47\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ap01_47-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ap01_47-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wurm EM, Soyer HP (October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20101019035021/http://australianprescriber.com/magazine/33/5/150/5\">\"Scanning for melanoma\"</a>. <i>Australian Prescriber</i> (33): 150\u201355. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.australianprescriber.com/magazine/33/5/150/5\">the original</a> on 2010-10-19.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Australian+Prescriber&amp;rft.atitle=Scanning+for+melanoma&amp;rft.issue=33&amp;rft.pages=150-55&amp;rft.date=2010-10&amp;rft.aulast=Wurm&amp;rft.aufirst=EM&amp;rft.au=Soyer%2C+HP&amp;rft_id=http%3A%2F%2Fwww.australianprescriber.com%2Fmagazine%2F33%2F5%2F150%2F5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20030423111111/http://melanomafoundation.org/prevention/abcd.htm\">\"Prevention: ABCD's of Melanoma\"</a>. American Melanoma Foundation. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.melanomafoundation.org/prevention/abcd.htm\">the original</a> on 2003-04-23.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prevention%3A+ABCD%27s+of+Melanoma&amp;rft.pub=American+Melanoma+Foundation&amp;rft_id=http%3A%2F%2Fwww.melanomafoundation.org%2Fprevention%2Fabcd.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Friedman R, Rigel D, Kopf A (1985). \"Early detection of malignant melanoma: the role of physician examination and self-examination of the skin\". <i>CA Cancer J Clin</i>. <b>35</b> (3): 130\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3322/canjclin.35.3.130\">10.3322/canjclin.35.3.130</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3921200\">3921200</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA+Cancer+J+Clin&amp;rft.atitle=Early+detection+of+malignant+melanoma%3A+the+role+of+physician+examination+and+self-examination+of+the+skin&amp;rft.volume=35&amp;rft.issue=3&amp;rft.pages=130-51&amp;rft.date=1985&amp;rft_id=info%3Adoi%2F10.3322%2Fcanjclin.35.3.130&amp;rft_id=info%3Apmid%2F3921200&amp;rft.aulast=Friedman&amp;rft.aufirst=R&amp;rft.au=Rigel%2C+D&amp;rft.au=Kopf%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid9828892-50\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid9828892_50-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid9828892_50-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mascaro JM, Mascaro JM (November 1998). \"The dermatologist's position concerning nevi: a vision ranging from \"the ugly duckling\" to \"little red riding hood<span style=\"padding-right:0.2em;\">\"</span>\". <i>Arch Dermatol</i>. <b>134</b> (11): 1484\u201385. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archderm.134.11.1484\">10.1001/archderm.134.11.1484</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9828892\">9828892</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch+Dermatol&amp;rft.atitle=The+dermatologist%27s+position+concerning+nevi%3A+a+vision+ranging+from+%22the+ugly+duckling%22+to+%22little+red+riding+hood%22&amp;rft.volume=134&amp;rft.issue=11&amp;rft.pages=1484-85&amp;rft.date=1998-11&amp;rft_id=info%3Adoi%2F10.1001%2Farchderm.134.11.1484&amp;rft_id=info%3Apmid%2F9828892&amp;rft.aulast=Mascaro&amp;rft.aufirst=JM&amp;rft.au=Mascaro%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-dermnetnz.org-51\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-dermnetnz.org_51-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-dermnetnz.org_51-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://dermnetnz.org/doctors/dermoscopy-course/introduction.html\">\"Introduction to Dermoscopy\"</a>. DermNet New Zealand. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090507183545/http://dermnetnz.org/doctors/dermoscopy-course/introduction.html\">Archived</a> from the original on 2009-05-07.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Introduction+to+Dermoscopy&amp;rft.pub=DermNet+New+Zealand&amp;rft_id=http%3A%2F%2Fdermnetnz.org%2Fdoctors%2Fdermoscopy-course%2Fintroduction.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19155361-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19155361_52-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Montgomery BD, Sadler GM (January 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628830\">\"Punch biopsy of pigmented lesions is potentially hazardous\"</a>. <i>Can Fam Physician</i>. <b>55</b> (1): 24. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628830\">2628830</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19155361\">19155361</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Can+Fam+Physician&amp;rft.atitle=Punch+biopsy+of+pigmented+lesions+is+potentially+hazardous&amp;rft.volume=55&amp;rft.issue=1&amp;rft.pages=24&amp;rft.date=2009-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2628830&amp;rft_id=info%3Apmid%2F19155361&amp;rft.aulast=Montgomery&amp;rft.aufirst=BD&amp;rft.au=Sadler%2C+GM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2628830&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25827527-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid25827527_53-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Luk PP, Vilain R, Crainic O, McCarthy SW, Thompson JF, Scolyer RA (August 2015). \"Punch biopsy of melanoma causing tumour cell implantation: another peril of utilising partial biopsies for melanocytic tumours\". <i>Australas J Dermatol</i>. <b>56</b> (3): 227\u201331. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/ajd.12333\">10.1111/ajd.12333</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25827527\">25827527</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Australas+J+Dermatol&amp;rft.atitle=Punch+biopsy+of+melanoma+causing+tumour+cell+implantation%3A+another+peril+of+utilising+partial+biopsies+for+melanocytic+tumours&amp;rft.volume=56&amp;rft.issue=3&amp;rft.pages=227-31&amp;rft.date=2015-08&amp;rft_id=info%3Adoi%2F10.1111%2Fajd.12333&amp;rft_id=info%3Apmid%2F25827527&amp;rft.aulast=Luk&amp;rft.aufirst=PP&amp;rft.au=Vilain%2C+R&amp;rft.au=Crainic%2C+O&amp;rft.au=McCarthy%2C+SW&amp;rft.au=Thompson%2C+JF&amp;rft.au=Scolyer%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid22471244-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid22471244_54-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lin SW, Kaye V, Goldfarb N, Rawal A, Warshaw E (July 2012). \"Melanoma tumor seeding after punch biopsy\". <i>Dermatol Surg</i>. <b>38</b> (7 pt 1): 1083\u201385. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1524-4725.2012.02384.x\">10.1111/j.1524-4725.2012.02384.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22471244\">22471244</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dermatol+Surg&amp;rft.atitle=Melanoma+tumor+seeding+after+punch+biopsy&amp;rft.volume=38&amp;rft.issue=7+pt+1&amp;rft.pages=1083-85&amp;rft.date=2012-07&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1524-4725.2012.02384.x&amp;rft_id=info%3Apmid%2F22471244&amp;rft.aulast=Lin&amp;rft.aufirst=SW&amp;rft.au=Kaye%2C+V&amp;rft.au=Goldfarb%2C+N&amp;rft.au=Rawal%2C+A&amp;rft.au=Warshaw%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16307945-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16307945_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Martin RC 2nd, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters KM (December 2005). \"Is incisional biopsy of melanoma harmful?\". <i>Am J Surg</i>. <b>190</b> (6): 913\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjsurg.2005.08.020\">10.1016/j.amjsurg.2005.08.020</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16307945\">16307945</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Surg&amp;rft.atitle=Is+incisional+biopsy+of+melanoma+harmful%3F&amp;rft.volume=190&amp;rft.issue=6&amp;rft.pages=913-17&amp;rft.date=2005-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjsurg.2005.08.020&amp;rft_id=info%3Apmid%2F16307945&amp;rft.aulast=Martin&amp;rft.aufirst=RC+2nd&amp;rft.au=Scoggins%2C+CR&amp;rft.au=Ross%2C+MI&amp;rft.au=Reintgen%2C+DS&amp;rft.au=Noyes%2C+RD&amp;rft.au=Edwards%2C+MJ&amp;rft.au=McMasters%2C+KM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid24665419-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid24665419_56-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yamashita Y, Hashimoto I, Abe Y, Seike T, Okawa K, Senzaki Y, Murao K, Kubo Y, Nakanishi H (March 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961608\">\"Effect of biopsy technique on the survival rate of malignant melanoma patients\"</a>. <i>Arch Plast Surg</i>. <b>41</b> (2): 122\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.5999/aps.2014.41.2.122\">10.5999/aps.2014.41.2.122</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961608\">3961608</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24665419\">24665419</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch+Plast+Surg&amp;rft.atitle=Effect+of+biopsy+technique+on+the+survival+rate+of+malignant+melanoma+patients&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=122-25&amp;rft.date=2014-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3961608&amp;rft_id=info%3Apmid%2F24665419&amp;rft_id=info%3Adoi%2F10.5999%2Faps.2014.41.2.122&amp;rft.aulast=Yamashita&amp;rft.aufirst=Y&amp;rft.au=Hashimoto%2C+I&amp;rft.au=Abe%2C+Y&amp;rft.au=Seike%2C+T&amp;rft.au=Okawa%2C+K&amp;rft.au=Senzaki%2C+Y&amp;rft.au=Murao%2C+K&amp;rft.au=Kubo%2C+Y&amp;rft.au=Nakanishi%2C+H&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3961608&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">James, William D.; Berger, Timothy G.;  et al. (2006). <i>Andrews' Diseases of the Skin: clinical Dermatology</i>. Saunders Elsevier. pp.&#160;694\u201399. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7216-2921-6\" title=\"Special:BookSources/978-0-7216-2921-6\">978-0-7216-2921-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Andrews%27+Diseases+of+the+Skin%3A+clinical+Dermatology&amp;rft.pages=694-99&amp;rft.pub=Saunders+Elsevier&amp;rft.date=2006&amp;rft.isbn=978-0-7216-2921-6&amp;rft.au=James%2C+William+D.&amp;rft.au=Berger%2C+Timothy+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bolognia-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bolognia_58-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). <i>Dermatology</i>. Mosby. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4160-2999-1\" title=\"Special:BookSources/978-1-4160-2999-1\">978-1-4160-2999-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Dermatology&amp;rft.pub=Mosby&amp;rft.date=2007&amp;rft.isbn=978-1-4160-2999-1&amp;rft.au=Rapini%2C+Ronald+P.&amp;rft.au=Bolognia%2C+Jean+L.&amp;rft.au=Jorizzo%2C+Joseph+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100718150647/http://chorus.rad.mcw.edu/doc/00955.html\">\"Malignant Melanoma: staging\"</a>. <i>Collaborative Hypertext of Radiology</i>. Medical College of Wisconsin. 1 September 2006. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://chorus.rad.mcw.edu/doc/00955.html\">the original</a> on 2010-07-18.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Collaborative+Hypertext+of+Radiology&amp;rft.atitle=Malignant+Melanoma%3A+staging&amp;rft.date=2006-09-01&amp;rft_id=http%3A%2F%2Fchorus.rad.mcw.edu%2Fdoc%2F00955.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-AJCC-60\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-AJCC_60-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-AJCC_60-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D, Fleming I, Gershenwald J, Houghton A, Kirkwood J, McMasters K, Mihm M, Morton D, Reintgen D, Ross M, Sober A, Thompson J, Thompson J (2001). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jco.org/cgi/content/full/19/16/3635\">\"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma\"</a>. <i>J Clin Oncol</i>. <b>19</b> (16): 3635\u201348. <a href=\"/wiki/CiteSeerX\" title=\"CiteSeerX\">CiteSeerX</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.475.6560\">10.1.1.475.6560</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2001.19.16.3635\">10.1200/JCO.2001.19.16.3635</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11504745\">11504745</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060305151011/http://www.jco.org/cgi/content/full/19/16/3635\">Archived</a> from the original on 2006-03-05.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Oncol&amp;rft.atitle=Final+version+of+the+American+Joint+Committee+on+Cancer+staging+system+for+cutaneous+melanoma&amp;rft.volume=19&amp;rft.issue=16&amp;rft.pages=3635-48&amp;rft.date=2001&amp;rft_id=%2F%2Fciteseerx.ist.psu.edu%2Fviewdoc%2Fsummary%3Fdoi%3D10.1.1.475.6560&amp;rft_id=info%3Apmid%2F11504745&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2001.19.16.3635&amp;rft.aulast=Balch&amp;rft.aufirst=C&amp;rft.au=Buzaid%2C+A&amp;rft.au=Soong%2C+S&amp;rft.au=Atkins%2C+M&amp;rft.au=Cascinelli%2C+N&amp;rft.au=Coit%2C+D&amp;rft.au=Fleming%2C+I&amp;rft.au=Gershenwald%2C+J&amp;rft.au=Houghton%2C+A&amp;rft.au=Kirkwood%2C+J&amp;rft.au=McMasters%2C+K&amp;rft.au=Mihm%2C+M&amp;rft.au=Morton%2C+D&amp;rft.au=Reintgen%2C+D&amp;rft.au=Ross%2C+M&amp;rft.au=Sober%2C+A&amp;rft.au=Thompson%2C+J&amp;rft.au=Thompson%2C+J&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fcontent%2Ffull%2F19%2F16%2F3635&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Autier P (2005). \"Cutaneous malignant melanoma: facts about sunbeds and sunscreen\". <i>Expert Rev Anticancer Ther</i>. <b>5</b> (5): 821\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/14737140.5.5.821\">10.1586/14737140.5.5.821</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16221052\">16221052</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Rev+Anticancer+Ther&amp;rft.atitle=Cutaneous+malignant+melanoma%3A+facts+about+sunbeds+and+sunscreen&amp;rft.volume=5&amp;rft.issue=5&amp;rft.pages=821-33&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1586%2F14737140.5.5.821&amp;rft_id=info%3Apmid%2F16221052&amp;rft.au=Autier+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Clough-Gorr KM, Titus-Ernstoff L, Perry AE, Spencer SK, Ernstoff MS (September 2008). \"Exposure to sunlamps, tanning beds, and melanoma risk\". <i>Cancer Causes Control</i>. <b>19</b> (7): 659\u201369. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10552-008-9129-6\">10.1007/s10552-008-9129-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18273687\">18273687</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Causes+Control&amp;rft.atitle=Exposure+to+sunlamps%2C+tanning+beds%2C+and+melanoma+risk&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=659-69&amp;rft.date=2008-09&amp;rft_id=info%3Adoi%2F10.1007%2Fs10552-008-9129-6&amp;rft_id=info%3Apmid%2F18273687&amp;rft.aulast=Clough-Gorr&amp;rft.aufirst=KM&amp;rft.au=Titus-Ernstoff%2C+L&amp;rft.au=Perry%2C+AE&amp;rft.au=Spencer%2C+SK&amp;rft.au=Ernstoff%2C+MS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greinert, R; de Vries, E; Erdmann, F; Espina, C; Auvinen, A; Kesminiene, A; Sch\u00fcz, J (December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancerepidemiology.net/article/S1877-7821(15)00002-8/fulltext\">\"European Code against Cancer 4th Edition: Ultraviolet radiation and cancer\"</a>. <i>Cancer Epidemiology</i>. <b>39</b> (Suppl 1): S75\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.canep.2014.12.014\">10.1016/j.canep.2014.12.014</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26096748\">26096748</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Epidemiology&amp;rft.atitle=European+Code+against+Cancer+4th+Edition%3A+Ultraviolet+radiation+and+cancer&amp;rft.volume=39&amp;rft.issue=Suppl+1&amp;rft.pages=S75-83&amp;rft.date=2015-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.canep.2014.12.014&amp;rft_id=info%3Apmid%2F26096748&amp;rft.aulast=Greinert&amp;rft.aufirst=R&amp;rft.au=de+Vries%2C+E&amp;rft.au=Erdmann%2C+F&amp;rft.au=Espina%2C+C&amp;rft.au=Auvinen%2C+A&amp;rft.au=Kesminiene%2C+A&amp;rft.au=Sch%C3%BCz%2C+J&amp;rft_id=http%3A%2F%2Fwww.cancerepidemiology.net%2Farticle%2FS1877-7821%2815%2900002-8%2Ffulltext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SunM-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-SunM_64-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kanavy HE, Gerstenblith MR (December 2011). \"Ultraviolet radiation and melanoma\". <i>Semin Cutan Med Surg</i>. <b>30</b> (4): 222\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.sder.2011.08.003\">10.1016/j.sder.2011.08.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22123420\">22123420</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Cutan+Med+Surg&amp;rft.atitle=Ultraviolet+radiation+and+melanoma&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=222-28&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.sder.2011.08.003&amp;rft_id=info%3Apmid%2F22123420&amp;rft.aulast=Kanavy&amp;rft.aufirst=HE&amp;rft.au=Gerstenblith%2C+MR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.org/docroot/cri/content/cri_2_4_2x_can_melanoma_be_prevented_50.asp\">Can Melanoma Be Prevented?</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060627025413/http://www.cancer.org/docroot/cri/content/cri_2_4_2x_can_melanoma_be_prevented_50.asp\">Archived</a> June 27, 2006, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-SunS-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-SunS_66-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Burnett M.E.; Wang S.Q. (April 2011). \"Current sunscreen controversies: a critical review\". <i>Photodermatology, Photoimmunology &amp; Photomedicine</i>. <b>27</b> (2): 58\u201367. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1600-0781.2011.00557.x\">10.1111/j.1600-0781.2011.00557.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21392107\">21392107</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Photodermatology%2C+Photoimmunology+%26+Photomedicine&amp;rft.atitle=Current+sunscreen+controversies%3A+a+critical+review&amp;rft.volume=27&amp;rft.issue=2&amp;rft.pages=58-67&amp;rft.date=2011-04&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0781.2011.00557.x&amp;rft_id=info%3Apmid%2F21392107&amp;rft.au=Burnett+M.E.&amp;rft.au=Wang+S.Q.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Planta, Margaret B. (2011-11-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jabfm.org/content/24/6/735\">\"Sunscreen and Melanoma: Is Our Prevention Message Correct?\"</a>. <i>The Journal of the American Board of Family Medicine</i>. <b>24</b> (6): 735\u201339. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3122/jabfm.2011.06.100178\">10.3122/jabfm.2011.06.100178</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22086817\">22086817</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140810061440/http://www.jabfm.org/content/24/6/735\">Archived</a> from the original on 2014-08-10.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+the+American+Board+of+Family+Medicine&amp;rft.atitle=Sunscreen+and+Melanoma%3A+Is+Our+Prevention+Message+Correct%3F&amp;rft.volume=24&amp;rft.issue=6&amp;rft.pages=735-39&amp;rft.date=2011-11-01&amp;rft_id=info%3Adoi%2F10.3122%2Fjabfm.2011.06.100178&amp;rft_id=info%3Apmid%2F22086817&amp;rft.aulast=Planta&amp;rft.aufirst=Margaret+B.&amp;rft_id=http%3A%2F%2Fwww.jabfm.org%2Fcontent%2F24%2F6%2F735&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dell2005-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Dell2005_68-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dellavalle, Robert; Drake, Amanda; Graber, Marla; Pointer, Lauren; Johnson, Kathryn; McNealy, Kristie; Schilling, Lisa (2005-10-19). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cochrane.org/CD003697/SKIN_currently-there-is-no-clear-evidence-that-cholesterol-drugs-reduce-melanoma-risk.\">\"Statins and fibrates for preventing melanoma\"</a>. <i>Cochrane Database of Systematic Reviews</i> (4): CD003697. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD003697.pub2\">10.1002/14651858.CD003697.pub2</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1465-1858\">1465-1858</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16235336\">16235336</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Statins+and+fibrates+for+preventing+melanoma&amp;rft.issue=4&amp;rft.pages=CD003697&amp;rft.date=2005-10-19&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F16235336&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003697.pub2&amp;rft.aulast=Dellavalle&amp;rft.aufirst=Robert&amp;rft.au=Drake%2C+Amanda&amp;rft.au=Graber%2C+Marla&amp;rft.au=Pointer%2C+Lauren&amp;rft.au=Johnson%2C+Kathryn&amp;rft.au=McNealy%2C+Kristie&amp;rft.au=Schilling%2C+Lisa&amp;rft_id=http%3A%2F%2Fwww.cochrane.org%2FCD003697%2FSKIN_currently-there-is-no-clear-evidence-that-cholesterol-drugs-reduce-melanoma-risk.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Freeman, SR; Drake, AL; Heilig, LF; Graber, M; McNealy, K; Schilling, LM; Dellavalle, RP (1 November 2006). \"Statins, fibrates, and melanoma risk: a systematic review and meta-analysis\". <i>Journal of the National Cancer Institute</i>. <b>98</b> (21): 1538\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/jnci/djj412\">10.1093/jnci/djj412</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17077356\">17077356</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.atitle=Statins%2C+fibrates%2C+and+melanoma+risk%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=98&amp;rft.issue=21&amp;rft.pages=1538-46&amp;rft.date=2006-11-01&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjj412&amp;rft_id=info%3Apmid%2F17077356&amp;rft.aulast=Freeman&amp;rft.aufirst=SR&amp;rft.au=Drake%2C+AL&amp;rft.au=Heilig%2C+LF&amp;rft.au=Graber%2C+M&amp;rft.au=McNealy%2C+K&amp;rft.au=Schilling%2C+LM&amp;rft.au=Dellavalle%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120711150413/http://www.malignant-melanoma.org/sentinel-node-biopsy/sentinel-node-biopsy-false-positivity/\">\"The Sentinel Node Biopsy Procedure in Melanoma does not offer a survival advantage\"</a>. Malignant Melanoma. 2008-01-08. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.malignant-melanoma.org/sentinel-node-biopsy/sentinel-node-biopsy-false-positivity/\">the original</a> on 2012-07-11<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-08-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Sentinel+Node+Biopsy+Procedure+in+Melanoma+does+not+offer+a+survival+advantage&amp;rft.pub=Malignant+Melanoma&amp;rft.date=2008-01-08&amp;rft_id=http%3A%2F%2Fwww.malignant-melanoma.org%2Fsentinel-node-biopsy%2Fsentinel-node-biopsy-false-positivity%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kyrgidis, Athanassios; Tzellos, Thrasivoulos; Mocellin, Simone; Apalla, Zoe; Lallas, Aimilios; Pilati, Pierluigi; Stratigos, Alexander (2015-05-16). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cochrane.org/CD010307/SKIN_lymph-node-biopsy-followed-lymph-node-dissection-localised-skin-cancer\">\"Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma\"</a>. <i>Cochrane Database of Systematic Reviews</i> (5): CD010307. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD010307.pub2\">10.1002/14651858.CD010307.pub2</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1465-1858\">1465-1858</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25978975\">25978975</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Sentinel+lymph+node+biopsy+followed+by+lymph+node+dissection+for+localised+primary+cutaneous+melanoma&amp;rft.issue=5&amp;rft.pages=CD010307&amp;rft.date=2015-05-16&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F25978975&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010307.pub2&amp;rft.aulast=Kyrgidis&amp;rft.aufirst=Athanassios&amp;rft.au=Tzellos%2C+Thrasivoulos&amp;rft.au=Mocellin%2C+Simone&amp;rft.au=Apalla%2C+Zoe&amp;rft.au=Lallas%2C+Aimilios&amp;rft.au=Pilati%2C+Pierluigi&amp;rft.au=Stratigos%2C+Alexander&amp;rft_id=https%3A%2F%2Fwww.cochrane.org%2FCD010307%2FSKIN_lymph-node-biopsy-followed-lymph-node-dissection-localised-skin-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-72\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-72\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Clark GS, Pappas-Politis EC, Cherpelis BS,  et al. (July 2008). \"Surgical management of melanoma in situ on chronically sun-damaged skin\". <i>Cancer Control</i>. <b>15</b> (3): 216\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/107327480801500304\">10.1177/107327480801500304</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18596673\">18596673</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Control&amp;rft.atitle=Surgical+management+of+melanoma+in+situ+on+chronically+sun-damaged+skin&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=216-24&amp;rft.date=2008-07&amp;rft_id=info%3Adoi%2F10.1177%2F107327480801500304&amp;rft_id=info%3Apmid%2F18596673&amp;rft.aulast=Clark&amp;rft.aufirst=GS&amp;rft.au=Pappas-Politis%2C+EC&amp;rft.au=Cherpelis%2C+BS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Balch C, Urist M, Karakousis C, Smith T, Temple W, Drzewiecki K, Jewell W, Bartolucci A, Mihm M, Barnhill R (1993). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1242959\">\"Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial\"</a>. <i>Ann Surg</i>. <b>218</b> (3): 262\u201367; discussion 267\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00000658-199309000-00005\">10.1097/00000658-199309000-00005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1242959\">1242959</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8373269\">8373269</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann+Surg&amp;rft.atitle=Efficacy+of+2-cm+surgical+margins+for+intermediate-thickness+melanomas+%281+to+4+mm%29.+Results+of+a+multi-institutional+randomized+surgical+trial&amp;rft.volume=218&amp;rft.issue=3&amp;rft.pages=262-67%3B+discussion+267-9&amp;rft.date=1993&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1242959&amp;rft_id=info%3Apmid%2F8373269&amp;rft_id=info%3Adoi%2F10.1097%2F00000658-199309000-00005&amp;rft.aulast=Balch&amp;rft.aufirst=C&amp;rft.au=Urist%2C+M&amp;rft.au=Karakousis%2C+C&amp;rft.au=Smith%2C+T&amp;rft.au=Temple%2C+W&amp;rft.au=Drzewiecki%2C+K&amp;rft.au=Jewell%2C+W&amp;rft.au=Bartolucci%2C+A&amp;rft.au=Mihm%2C+M&amp;rft.au=Barnhill%2C+R&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1242959&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-74\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sladden, MJ; Balch, C; Barzilai, DA; Berg, D; Freiman, A; Handiside, T; Hollis, S; Lens, MB; Thompson, JF (7 October 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S1516-31802011000100014\">\"Surgical excision margins for primary cutaneous melanoma\"</a> <span style=\"font-size:85%;\">(Submitted manuscript)</span>. <i>The Cochrane Database of Systematic Reviews</i> (4): CD004835. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD004835.pub2\">10.1002/14651858.CD004835.pub2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19821334\">19821334</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Surgical+excision+margins+for+primary+cutaneous+melanoma&amp;rft.issue=4&amp;rft.pages=CD004835&amp;rft.date=2009-10-07&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004835.pub2&amp;rft_id=info%3Apmid%2F19821334&amp;rft.aulast=Sladden&amp;rft.aufirst=MJ&amp;rft.au=Balch%2C+C&amp;rft.au=Barzilai%2C+DA&amp;rft.au=Berg%2C+D&amp;rft.au=Freiman%2C+A&amp;rft.au=Handiside%2C+T&amp;rft.au=Hollis%2C+S&amp;rft.au=Lens%2C+MB&amp;rft.au=Thompson%2C+JF&amp;rft_id=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1516-31802011000100014&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mikhail91-75\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mikhail91_75-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mikhail91_75-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Mohs, Frederic Edward; Mikhail, George R. (January 1991). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=8j9sAAAAMAAJ\"><i>Mohs micrographic surgery</i></a>. W.B. Saunders. pp.&#160;13\u201314. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-7216-3415-9\" title=\"Special:BookSources/978-0-7216-3415-9\">978-0-7216-3415-9</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160107215207/https://books.google.com/books?id=8j9sAAAAMAAJ\">Archived</a> from the original on 2016-01-07.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Mohs+micrographic+surgery&amp;rft.pages=13-14&amp;rft.pub=W.B.+Saunders&amp;rft.date=1991-01&amp;rft.isbn=978-0-7216-3415-9&amp;rft.aulast=Mohs&amp;rft.aufirst=Frederic+Edward&amp;rft.au=Mikhail%2C+George+R.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D8j9sAAAAMAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bene08-76\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bene08_76-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bene08_76-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bene NI, Healy C, Coldiron BM (May 2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=1076-0512&amp;date=2008&amp;volume=34&amp;issue=5&amp;spage=660\">\"Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases\"</a>. <i>Dermatol Surg</i>. <b>34</b> (5): 660\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1524-4725.2007.34124.x\">10.1111/j.1524-4725.2007.34124.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18261099\">18261099</a>. <q>Cure rate as high as 98% for small melanoma in situ, and as high as 95% noted for lentigo maligna variant of melanona in situ has been reported with <a href=\"/wiki/Mohs_surgery\" title=\"Mohs surgery\">Mohs surgery</a>.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dermatol+Surg&amp;rft.atitle=Mohs+micrographic+surgery+is+accurate+95.1%25+of+the+time+for+melanoma+in+situ%3A+a+prospective+study+of+167+cases&amp;rft.volume=34&amp;rft.issue=5&amp;rft.pages=660-64&amp;rft.date=2008-05&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1524-4725.2007.34124.x&amp;rft_id=info%3Apmid%2F18261099&amp;rft.aulast=Bene&amp;rft.aufirst=NI&amp;rft.au=Healy%2C+C&amp;rft.au=Coldiron%2C+BM&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D1076-0512%26date%3D2008%26volume%3D34%26issue%3D5%26spage%3D660&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090106181514/http://www.malignant-melanoma.org/surgery/lymph-node-dissection-surgery/\">\"The Screening and Surveillance of Ultrasound in Melanoma trial (SUNMEL)\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.malignant-melanoma.org/surgery/lymph-node-dissection-surgery/\">the original</a> on 2009-01-06.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Screening+and+Surveillance+of+Ultrasound+in+Melanoma+trial+%28SUNMEL%29&amp;rft_id=http%3A%2F%2Fwww.malignant-melanoma.org%2Fsurgery%2Flymph-node-dissection-surgery%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crowson, AN; Haskell, H (Oct 2013). \"The role of sentinel lymph-node biopsy in the management of cutaneous melanoma\". <i>Giornale Italiano di Dermatologia e Venereologia&#160;: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia</i>. <b>148</b> (5): 493\u201399. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24005142\">24005142</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Giornale+Italiano+di+Dermatologia+e+Venereologia+%3A+Organo+Ufficiale%2C+Societa+Italiana+di+Dermatologia+e+Sifilografia&amp;rft.atitle=The+role+of+sentinel+lymph-node+biopsy+in+the+management+of+cutaneous+melanoma&amp;rft.volume=148&amp;rft.issue=5&amp;rft.pages=493-99&amp;rft.date=2013-10&amp;rft_id=info%3Apmid%2F24005142&amp;rft.aulast=Crowson&amp;rft.aufirst=AN&amp;rft.au=Haskell%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ross, MI; Gershenwald, JE (May\u2013Jun 2013). \"Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience\". <i>Clinics in Dermatology</i>. <b>31</b> (3): 298\u2013310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.clindermatol.2012.08.004\">10.1016/j.clindermatol.2012.08.004</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23608449\">23608449</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinics+in+Dermatology&amp;rft.atitle=Sentinel+lymph+node+biopsy+for+melanoma%3A+a+critical+update+for+dermatologists+after+two+decades+of+experience&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=298-310&amp;rft.date=2013-05%2F2013-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2012.08.004&amp;rft_id=info%3Apmid%2F23608449&amp;rft.aulast=Ross&amp;rft.aufirst=MI&amp;rft.au=Gershenwald%2C+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-AADfive-80\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-AADfive_80-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-AADfive_80-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-AADfive_80-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-AADfive_80-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite id=\"CITEREFAmerican_Academy_of_Dermatology2013\" class=\"citation\"><a href=\"/wiki/American_Academy_of_Dermatology\" title=\"American Academy of Dermatology\">American Academy of Dermatology</a> (February 2013), <a rel=\"nofollow\" class=\"external text\" href=\"http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-dermatology/\">\"Five Things Physicians and Patients Should Question\"</a>, <i><a href=\"/wiki/Choosing_Wisely\" title=\"Choosing Wisely\">Choosing Wisely</a>: an initiative of the <a href=\"/wiki/ABIM_Foundation\" class=\"mw-redirect\" title=\"ABIM Foundation\">ABIM Foundation</a></i>, <a href=\"/wiki/American_Academy_of_Dermatology\" title=\"American Academy of Dermatology\">American Academy of Dermatology</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131201171621/http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-dermatology/\">archived</a> from the original on 1 December 2013<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">5 December</span> 2013</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Choosing+Wisely%3A+an+initiative+of+the+ABIM+Foundation&amp;rft.atitle=Five+Things+Physicians+and+Patients+Should+Question&amp;rft.date=2013-02&amp;rft.au=American+Academy+of+Dermatology&amp;rft_id=http%3A%2F%2Fwww.choosingwisely.org%2Fdoctor-patient-lists%2Famerican-academy-of-dermatology%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span>, which cites\n<ul><li><cite class=\"citation journal\">Bichakjian, CK; Halpern, AC; Johnson, TM; Foote Hood, A; Grichnik, JM; Swetter, SM; Tsao, H; Barbosa, VH; Chuang, TY; Duvic, M; Ho, VC; Sober, AJ; Beutner, KR; Bhushan, R; Smith Begolka, W; American Academy of Dermatology (Nov 2011). \"Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology\". <i>Journal of the American Academy of Dermatology</i>. <b>65</b> (5): 1032\u201347. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jaad.2011.04.031\">10.1016/j.jaad.2011.04.031</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21868127\">21868127</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&amp;rft.atitle=Guidelines+of+care+for+the+management+of+primary+cutaneous+melanoma.+American+Academy+of+Dermatology&amp;rft.volume=65&amp;rft.issue=5&amp;rft.pages=1032-47&amp;rft.date=2011-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2011.04.031&amp;rft_id=info%3Apmid%2F21868127&amp;rft.aulast=Bichakjian&amp;rft.aufirst=CK&amp;rft.au=Halpern%2C+AC&amp;rft.au=Johnson%2C+TM&amp;rft.au=Foote+Hood%2C+A&amp;rft.au=Grichnik%2C+JM&amp;rft.au=Swetter%2C+SM&amp;rft.au=Tsao%2C+H&amp;rft.au=Barbosa%2C+VH&amp;rft.au=Chuang%2C+TY&amp;rft.au=Duvic%2C+M&amp;rft.au=Ho%2C+VC&amp;rft.au=Sober%2C+AJ&amp;rft.au=Beutner%2C+KR&amp;rft.au=Bhushan%2C+R&amp;rft.au=Smith+Begolka%2C+W&amp;rft.au=American+Academy+of+Dermatology&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation book\">American Joint Committee on Cancer (2010).  Edge, Stephen B., ed. <i>AJCC cancer staging manual</i> (7th ed.). Springer. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-387-88440-0\" title=\"Special:BookSources/978-0-387-88440-0\">978-0-387-88440-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=AJCC+cancer+staging+manual&amp;rft.edition=7th&amp;rft.pub=Springer&amp;rft.date=2010&amp;rft.isbn=978-0-387-88440-0&amp;rft.au=American+Joint+Committee+on+Cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite id=\"CITEREFNational_Comprehensive_Cancer_Network2012\" class=\"citation\">National Comprehensive Cancer Network (2012), <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131228154542/https://subscriptions.nccn.org/gl_login.aspx?ReturnURL=http%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2FPDF%2Fmelanoma.pdf\"><i>National Comprehensive Cancer Network clinical practice guidelines in oncology (NCCN Guidelines): melanoma</i></a> <span style=\"font-size:85%;\">(PDF)</span>, <a href=\"/wiki/Fort_Washington,_Pennsylvania\" title=\"Fort Washington, Pennsylvania\">Fort Washington, Pennsylvania</a>: National Comprehensive Cancer Network, archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://subscriptions.nccn.org/gl_login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 28 December 2013<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">5 December</span> 2013</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=National+Comprehensive+Cancer+Network+clinical+practice+guidelines+in+oncology+%28NCCN+Guidelines%29%3A+melanoma&amp;rft.place=Fort+Washington%2C+Pennsylvania&amp;rft.pub=National+Comprehensive+Cancer+Network&amp;rft.date=2012&amp;rft.au=National+Comprehensive+Cancer+Network&amp;rft_id=https%3A%2F%2Fsubscriptions.nccn.org%2Fgl_login.aspx%3FReturnURL%3Dhttp%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fpdf%2Fmelanoma.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Paywall\" title=\"closed access publication \u2013 behind paywall\"><img alt=\"closed access publication \u2013 behind paywall\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/9px-Closed_Access_logo_alternative.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/14px-Closed_Access_logo_alternative.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/18px-Closed_Access_logo_alternative.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></li></ul>\n</span></li>\n<li id=\"cite_note-:0-81\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_81-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_81-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Kempen, Leon (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6094595\">\"Molecular pathology of cutaneous melanoma\"</a>. <i>Melanoma Management</i>. <b>1</b> (2): 151\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/mmt.14.23\">10.2217/mmt.14.23</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC6094595\">6094595</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/30190820\">30190820</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Melanoma+Management&amp;rft.atitle=Molecular+pathology+of+cutaneous+melanoma&amp;rft.volume=1&amp;rft.issue=2&amp;rft.pages=151-64&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6094595&amp;rft_id=info%3Apmid%2F30190820&amp;rft_id=info%3Adoi%2F10.2217%2Fmmt.14.23&amp;rft.aulast=van+Kempen&amp;rft.aufirst=Leon&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6094595&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Brunner13-82\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Brunner13_82-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Brunner13_82-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brunner G, Reitz M, Heinecke A, Lippold A, Berking C, Suter L, Atzpodien J (2013). \"A nine-gene signature predicting clinical outcome in cutaneous melanoma\". <i>J. Cancer Res. Clin. Oncol</i>. <b>139</b> (2): 249\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00432-012-1322-z\">10.1007/s00432-012-1322-z</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23052696\">23052696</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cancer+Res.+Clin.+Oncol.&amp;rft.atitle=A+nine-gene+signature+predicting+clinical+outcome+in+cutaneous+melanoma&amp;rft.volume=139&amp;rft.issue=2&amp;rft.pages=249-58&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1007%2Fs00432-012-1322-z&amp;rft_id=info%3Apmid%2F23052696&amp;rft.aulast=Brunner&amp;rft.aufirst=G&amp;rft.au=Reitz%2C+M&amp;rft.au=Heinecke%2C+A&amp;rft.au=Lippold%2C+A&amp;rft.au=Berking%2C+C&amp;rft.au=Suter%2C+L&amp;rft.au=Atzpodien%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-83\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Swanson N, Lee K, Gorman A, Lee H (2002). \"Biopsy techniques. Diagnosis of melanoma\". <i>Intensive 2011: The Third International Conference on Resource Intensive Applications and Services</i>. <b>20</b> (4): 677\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0733-8635%2802%2900025-6\">10.1016/S0733-8635(02)00025-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12380054\">12380054</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Intensive+2011%3A+The+Third+International+Conference+on+Resource+Intensive+Applications+and+Services&amp;rft.atitle=Biopsy+techniques.+Diagnosis+of+melanoma&amp;rft.volume=20&amp;rft.issue=4&amp;rft.pages=677-80&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0733-8635%2802%2900025-6&amp;rft_id=info%3Apmid%2F12380054&amp;rft.aulast=Swanson&amp;rft.aufirst=N&amp;rft.au=Lee%2C+K&amp;rft.au=Gorman%2C+A&amp;rft.au=Lee%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-84\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kirkwood J, Strawderman M, Ernstoff M, Smith T, Borden E, Blum R (1996). \"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684\". <i>J Clin Oncol</i>. <b>14</b> (1): 7\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.1996.14.1.7\">10.1200/JCO.1996.14.1.7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8558223\">8558223</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Oncol&amp;rft.atitle=Interferon+alfa-2b+adjuvant+therapy+of+high-risk+resected+cutaneous+melanoma%3A+the+Eastern+Cooperative+Oncology+Group+Trial+EST+1684&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=7-17&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.1996.14.1.7&amp;rft_id=info%3Apmid%2F8558223&amp;rft.aulast=Kirkwood&amp;rft.aufirst=J&amp;rft.au=Strawderman%2C+M&amp;rft.au=Ernstoff%2C+M&amp;rft.au=Smith%2C+T&amp;rft.au=Borden%2C+E&amp;rft.au=Blum%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dermatologists&#39;_Management_Guidelines-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Dermatologists&#39;_Management_Guidelines_85-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">English (2010).  Neil H. Cox; John S.C., eds. <a rel=\"nofollow\" class=\"external text\" href=\"http://as.wiley.com/WileyCDA/WileyTitle/productCd-1444335529,descCd-buy.html\"><i>British Association of Dermatologists' management guidelines</i></a>. Wiley-Blackwell. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4443-3552-1\" title=\"Special:BookSources/978-1-4443-3552-1\">978-1-4443-3552-1</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">19 August</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=British+Association+of+Dermatologists%27+management+guidelines&amp;rft.pub=Wiley-Blackwell&amp;rft.date=2010&amp;rft.isbn=978-1-4443-3552-1&amp;rft.au=English&amp;rft_id=http%3A%2F%2Fas.wiley.com%2FWileyCDA%2FWileyTitle%2FproductCd-1444335529%2CdescCd-buy.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mocellin, Simone; Lens, Marko B; Pasquali, Sandro; Pilati, Pierluigi; Chiarion Sileni, Vanna (2013-06-18). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cochrane.org/CD008955/SKIN_interferon-treatment-melanoma-patients-after-surgical-removal-their-tumour\">\"Interferon alpha for the adjuvant treatment of cutaneous melanoma\"</a>. <i>Cochrane Database of Systematic Reviews</i> (6): CD008955. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD008955.pub2\">10.1002/14651858.CD008955.pub2</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1465-1858\">1465-1858</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23775773\">23775773</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interferon+alpha+for+the+adjuvant+treatment+of+cutaneous+melanoma&amp;rft.issue=6&amp;rft.pages=CD008955&amp;rft.date=2013-06-18&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F23775773&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008955.pub2&amp;rft.aulast=Mocellin&amp;rft.aufirst=Simone&amp;rft.au=Lens%2C+Marko+B&amp;rft.au=Pasquali%2C+Sandro&amp;rft.au=Pilati%2C+Pierluigi&amp;rft.au=Chiarion+Sileni%2C+Vanna&amp;rft_id=http%3A%2F%2Fwww.cochrane.org%2FCD008955%2FSKIN_interferon-treatment-melanoma-patients-after-surgical-removal-their-tumour&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-87\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wheatley K, Ives N, Eggermont A,  et al. (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://ascopubs.org/doi/abs/10.1200/jco.2007.25.18_suppl.8526\">\"Interferon-\u03b1 as an adjuvant therapy for melanoma: an individual patient meta-analysis of randomised trials\"</a>. <i>J Clin Oncol</i>. <b>25</b> (18 Suppl): 8526. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/jco.2007.25.18_suppl.8526\">10.1200/jco.2007.25.18_suppl.8526</a> (inactive 2018-09-10).</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Oncol&amp;rft.atitle=Interferon-%CE%B1+as+an+adjuvant+therapy+for+melanoma%3A+an+individual+patient+meta-analysis+of+randomised+trials&amp;rft.volume=25&amp;rft.issue=18+Suppl&amp;rft.pages=8526&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1200%2Fjco.2007.25.18_suppl.8526&amp;rft.aulast=Wheatley&amp;rft.aufirst=K&amp;rft.au=Ives%2C+N&amp;rft.au=Eggermont%2C+A&amp;rft_id=http%3A%2F%2Fascopubs.org%2Fdoi%2Fabs%2F10.1200%2Fjco.2007.25.18_suppl.8526&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kirkwood J, Ibrahim J, Sondak V, Richards J, Flaherty L, Ernstoff M, Smith T, Rao U, Steele M, Blum R (2000). \"High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190\". <i>J Clin Oncol</i>. <b>18</b> (12): 2444\u201358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2000.18.12.2444\">10.1200/JCO.2000.18.12.2444</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10856105\">10856105</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Oncol&amp;rft.atitle=High-+and+low-dose+interferon+alfa-2b+in+high-risk+melanoma%3A+first+analysis+of+intergroup+trial+E1690%2FS9111%2FC9190&amp;rft.volume=18&amp;rft.issue=12&amp;rft.pages=2444-58&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2000.18.12.2444&amp;rft_id=info%3Apmid%2F10856105&amp;rft.aulast=Kirkwood&amp;rft.aufirst=J&amp;rft.au=Ibrahim%2C+J&amp;rft.au=Sondak%2C+V&amp;rft.au=Richards%2C+J&amp;rft.au=Flaherty%2C+L&amp;rft.au=Ernstoff%2C+M&amp;rft.au=Smith%2C+T&amp;rft.au=Rao%2C+U&amp;rft.au=Steele%2C+M&amp;rft.au=Blum%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kirkwood J, Ibrahim J, Sondak V, Ernstoff M, Ross M (2002). \"Interferon alfa-2a for melanoma metastases\". <i>Lancet</i>. <b>359</b> (9310): 978\u201379. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2802%2908001-7\">10.1016/S0140-6736(02)08001-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11918944\">11918944</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Interferon+alfa-2a+for+melanoma+metastases&amp;rft.volume=359&amp;rft.issue=9310&amp;rft.pages=978-79&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2802%2908001-7&amp;rft_id=info%3Apmid%2F11918944&amp;rft.aulast=Kirkwood&amp;rft.aufirst=J&amp;rft.au=Ibrahim%2C+J&amp;rft.au=Sondak%2C+V&amp;rft.au=Ernstoff%2C+M&amp;rft.au=Ross%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-90\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weight RM, Viator JA, Dale PS, Caldwell CW, Lisle AE (2006). \"Photoacoustic detection of metastatic melanoma cells in the human circulatory system\". <i>Opt. Lett</i>. <b>31</b> (20): 2998\u20133000. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1364/OL.31.002998\">10.1364/OL.31.002998</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17001379\">17001379</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Opt.+Lett.&amp;rft.atitle=Photoacoustic+detection+of+metastatic+melanoma+cells+in+the+human+circulatory+system&amp;rft.volume=31&amp;rft.issue=20&amp;rft.pages=2998-3000&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1364%2FOL.31.002998&amp;rft_id=info%3Apmid%2F17001379&amp;rft.aulast=Weight&amp;rft.aufirst=RM&amp;rft.au=Viator%2C+JA&amp;rft.au=Dale%2C+PS&amp;rft.au=Caldwell%2C+CW&amp;rft.au=Lisle%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-91\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bajetta E, Del Vecchio M, Bernard-Marty C, Vitali M, Buzzoni R, Rixe O, Nova P, Aglione S, Taillibert S, Khayat D (2002). \"Metastatic melanoma: chemotherapy\". <i>Semin Oncol</i>. <b>29</b> (5): 427\u201345. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/sonc.2002.35238\">10.1053/sonc.2002.35238</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12407508\">12407508</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Oncol&amp;rft.atitle=Metastatic+melanoma%3A+chemotherapy&amp;rft.volume=29&amp;rft.issue=5&amp;rft.pages=427-45&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2002.35238&amp;rft_id=info%3Apmid%2F12407508&amp;rft.aulast=Bajetta&amp;rft.aufirst=E&amp;rft.au=Del+Vecchio%2C+M&amp;rft.au=Bernard-Marty%2C+C&amp;rft.au=Vitali%2C+M&amp;rft.au=Buzzoni%2C+R&amp;rft.au=Rixe%2C+O&amp;rft.au=Nova%2C+P&amp;rft.au=Aglione%2C+S&amp;rft.au=Taillibert%2C+S&amp;rft.au=Khayat%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Buzaid A (2004). \"Management of metastatic cutaneous melanoma\". <i>Oncology (Williston Park)</i>. <b>18</b> (11): 1443\u201350; discussion 1457\u201359. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15609471\">15609471</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology+%28Williston+Park%29&amp;rft.atitle=Management+of+metastatic+cutaneous+melanoma&amp;rft.volume=18&amp;rft.issue=11&amp;rft.pages=1443-50%3B+discussion+1457-59&amp;rft.date=2004&amp;rft_id=info%3Apmid%2F15609471&amp;rft.au=Buzaid+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Current_Future_Melanoma-93\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Current_Future_Melanoma_93-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Current_Future_Melanoma_93-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Current_Future_Melanoma_93-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Current_Future_Melanoma_93-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Maverakis E, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F (2015). \"Metastatic melanoma \u2013 a review of current and future treatment options\". <i>Acta Derm Venereol</i>. <b>95</b> (5): 516\u2013524. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2340/00015555-2035\">10.2340/00015555-2035</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25520039\">25520039</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Derm+Venereol&amp;rft.atitle=Metastatic+melanoma+%E2%80%93+a+review+of+current+and+future+treatment+options&amp;rft.volume=95&amp;rft.issue=5&amp;rft.pages=516-524&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.2340%2F00015555-2035&amp;rft_id=info%3Apmid%2F25520039&amp;rft.aulast=Maverakis&amp;rft.aufirst=E&amp;rft.au=Cornelius%2C+LA&amp;rft.au=Bowen%2C+GM&amp;rft.au=Phan%2C+T&amp;rft.au=Patel%2C+FB&amp;rft.au=Fitzmaurice%2C+S&amp;rft.au=He%2C+Y&amp;rft.au=Burrall%2C+B&amp;rft.au=Duong%2C+C&amp;rft.au=Kloxin%2C+AM&amp;rft.au=Sultani%2C+H&amp;rft.au=Wilken%2C+R&amp;rft.au=Martinez%2C+SR&amp;rft.au=Patel%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-94\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Danson S, Lorigan P (2005). \"Improving outcomes in advanced malignant melanoma: update on systemic therapy\". <i>Drugs</i>. <b>65</b> (6): 733\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00003495-200565060-00002\">10.2165/00003495-200565060-00002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15819587\">15819587</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Improving+outcomes+in+advanced+malignant+melanoma%3A+update+on+systemic+therapy&amp;rft.volume=65&amp;rft.issue=6&amp;rft.pages=733-43&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-200565060-00002&amp;rft_id=info%3Apmid%2F15819587&amp;rft.aulast=Danson&amp;rft.aufirst=S&amp;rft.au=Lorigan%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-95\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bhatia S, Tykodi SS, Thompson JA (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancernetwork.com/display/article/10165/1413720\">\"Treatment of Metastatic Melanoma: An Overview\"</a>. <i>Oncology</i>. <b>23</b> (6): 488\u201396. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459\">2737459</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19544689\">19544689</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090530081051/http://www.cancernetwork.com/display/article/10165/1413720\">Archived</a> from the original on 2009-05-30.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology&amp;rft.atitle=Treatment+of+Metastatic+Melanoma%3A+An+Overview&amp;rft.volume=23&amp;rft.issue=6&amp;rft.pages=488-96&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2737459&amp;rft_id=info%3Apmid%2F19544689&amp;rft.aulast=Bhatia&amp;rft.aufirst=S&amp;rft.au=Tykodi%2C+SS&amp;rft.au=Thompson%2C+JA&amp;rft_id=http%3A%2F%2Fwww.cancernetwork.com%2Fdisplay%2Farticle%2F10165%2F1413720&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pas2018-96\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pas2018_96-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pas2018_96-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Pas2018_96-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Pas2018_96-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Pas2018_96-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pasquali, Sandro; Hadjinicolaou, Andreas V; Chiarion Sileni, Vanna; Rossi, Carlo Riccardo; Mocellin, Simone (2018-02-06). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cochrane.org/CD011123/SKIN_systemic-treatments-tablets-or-injections-taken-metastatic-melanoma-expanded-its-starting-point\">\"Systemic treatments for metastatic cutaneous melanoma\"</a>. <i>Cochrane Database of Systematic Reviews</i>. <b>2</b>: CD011123. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD011123.pub2\">10.1002/14651858.CD011123.pub2</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1465-1858\">1465-1858</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29405038\">29405038</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Systemic+treatments+for+metastatic+cutaneous+melanoma&amp;rft.volume=2&amp;rft.pages=CD011123&amp;rft.date=2018-02-06&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F29405038&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD011123.pub2&amp;rft.aulast=Pasquali&amp;rft.aufirst=Sandro&amp;rft.au=Hadjinicolaou%2C+Andreas+V&amp;rft.au=Chiarion+Sileni%2C+Vanna&amp;rft.au=Rossi%2C+Carlo+Riccardo&amp;rft.au=Mocellin%2C+Simone&amp;rft_id=https%3A%2F%2Fwww.cochrane.org%2FCD011123%2FSKIN_systemic-treatments-tablets-or-injections-taken-metastatic-melanoma-expanded-its-starting-point&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-97\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rosenberg, SA; Restifo, NP (3 April 2015). \"Adoptive cell transfer as personalized immunotherapy for human cancer\". <i>Science</i>. <b>348</b> (6230): 62\u201368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.aaa4967\">10.1126/science.aaa4967</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25838374\">25838374</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Adoptive+cell+transfer+as+personalized+immunotherapy+for+human+cancer&amp;rft.volume=348&amp;rft.issue=6230&amp;rft.pages=62-68&amp;rft.date=2015-04-03&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aaa4967&amp;rft_id=info%3Apmid%2F25838374&amp;rft.aulast=Rosenberg&amp;rft.aufirst=SA&amp;rft.au=Restifo%2C+NP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-98\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zang YW, Gu XD, Xiang JB, Chen ZY (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.medscimonit.com/download/index/idArt/890496\">\"Clinical application of adoptive T cell therapy in solid tumors\"</a>. <i>Med. Sci. Monit</i>. <b>20</b>: 953\u201359. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.12659/MSM.890496\">10.12659/MSM.890496</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4063985\">4063985</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24912947\">24912947</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170629085737/http://medscimonit.com/download/index/idArt/890496\">Archived</a> from the original on 2017-06-29.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Med.+Sci.+Monit.&amp;rft.atitle=Clinical+application+of+adoptive+T+cell+therapy+in+solid+tumors&amp;rft.volume=20&amp;rft.pages=953-59&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4063985&amp;rft_id=info%3Apmid%2F24912947&amp;rft_id=info%3Adoi%2F10.12659%2FMSM.890496&amp;rft.aulast=Zang&amp;rft.aufirst=YW&amp;rft.au=Gu%2C+XD&amp;rft.au=Xiang%2C+JB&amp;rft.au=Chen%2C+ZY&amp;rft_id=http%3A%2F%2Fwww.medscimonit.com%2Fdownload%2Findex%2FidArt%2F890496&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-99\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Van Lint, S; Wilgenhof, S; Heirman, C; Corthals, J; Breckpot, K; Bonehill, A; Neyns, B; Thielemans, K (September 2014). \"Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula\". <i>Cancer Immunology, Immunotherapy&#160;: CII</i>. <b>63</b> (9): 959\u201367. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00262-014-1558-3\">10.1007/s00262-014-1558-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24878889\">24878889</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Immunology%2C+Immunotherapy+%3A+CII&amp;rft.atitle=Optimized+dendritic+cell-based+immunotherapy+for+melanoma%3A+the+TriMix-formula&amp;rft.volume=63&amp;rft.issue=9&amp;rft.pages=959-67&amp;rft.date=2014-09&amp;rft_id=info%3Adoi%2F10.1007%2Fs00262-014-1558-3&amp;rft_id=info%3Apmid%2F24878889&amp;rft.aulast=Van+Lint&amp;rft.aufirst=S&amp;rft.au=Wilgenhof%2C+S&amp;rft.au=Heirman%2C+C&amp;rft.au=Corthals%2C+J&amp;rft.au=Breckpot%2C+K&amp;rft.au=Bonehill%2C+A&amp;rft.au=Neyns%2C+B&amp;rft.au=Thielemans%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-100\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_100-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_100-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tzellos, Thrasivoulos; Kyrgidis, Athanassios; Mocellin, Simone; Chan, An-Wen; Pilati, Pierluigi; Apalla, Zoe (2014-12-19). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cochrane.org/CD010308/SKIN_interventions-treatment-melanoma-situ-including-lentigo-maligna\">\"Interventions for melanoma in situ, including lentigo maligna\"</a>. <i>Cochrane Database of Systematic Reviews</i> (12): CD010308. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD010308.pub2\">10.1002/14651858.CD010308.pub2</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1465-1858\">1465-1858</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25526608\">25526608</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interventions+for+melanoma+in+situ%2C+including+lentigo+maligna&amp;rft.issue=12&amp;rft.pages=CD010308&amp;rft.date=2014-12-19&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F25526608&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010308.pub2&amp;rft.aulast=Tzellos&amp;rft.aufirst=Thrasivoulos&amp;rft.au=Kyrgidis%2C+Athanassios&amp;rft.au=Mocellin%2C+Simone&amp;rft.au=Chan%2C+An-Wen&amp;rft.au=Pilati%2C+Pierluigi&amp;rft.au=Apalla%2C+Zoe&amp;rft_id=http%3A%2F%2Fwww.cochrane.org%2FCD010308%2FSKIN_interventions-treatment-melanoma-situ-including-lentigo-maligna&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-101\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson TM, Headington JT, Baker SR, Lowe L (November 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(97)70114-2\">\"Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the \"square\" procedure\"</a>. <i>J. Am. Acad. Dermatol</i>. <b>37</b> (5 Pt 1): 758\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0190-9622%2897%2970114-2\">10.1016/S0190-9622(97)70114-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9366823\">9366823</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.atitle=Usefulness+of+the+staged+excision+for+lentigo+maligna+and+lentigo+maligna+melanoma%3A+the+%22square%22+procedure&amp;rft.volume=37&amp;rft.issue=5+Pt+1&amp;rft.pages=758-64&amp;rft.date=1997-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0190-9622%2897%2970114-2&amp;rft_id=info%3Apmid%2F9366823&amp;rft.aulast=Johnson&amp;rft.aufirst=TM&amp;rft.au=Headington%2C+JT&amp;rft.au=Baker%2C+SR&amp;rft.au=Lowe%2C+L&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0190-9622%2897%2970114-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-102\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hill, R; Healy, B; Holloway, L; Kuncic, Z; Thwaites, D; Baldock, C (21 March 2014). \"Advances in kilovoltage x-ray beam dosimetry\". <i>Physics in Medicine and Biology</i>. <b>59</b> (6): R183\u2013231. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1088/0031-9155/59/6/r183\">10.1088/0031-9155/59/6/r183</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24584183\">24584183</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Physics+in+Medicine+and+Biology&amp;rft.atitle=Advances+in+kilovoltage+x-ray+beam+dosimetry&amp;rft.volume=59&amp;rft.issue=6&amp;rft.pages=R183-231&amp;rft.date=2014-03-21&amp;rft_id=info%3Adoi%2F10.1088%2F0031-9155%2F59%2F6%2Fr183&amp;rft_id=info%3Apmid%2F24584183&amp;rft.aulast=Hill&amp;rft.aufirst=R&amp;rft.au=Healy%2C+B&amp;rft.au=Holloway%2C+L&amp;rft.au=Kuncic%2C+Z&amp;rft.au=Thwaites%2C+D&amp;rft.au=Baldock%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-103\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bastiaannet E, Beukema J, Hoekstra H (2005). \"Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications\". <i>Cancer Treat Rev</i>. <b>31</b> (1): 18\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ctrv.2004.09.005\">10.1016/j.ctrv.2004.09.005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15707701\">15707701</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Treat+Rev&amp;rft.atitle=Radiation+therapy+following+lymph+node+dissection+in+melanoma+patients%3A+treatment%2C+outcome+and+complications&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=18-26&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2004.09.005&amp;rft_id=info%3Apmid%2F15707701&amp;rft.aulast=Bastiaannet&amp;rft.aufirst=E&amp;rft.au=Beukema%2C+J&amp;rft.au=Hoekstra%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-104\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-104\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Boyer (1999). <i>Primary Care Oncology</i>. Ford.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Primary+Care+Oncology&amp;rft.date=1999&amp;rft.au=Boyer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-105\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Homsi J, Kashani-Sabet M, Messina J, Daud A (2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://wayback.archive-it.org/all/20080216112052/https://www.moffitt.usf.edu/pubs/ccj/v12n4/pdf/223.pdf\">\"Cutaneous melanoma: prognostic factors\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Cancer Control</i>. <b>12</b> (4): 223\u201329. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/107327480501200403\">10.1177/107327480501200403</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16258493\">16258493</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.moffitt.usf.edu/pubs/ccj/v12n4/pdf/223.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2008-02-16.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Control&amp;rft.atitle=Cutaneous+melanoma%3A+prognostic+factors&amp;rft.volume=12&amp;rft.issue=4&amp;rft.pages=223-29&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1177%2F107327480501200403&amp;rft_id=info%3Apmid%2F16258493&amp;rft.aulast=Homsi&amp;rft.aufirst=J&amp;rft.au=Kashani-Sabet%2C+M&amp;rft.au=Messina%2C+J&amp;rft.au=Daud%2C+A&amp;rft_id=https%3A%2F%2Fwww.moffitt.usf.edu%2Fpubs%2Fccj%2Fv12n4%2Fpdf%2F223.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-106\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bae, JM; Choi, YY; Kim, DS; Lee, JH; Jang, HS; Lee, JH; Kim, H; Oh, BH; Roh, MR; Nam, KA; Chung, KY (January 2015). \"Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies\". <i>Journal of the American Academy of Dermatology</i>. <b>72</b> (1): 59\u201370. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jaad.2014.09.029\">10.1016/j.jaad.2014.09.029</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25440435\">25440435</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&amp;rft.atitle=Metastatic+melanomas+of+unknown+primary+show+better+prognosis+than+those+of+known+primary%3A+a+systematic+review+and+meta-analysis+of+observational+studies&amp;rft.volume=72&amp;rft.issue=1&amp;rft.pages=59-70&amp;rft.date=2015-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2014.09.029&amp;rft_id=info%3Apmid%2F25440435&amp;rft.aulast=Bae&amp;rft.aufirst=JM&amp;rft.au=Choi%2C+YY&amp;rft.au=Kim%2C+DS&amp;rft.au=Lee%2C+JH&amp;rft.au=Jang%2C+HS&amp;rft.au=Lee%2C+JH&amp;rft.au=Kim%2C+H&amp;rft.au=Oh%2C+BH&amp;rft.au=Roh%2C+MR&amp;rft.au=Nam%2C+KA&amp;rft.au=Chung%2C+KY&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-107\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www-dep.iarc.fr/\">\"CANCERMondial (GLOBOCAN)\"</a>. <i><a href=\"/w/index.php?title=GLOBOCAN&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"GLOBOCAN (page does not exist)\">GLOBOCAN</a></i>. 2010. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20120217163455/http://www-dep.iarc.fr/\">Archived</a> from the original on 17 February 2012<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">12 August</span> 2010</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GLOBOCAN&amp;rft.atitle=CANCERMondial+%28GLOBOCAN%29&amp;rft.date=2010&amp;rft_id=http%3A%2F%2Fwww-dep.iarc.fr%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-108\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Berwick M, Wiggins C (2006). \"The current epidemiology of cutaneous malignant melanoma\". <i>Front Biosci</i>. <b>11</b>: 1244\u201354. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2741/1877\">10.2741/1877</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16368510\">16368510</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Front+Biosci&amp;rft.atitle=The+current+epidemiology+of+cutaneous+malignant+melanoma&amp;rft.volume=11&amp;rft.pages=1244-54&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.2741%2F1877&amp;rft_id=info%3Apmid%2F16368510&amp;rft.aulast=Berwick&amp;rft.aufirst=M&amp;rft.au=Wiggins%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-aihw2012-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-aihw2012_109-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://aihw.gov.au/cancer/cancer-in-australia-overview-2012/\">\"Cancer in Australia: an overview 2012\"</a>. AIHW. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140602195619/http://aihw.gov.au/cancer/cancer-in-australia-overview-2012/\">Archived</a> from the original on 2014-06-02.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Cancer+in+Australia%3A+an+overview+2012&amp;rft.pub=AIHW&amp;rft_id=http%3A%2F%2Faihw.gov.au%2Fcancer%2Fcancer-in-australia-overview-2012%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Vital2015-110\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Vital2015_110-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Vital2015_110-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Guy GP, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC (2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm\">\"Vital signs: melanoma incidence and mortality trends and projections \u2013 United States, 1982\u20132030\"</a>. <i>MMWR Morb. Mortal. Wkly. Rep</i>. <b>64</b> (21): 591\u20136. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4584771\">4584771</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26042651\">26042651</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170531141344/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm\">Archived</a> from the original on 2017-05-31.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR+Morb.+Mortal.+Wkly.+Rep.&amp;rft.atitle=Vital+signs%3A+melanoma+incidence+and+mortality+trends+and+projections+%E2%80%93+United+States%2C+1982%E2%80%932030&amp;rft.volume=64&amp;rft.issue=21&amp;rft.pages=591-6&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4584771&amp;rft_id=info%3Apmid%2F26042651&amp;rft.aulast=Guy&amp;rft.aufirst=GP&amp;rft.au=Thomas%2C+CC&amp;rft.au=Thompson%2C+T&amp;rft.au=Watson%2C+M&amp;rft.au=Massetti%2C+GM&amp;rft.au=Richardson%2C+LC&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fpreview%2Fmmwrhtml%2Fmm6421a6.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-111\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/cancer/skin/statistics/\">\"CDC \u2013 Skin Cancer Statistics\"</a>. <i>www.cdc.gov</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170410214142/https://www.cdc.gov/cancer/skin/statistics/\">Archived</a> from the original on 2017-04-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-04-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cdc.gov&amp;rft.atitle=CDC+%E2%80%93+Skin+Cancer+Statistics&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fskin%2Fstatistics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-112\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html\">\"Key Statistics for Melanoma Skin Cancer\"</a>. <i>www.cancer.org</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170410135926/https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html\">Archived</a> from the original on 2017-04-10<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-04-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cancer.org&amp;rft.atitle=Key+Statistics+for+Melanoma+Skin+Cancer&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Fmelanoma-skin-cancer%2Fabout%2Fkey-statistics.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-urteaga-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urteaga_113-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Urteaga O, Pack G (1966). \"On the antiquity of melanoma\". <i>Cancer</i>. <b>19</b> (5): 607\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/1097-0142%28196605%2919%3A5%3C607%3A%3AAID-CNCR2820190502%3E3.0.CO%3B2-8\">10.1002/1097-0142(196605)19:5&#60;607::AID-CNCR2820190502&#62;3.0.CO;2-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5326247\">5326247</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=On+the+antiquity+of+melanoma&amp;rft.volume=19&amp;rft.issue=5&amp;rft.pages=607-10&amp;rft.date=1966&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%28196605%2919%3A5%3C607%3A%3AAID-CNCR2820190502%3E3.0.CO%3B2-8&amp;rft_id=info%3Apmid%2F5326247&amp;rft.aulast=Urteaga&amp;rft.aufirst=O&amp;rft.au=Pack%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-bodenham-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-bodenham_114-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bodenham D (1968). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2312310\">\"A study of 650 observed malignant melanomas in the South-West region\"</a>. <i>Annals of the Royal College of Surgeons of England</i>. <b>43</b> (4): 218\u201339. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2312310\">2312310</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5698493\">5698493</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+Royal+College+of+Surgeons+of+England&amp;rft.atitle=A+study+of+650+observed+malignant+melanomas+in+the+South-West+region&amp;rft.volume=43&amp;rft.issue=4&amp;rft.pages=218-39&amp;rft.date=1968&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2312310&amp;rft_id=info%3Apmid%2F5698493&amp;rft.au=Bodenham+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2312310&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-laennec-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-laennec_115-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Laennec RTH (1806). \"Sur les melanoses\". <i>Bulletin de la Faculte de Medecine de Paris</i>. <b>1</b>: 24\u201326.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bulletin+de+la+Faculte+de+Medecine+de+Paris&amp;rft.atitle=Sur+les+melanoses&amp;rft.volume=1&amp;rft.pages=24-26&amp;rft.date=1806&amp;rft.au=Laennec+RTH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-norris1-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-norris1_116-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Norris, W. (1820). \"A case of fungoid disease\". <i>Edinb. Med. Surg. J</i>. <b>16</b>: 562\u201365.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Edinb.+Med.+Surg.+J.&amp;rft.atitle=A+case+of+fungoid+disease&amp;rft.volume=16&amp;rft.pages=562-65&amp;rft.date=1820&amp;rft.au=Norris%2C+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-117\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-117\">^</a></b></span> <span class=\"reference-text\">Norris W. Eight cases of Melanosis with pathological and therapeutical remarks on that disease. London: Longman; 1857.</span>\n</li>\n<li id=\"cite_note-cooper-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cooper_118-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Cooper, Samuel (1844). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=hgE0AQAAMAAJ\"><i>The First Lines of the Theory and Practice of Surgery: Including the Principle Operations</i></a>. S.S. and W. Wood.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+First+Lines+of+the+Theory+and+Practice+of+Surgery%3A+Including+the+Principle+Operations&amp;rft.pub=S.S.+and+W.+Wood&amp;rft.date=1844&amp;rft.aulast=Cooper&amp;rft.aufirst=Samuel&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DhgE0AQAAMAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MW_Collegiate-119\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MW_Collegiate_119-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFMerriam-Webster\" class=\"citation\"><a href=\"/wiki/Merriam-Webster\" title=\"Merriam-Webster\">Merriam-Webster</a>, <a rel=\"nofollow\" class=\"external text\" href=\"http://unabridged.merriam-webster.com/collegiate/\"><i>Merriam-Webster's Collegiate Dictionary</i></a>, Merriam-Webster.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Merriam-Webster%27s+Collegiate+Dictionary&amp;rft.pub=Merriam-Webster&amp;rft.au=Merriam-Webster&amp;rft_id=http%3A%2F%2Funabridged.merriam-webster.com%2Fcollegiate%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.perseus.tufts.edu/hopper/text?doc=Perseus%3Atext%3A1999.04.0057%3Aentry%3Dme%2Flas\">\u03bc\u03ad\u03bb\u03b1\u03c2</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110605183904/http://www.perseus.tufts.edu/hopper/text?doc=Perseus%3Atext%3A1999.04.0057%3Aentry%3Dme%2Flas\">Archived</a> 2011-06-05 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>., Henry George Liddell, Robert Scott, <i>A Greek-English Lexicon</i>, on Perseus</span>\n</li>\n<li id=\"cite_note-Dorlands-121\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Dorlands_121-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFElsevier\" class=\"citation\"><a href=\"/wiki/Elsevier\" title=\"Elsevier\">Elsevier</a>, <a rel=\"nofollow\" class=\"external text\" href=\"http://dorlands.com/\"><i>Dorland's Illustrated Medical Dictionary</i></a>, Elsevier.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Dorland%27s+Illustrated+Medical+Dictionary&amp;rft.pub=Elsevier&amp;rft.au=Elsevier&amp;rft_id=http%3A%2F%2Fdorlands.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-AHD-122\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-AHD_122-0\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFHoughton_Mifflin_Harcourt\" class=\"citation\">Houghton Mifflin Harcourt, <a rel=\"nofollow\" class=\"external text\" href=\"https://ahdictionary.com/\"><i>The American Heritage Dictionary of the English Language</i></a>, Houghton Mifflin Harcourt.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+American+Heritage+Dictionary+of+the+English+Language&amp;rft.pub=Houghton+Mifflin+Harcourt&amp;rft.au=Houghton+Mifflin+Harcourt&amp;rft_id=https%3A%2F%2Fahdictionary.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-melanoma2012-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-melanoma2012_123-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a rel=\"nofollow\" class=\"external text\" href=\"http://adisonline.com/pharmaceuticalmedicine/Abstract/2012/26030/Drugs_in_Clinical_Development_for_Melanoma__.4.aspx\">\"Drugs in Clinical Development for Melanoma\"</a>. <i>Pharmaceutical Medicine</i>. <b>26</b> (3): 171\u201383. 23 December 2012. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/BF03262391\">10.1007/BF03262391</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmaceutical+Medicine&amp;rft.atitle=Drugs+in+Clinical+Development+for+Melanoma&amp;rft.volume=26&amp;rft.issue=3&amp;rft.pages=171-83&amp;rft.date=2012-12-23&amp;rft_id=info%3Adoi%2F10.1007%2FBF03262391&amp;rft_id=http%3A%2F%2Fadisonline.com%2Fpharmaceuticalmedicine%2FAbstract%2F2012%2F26030%2FDrugs_in_Clinical_Development_for_Melanoma&#95;_.4.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-124\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sotomayor M, Yu H, Antonia S, Sotomayor E, Pardoll D (2002). \"Advances in gene therapy for malignant melanoma\". <i>Cancer Control</i>. <b>9</b> (1): 39\u201348. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/107327480200900106\">10.1177/107327480200900106</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11907465\">11907465</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Control&amp;rft.atitle=Advances+in+gene+therapy+for+malignant+melanoma&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=39-48&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1177%2F107327480200900106&amp;rft_id=info%3Apmid%2F11907465&amp;rft.aulast=Sotomayor&amp;rft.aufirst=M&amp;rft.au=Yu%2C+H&amp;rft.au=Antonia%2C+S&amp;rft.au=Sotomayor%2C+E&amp;rft.au=Pardoll%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-125\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dudley ME, Yang JC, Sherry R,  et al. (November 2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://jco.ascopubs.org/content/26/32/5233.full\">\"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens\"</a>. <i>J. Clin. Oncol</i>. <b>26</b> (32): 5233\u201339. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2008.16.5449\">10.1200/JCO.2008.16.5449</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090\">2652090</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18809613\">18809613</a>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150210005932/http://jco.ascopubs.org/content/26/32/5233.full\">Archived</a> from the original on 2015-02-10.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.atitle=Adoptive+cell+therapy+for+patients+with+metastatic+melanoma%3A+evaluation+of+intensive+myeloablative+chemoradiation+preparative+regimens&amp;rft.volume=26&amp;rft.issue=32&amp;rft.pages=5233-39&amp;rft.date=2008-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2652090&amp;rft_id=info%3Apmid%2F18809613&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2008.16.5449&amp;rft.aulast=Dudley&amp;rft.aufirst=ME&amp;rft.au=Yang%2C+JC&amp;rft.au=Sherry%2C+R&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcontent%2F26%2F32%2F5233.full&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Besser10-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Besser10_126-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Besser MJ, Shapira-Frommer R, Treves AJ,  et al. (May 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=20406835\">\"Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients\"</a>. <i>Clin. Cancer Res</i>. <b>16</b> (9): 2646\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/1078-0432.CCR-10-0041\">10.1158/1078-0432.CCR-10-0041</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20406835\">20406835</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.atitle=Clinical+responses+in+a+phase+II+study+using+adoptive+transfer+of+short-term+cultured+tumor+infiltration+lymphocytes+in+metastatic+melanoma+patients&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=2646-55&amp;rft.date=2010-05&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-0041&amp;rft_id=info%3Apmid%2F20406835&amp;rft.aulast=Besser&amp;rft.aufirst=MJ&amp;rft.au=Shapira-Frommer%2C+R&amp;rft.au=Treves%2C+AJ&amp;rft_id=http%3A%2F%2Fclincancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D20406835&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-nih-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-nih_127-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nih.gov/news/pr/aug2006/nci-31b.htm\">\"New Method of Gene Therapy Alters Immune Cells for Treatment of Advanced Melanoma; Technique May Also Apply to Other Common Cancers\"</a>. 30 December 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060928214625/http://www.nih.gov/news/pr/aug2006/nci-31b.htm\">Archived</a> from the original on 28 September 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=New+Method+of+Gene+Therapy+Alters+Immune+Cells+for+Treatment+of+Advanced+Melanoma%3B+Technique+May+Also+Apply+to+Other+Common+Cancers&amp;rft.date=2015-12-30&amp;rft_id=http%3A%2F%2Fwww.nih.gov%2Fnews%2Fpr%2Faug2006%2Fnci-31b.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-128\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cbsnews.com/stories/2009/05/30/health/main5050957.shtml\">\"Immune System Taught To Fight Melanoma\"</a>. CBSNews. 30 May 2009. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20101029214646/http://www.cbsnews.com/stories/2009/05/30/health/main5050957.shtml\">Archived</a> from the original on 29 October 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Immune+System+Taught+To+Fight+Melanoma&amp;rft.date=2009-05-30&amp;rft_id=http%3A%2F%2Fwww.cbsnews.com%2Fstories%2F2009%2F05%2F30%2Fhealth%2Fmain5050957.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-129\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schwartzentruber, D. J.; Lawson, D. H.; Richards, J. M.; Conry, R. M.; Miller, D. M.; Treisman, J.; Gailani, F.; Riley, L.; Conlon, K.; Pockaj, B.; Kendra, K. L.; White, R. L.; Gonzalez, R.; Kuzel, T. M.; Curti, B.; Leming, P. D.; Whitman, E. D.; Balkissoon, J.; Reintgen, D. S.; Kaufman, H.; Marincola, F. M.; Merino, M. J.; Rosenberg, S. A.; Choyke, P.; Vena, D.; Hwu, P. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3517182\">\"Gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\"</a>. <i>New England Journal of Medicine</i>. <b>364</b> (22): 2119\u201327. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1012863\">10.1056/NEJMoa1012863</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3517182\">3517182</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21631324\">21631324</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Gp100+Peptide+Vaccine+and+Interleukin-2+in+Patients+with+Advanced+Melanoma&amp;rft.volume=364&amp;rft.issue=22&amp;rft.pages=2119-27&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3517182&amp;rft_id=info%3Apmid%2F21631324&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1012863&amp;rft.aulast=Schwartzentruber&amp;rft.aufirst=D.+J.&amp;rft.au=Lawson%2C+D.+H.&amp;rft.au=Richards%2C+J.+M.&amp;rft.au=Conry%2C+R.+M.&amp;rft.au=Miller%2C+D.+M.&amp;rft.au=Treisman%2C+J.&amp;rft.au=Gailani%2C+F.&amp;rft.au=Riley%2C+L.&amp;rft.au=Conlon%2C+K.&amp;rft.au=Pockaj%2C+B.&amp;rft.au=Kendra%2C+K.+L.&amp;rft.au=White%2C+R.+L.&amp;rft.au=Gonzalez%2C+R.&amp;rft.au=Kuzel%2C+T.+M.&amp;rft.au=Curti%2C+B.&amp;rft.au=Leming%2C+P.+D.&amp;rft.au=Whitman%2C+E.+D.&amp;rft.au=Balkissoon%2C+J.&amp;rft.au=Reintgen%2C+D.+S.&amp;rft.au=Kaufman%2C+H.&amp;rft.au=Marincola%2C+F.+M.&amp;rft.au=Merino%2C+M.+J.&amp;rft.au=Rosenberg%2C+S.+A.&amp;rft.au=Choyke%2C+P.&amp;rft.au=Vena%2C+D.&amp;rft.au=Hwu%2C+P.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3517182&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Harmon, Amy (February 21, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2010/02/22/health/research/22trial.html?\">\"A Roller Coaster Chase for a Cure\"</a>. <i>The New York Times</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170210085433/http://www.nytimes.com/2010/02/22/health/research/22trial.html\">Archived</a> from the original on February 10, 2017.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Roller+Coaster+Chase+for+a+Cure&amp;rft.date=2010-02-21&amp;rft.aulast=Harmon&amp;rft.aufirst=Amy&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F02%2F22%2Fhealth%2Fresearch%2F22trial.html%3F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-studies-131\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-studies_131-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-studies_131-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Andrew Pollack (June 5, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2011/06/06/health/research/06melanoma.html\">\"Drugs Show Promise Slowing Advanced Melanoma\"</a>. New York Times. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20170131105246/http://www.nytimes.com/2011/06/06/health/research/06melanoma.html\">Archived</a> from the original on January 31, 2017.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Drugs+Show+Promise+Slowing+Advanced+Melanoma&amp;rft.date=2011-06-05&amp;rft.au=Andrew+Pollack&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2011%2F06%2F06%2Fhealth%2Fresearch%2F06melanoma.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21639808-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21639808_132-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA, BRIM-3 Study Group (30 June 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549296\">\"Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation\"</a>. <i>New England Journal of Medicine</i>. <b>364</b> (26): 2507\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1103782\">10.1056/NEJMoa1103782</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549296\">3549296</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21639808\">21639808</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Improved+Survival+with+Vemurafenib+in+Melanoma+with+BRAF+V600E+Mutation&amp;rft.volume=364&amp;rft.issue=26&amp;rft.pages=2507-16&amp;rft.date=2011-06-30&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549296&amp;rft_id=info%3Apmid%2F21639808&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1103782&amp;rft.aulast=Chapman&amp;rft.aufirst=PB&amp;rft.au=Hauschild%2C+A&amp;rft.au=Robert%2C+C&amp;rft.au=Haanen%2C+JB&amp;rft.au=Ascierto%2C+P&amp;rft.au=Larkin%2C+J&amp;rft.au=Dummer%2C+R&amp;rft.au=Garbe%2C+C&amp;rft.au=Testori%2C+A&amp;rft.au=Maio%2C+M&amp;rft.au=Hogg%2C+D&amp;rft.au=Lorigan%2C+P&amp;rft.au=Lebbe%2C+C&amp;rft.au=Jouary%2C+T&amp;rft.au=Schadendorf%2C+D&amp;rft.au=Ribas%2C+A&amp;rft.au=O%27Day%2C+SJ&amp;rft.au=Sosman%2C+JA&amp;rft.au=Kirkwood%2C+JM&amp;rft.au=Eggermont%2C+AM&amp;rft.au=Dreno%2C+B&amp;rft.au=Nolop%2C+K&amp;rft.au=Li%2C+J&amp;rft.au=Nelson%2C+B&amp;rft.au=Hou%2C+J&amp;rft.au=Lee%2C+RJ&amp;rft.au=Flaherty%2C+KT&amp;rft.au=McArthur%2C+GA&amp;rft.au=BRIM-3+Study+Group&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549296&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-r20150530-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-r20150530_133-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/2013/05/30/us-glaxosmithkline-approvals-idUSBRE94S1A020130530\">\"GSK melanoma drugs add to tally of U.S. drug approvals\"</a>. Reuters. May 30, 2013. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150924181713/http://www.reuters.com/article/2013/05/30/us-glaxosmithkline-approvals-idUSBRE94S1A020130530\">Archived</a> from the original on September 24, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=GSK+melanoma+drugs+add+to+tally+of+U.S.+drug+approvals&amp;rft.date=2013-05-30&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2013%2F05%2F30%2Fus-glaxosmithkline-approvals-idUSBRE94S1A020130530&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-134\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.news-medical.net/news/20121001/Combination-of-dabrafenib-and-trametinib-delays-development-of-treatment-resistance-in-MM-patients.aspx?page=2\">\"Combination of dabrafenib and trametinib delays development of treatment resistance in MM patients\"</a>. News Medical. October 1, 2012. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130514034005/http://www.news-medical.net/news/20121001/Combination-of-dabrafenib-and-trametinib-delays-development-of-treatment-resistance-in-MM-patients.aspx?page=2\">Archived</a> from the original on May 14, 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Combination+of+dabrafenib+and+trametinib+delays+development+of+treatment+resistance+in+MM+patients&amp;rft.date=2012-10-01&amp;rft_id=http%3A%2F%2Fwww.news-medical.net%2Fnews%2F20121001%2FCombination-of-dabrafenib-and-trametinib-delays-development-of-treatment-resistance-in-MM-patients.aspx%3Fpage%3D2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23020132-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23020132_135-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Burris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KB, Patel K, Weber J (1 November 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549295\">\"Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations\"</a>. <i>New England Journal of Medicine</i>. <b>367</b> (18): 1694\u20131703. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1210093\">10.1056/NEJMoa1210093</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549295\">3549295</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23020132\">23020132</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Combined+BRAF+and+MEK+Inhibition+in+Melanoma+with+BRAF+V600+Mutations&amp;rft.volume=367&amp;rft.issue=18&amp;rft.pages=1694-1703&amp;rft.date=2012-11-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549295&amp;rft_id=info%3Apmid%2F23020132&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1210093&amp;rft.aulast=Flaherty&amp;rft.aufirst=KT&amp;rft.au=Infante%2C+JR&amp;rft.au=Daud%2C+A&amp;rft.au=Gonzalez%2C+R&amp;rft.au=Kefford%2C+RF&amp;rft.au=Sosman%2C+J&amp;rft.au=Hamid%2C+O&amp;rft.au=Schuchter%2C+L&amp;rft.au=Cebon%2C+J&amp;rft.au=Ibrahim%2C+N&amp;rft.au=Kudchadkar%2C+R&amp;rft.au=Burris%2C+HA+3rd&amp;rft.au=Falchook%2C+G&amp;rft.au=Algazi%2C+A&amp;rft.au=Lewis%2C+K&amp;rft.au=Long%2C+GV&amp;rft.au=Puzanov%2C+I&amp;rft.au=Lebowitz%2C+P&amp;rft.au=Singh%2C+A&amp;rft.au=Little%2C+S&amp;rft.au=Sun%2C+P&amp;rft.au=Allred%2C+A&amp;rft.au=Ouellet%2C+D&amp;rft.au=Kim%2C+KB&amp;rft.au=Patel%2C+K&amp;rft.au=Weber%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3549295&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-136\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.onclive.com/web-exclusives/FDA-Approves-First-Ever-Combination-for-Metastatic-Melanoma\">\"Dabrafenib/Trametinib Combination Approved for Advanced Melanoma\"</a>. OncLive. January 9, 2014. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140125190539/http://www.onclive.com/web-exclusives/FDA-Approves-First-Ever-Combination-for-Metastatic-Melanoma\">Archived</a> from the original on January 25, 2014.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dabrafenib%2FTrametinib+Combination+Approved+for+Advanced+Melanoma&amp;rft.date=2014-01-09&amp;rft_id=http%3A%2F%2Fwww.onclive.com%2Fweb-exclusives%2FFDA-Approves-First-Ever-Combination-for-Metastatic-Melanoma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-137\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-137\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/counteracting-drug-resistance-melanoma\">\"Counteracting Drug Resistance in Melanoma\"</a>. 2015. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150204044952/http://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/counteracting-drug-resistance-melanoma\">Archived</a> from the original on 2015-02-04.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Counteracting+Drug+Resistance+in+Melanoma&amp;rft.date=2015&amp;rft_id=http%3A%2F%2Fwww.oncotherapynetwork.com%2Fskin-cancer-melanoma-targets%2Fcounteracting-drug-resistance-melanoma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-138\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-138\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/idUSN0218461520100605\">\"Bristol drug cuts death risk in advanced melanoma\"</a>. <i>Reuters</i>. June 5, 2010. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20101109095301/http://www.reuters.com/article/idUSN0218461520100605\">Archived</a> from the original on November 9, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Bristol+drug+cuts+death+risk+in+advanced+melanoma&amp;rft.date=2010-06-05&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2FidUSN0218461520100605&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-139\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-139\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110315041905/http://blogs.forbes.com/sciencebiz/2010/06/06/the-risk-for-bristol/\">\"The Risk For Bristol\"</a>. <i>Forbes</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://blogs.forbes.com/sciencebiz/2010/06/the-risk-for-bristol/\">the original</a> on 2011-03-15.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=The+Risk+For+Bristol&amp;rft_id=https%3A%2F%2Fblogs.forbes.com%2Fsciencebiz%2F2010%2F06%2Fthe-risk-for-bristol%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-140\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-140\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.news-medical.net/news/20100609/Phase-3-clinical-study-Ipilimumab-boosts-sustains-immune-system-responses-against-melanoma-tumors.aspx\">\"Phase 3 clinical study: Ipilimumab boosts, sustains immune system responses against melanoma tumors\"</a>. News-medical.net. 2010-06-09. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20121019003945/http://www.news-medical.net/news/20100609/Phase-3-clinical-study-Ipilimumab-boosts-sustains-immune-system-responses-against-melanoma-tumors.aspx\">Archived</a> from the original on 2012-10-19<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-08-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Phase+3+clinical+study%3A+Ipilimumab+boosts%2C+sustains+immune+system+responses+against+melanoma+tumors&amp;rft.pub=News-medical.net&amp;rft.date=2010-06-09&amp;rft_id=http%3A%2F%2Fwww.news-medical.net%2Fnews%2F20100609%2FPhase-3-clinical-study-Ipilimumab-boosts-sustains-immune-system-responses-against-melanoma-tumors.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-141\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\">Jefferson E (2011-03-25). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm\">\"FDA approves new treatment for a type of late-stage skin cancer\"</a> (Press release). <a href=\"/wiki/Food_and_Drug_Administration_(United_States)\" class=\"mw-redirect\" title=\"Food and Drug Administration (United States)\">U.S. Food and Drug Administration</a> (FDA). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110327063147/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm\">Archived</a> from the original on 2011-03-27<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-03-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+new+treatment+for+a+type+of+late-stage+skin+cancer&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2011-03-25&amp;rft.au=Jefferson+E&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm1193237.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-142\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Pollack, Andrew (2011-03-25). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2011/03/26/business/26drug.html\">\"Approval for Drug That Treats Melanoma\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110401011816/http://www.nytimes.com/2011/03/26/business/26drug.html\">Archived</a> from the original on 2011-04-01<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-03-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Approval+for+Drug+That+Treats+Melanoma&amp;rft.date=2011-03-25&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2011%2F03%2F26%2Fbusiness%2F26drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Drugs.com-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Drugs.com_143-0\">^</a></b></span> <span class=\"reference-text\">Drugs.com: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/yervoy.html\">Yervoy</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110809231412/http://www.drugs.com/yervoy.html\">Archived</a> 2011-08-09 at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-144\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-144\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Robert C, Thomas L, Bondarenko I,  et al. (June 2011). \"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma\". <i>N. Engl. J. Med</i>. <b>364</b> (26): 2517\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMoa1104621\">10.1056/NEJMoa1104621</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21639810\">21639810</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Ipilimumab+plus+dacarbazine+for+previously+untreated+metastatic+melanoma&amp;rft.volume=364&amp;rft.issue=26&amp;rft.pages=2517-26&amp;rft.date=2011-06&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1104621&amp;rft_id=info%3Apmid%2F21639810&amp;rft.aulast=Robert&amp;rft.aufirst=C&amp;rft.au=Thomas%2C+L&amp;rft.au=Bondarenko%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-145\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-145\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Voit C, Van Akkooi AC, Sch\u00e4fer-Hesterberg G,  et al. (February 2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=20065175\">\"Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma\"</a>. <i>J. Clin. Oncol</i>. <b>28</b> (5): 847\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2009.25.7428\">10.1200/JCO.2009.25.7428</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20065175\">20065175</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.atitle=Ultrasound+morphology+criteria+predict+metastatic+disease+of+the+sentinel+nodes+in+patients+with+melanoma&amp;rft.volume=28&amp;rft.issue=5&amp;rft.pages=847-52&amp;rft.date=2010-02&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.25.7428&amp;rft_id=info%3Apmid%2F20065175&amp;rft.aulast=Voit&amp;rft.aufirst=C&amp;rft.au=Van+Akkooi%2C+AC&amp;rft.au=Sch%C3%A4fer-Hesterberg%2C+G&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D20065175&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-146\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-146\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20111014181613/http://www.malignant-melanoma.org/sunmel/\">\"malignant-melanoma.org\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.malignant-melanoma.org/sunmel\">the original</a> on 2011-10-14.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=malignant-melanoma.org&amp;rft_id=http%3A%2F%2Fwww.malignant-melanoma.org%2Fsunmel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-147\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-147\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Forbes, NE; Abdelbary, H; Lupien, M; Bell, JC; Diallo, JS (Sep 20, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3778850\">\"Exploiting tumor epigenetics to improve oncolytic virotherapy\"</a>. <i>Frontiers in Genetics</i>. <b>4</b>: 184. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fgene.2013.00184\">10.3389/fgene.2013.00184</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3778850\">3778850</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24062768\">24062768</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Genetics&amp;rft.atitle=Exploiting+tumor+epigenetics+to+improve+oncolytic+virotherapy&amp;rft.volume=4&amp;rft.pages=184&amp;rft.date=2013-09-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3778850&amp;rft_id=info%3Apmid%2F24062768&amp;rft_id=info%3Adoi%2F10.3389%2Ffgene.2013.00184&amp;rft.aulast=Forbes&amp;rft.aufirst=NE&amp;rft.au=Abdelbary%2C+H&amp;rft.au=Lupien%2C+M&amp;rft.au=Bell%2C+JC&amp;rft.au=Diallo%2C+JS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3778850&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-148\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS (2015). \"Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma\". <i>Journal of Clinical Oncology</i>. <b>33</b> (25): 2780\u201388. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2014.58.3377\">10.1200/JCO.2014.58.3377</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26014293\">26014293</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Talimogene+Laherparepvec+Improves+Durable+Response+Rate+in+Patients+With+Advanced+Melanoma&amp;rft.volume=33&amp;rft.issue=25&amp;rft.pages=2780-88&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2014.58.3377&amp;rft_id=info%3Apmid%2F26014293&amp;rft.aulast=Andtbacka&amp;rft.aufirst=RH&amp;rft.au=Kaufman%2C+HL&amp;rft.au=Collichio%2C+F&amp;rft.au=Amatruda%2C+T&amp;rft.au=Senzer%2C+N&amp;rft.au=Chesney%2C+J&amp;rft.au=Delman%2C+KA&amp;rft.au=Spitler%2C+LE&amp;rft.au=Puzanov%2C+I&amp;rft.au=Agarwala%2C+SS&amp;rft.au=Milhem%2C+M&amp;rft.au=Cranmer%2C+L&amp;rft.au=Curti%2C+B&amp;rft.au=Lewis%2C+K&amp;rft.au=Ross%2C+M&amp;rft.au=Guthrie%2C+T&amp;rft.au=Linette%2C+GP&amp;rft.au=Daniels%2C+GA&amp;rft.au=Harrington%2C+K&amp;rft.au=Middleton%2C+MR&amp;rft.au=Miller%2C+WH+Jr&amp;rft.au=Zager%2C+JS&amp;rft.au=Ye%2C+Y&amp;rft.au=Yao%2C+B&amp;rft.au=Li%2C+A&amp;rft.au=Doleman%2C+S&amp;rft.au=VanderWalde%2C+A&amp;rft.au=Gansert%2C+J&amp;rft.au=Coffin%2C+RS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMelanoma\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Melanoma&amp;action=edit&amp;section=36\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q180614\" class=\"extiw\" title=\"d:Q180614\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/C43\">C43</a></li><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/List_of_ICD-9_codes\" title=\"List of ICD-9 codes\">9-CM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icd9data.com/getICD9Code.ashx?icd9=172.9\">172.9</a></li><li><b><a href=\"/wiki/International_Classification_of_Diseases_for_Oncology\" title=\"International Classification of Diseases for Oncology\">ICD-O</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://progenetix.org/subsets/?term_id=icdom:8720_3\">M8720/3</a></li><li><b><a href=\"/wiki/OMIM\" class=\"mw-redirect\" title=\"OMIM\">OMIM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/155600\">155600</a></li><li><b><a href=\"/wiki/Medical_Subject_Headings\" title=\"Medical Subject Headings\">MeSH</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D008545\">D008545</a></li><li><b><a href=\"/wiki/Diseases_Database\" title=\"Diseases Database\">DiseasesDB</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.diseasesdatabase.com/ddb7947.htm\">7947</a></li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/MedlinePlus\" title=\"MedlinePlus\">MedlinePlus</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000850.htm\">000850</a></li><li><b><a href=\"/wiki/EMedicine\" title=\"EMedicine\">eMedicine</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/derm/topic257.htm\">derm/257</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/med/topic1386.htm#\">med/1386</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/ent/topic27.htm#\">ent/27</a> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.emedicine.com/plastic/topic456.htm#\">plastic/456</a></li><li><b><a href=\"/wiki/National_Cancer_Institute\" title=\"National Cancer Institute\">NCI</a></b>:\n<a rel=\"nofollow\" class=\"external text\" href=\"https://www.cancer.gov//cancertopics/types/melanoma\">Melanoma</a></li></ul></div></td></tr></tbody></table>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/40px-Wiktionary-logo-en-v2.svg.png\" width=\"40\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/60px-Wiktionary-logo-en-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/80px-Wiktionary-logo-en-v2.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></td>\n<td class=\"mbox-text plainlist\">Look up <i><b><a href=\"https://en.wiktionary.org/wiki/melanoma\" class=\"extiw\" title=\"wiktionary:melanoma\">melanoma</a></b></i> in Wiktionary, the free dictionary.</td></tr></tbody></table>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" width=\"30\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /></td>\n<td class=\"mbox-text plainlist\">Wikimedia Commons has media related to <i><b><a href=\"https://commons.wikimedia.org/wiki/Category:Melanoma\" class=\"extiw\" title=\"commons:Category:Melanoma\">Melanoma</a></b></i>.</td></tr></tbody></table>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://curlie.org/Health/Conditions_and_Diseases/Cancer/Melanoma/\">Melanoma</a> at Curlie (based on <a href=\"/wiki/DMOZ\" title=\"DMOZ\">DMOZ</a>)</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Diseases_of_the_skin_and_appendages_by_morphology\" style=\"padding:3px\"><table class=\"nowraplinks collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Diseases_of_the_skin_and_appendages_by_morphology\" title=\"Template:Diseases of the skin and appendages by morphology\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Diseases_of_the_skin_and_appendages_by_morphology\" title=\"Template talk:Diseases of the skin and appendages by morphology\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Diseases_of_the_skin_and_appendages_by_morphology&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Diseases_of_the_skin_and_appendages_by_morphology\" style=\"font-size:114%;margin:0 4em\">Diseases of the skin and appendages by morphology</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Growths</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Epidermis\" title=\"Epidermis\">Epidermal</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Wart\" title=\"Wart\">wart</a></li>\n<li><a href=\"/wiki/Callus\" title=\"Callus\">callus</a></li>\n<li><a href=\"/wiki/Seborrheic_keratosis\" title=\"Seborrheic keratosis\">seborrheic keratosis</a></li>\n<li><a href=\"/wiki/Acrochordon\" class=\"mw-redirect\" title=\"Acrochordon\">acrochordon</a></li>\n<li><a href=\"/wiki/Molluscum_contagiosum\" title=\"Molluscum contagiosum\">molluscum contagiosum</a></li>\n<li><a href=\"/wiki/Actinic_keratosis\" title=\"Actinic keratosis\">actinic keratosis</a></li>\n<li><a href=\"/wiki/Squamous-cell_carcinoma\" class=\"mw-redirect\" title=\"Squamous-cell carcinoma\">squamous-cell carcinoma</a></li>\n<li><a href=\"/wiki/Basal-cell_carcinoma\" title=\"Basal-cell carcinoma\">basal-cell carcinoma</a></li>\n<li><a href=\"/wiki/Merkel-cell_carcinoma\" title=\"Merkel-cell carcinoma\">Merkel-cell carcinoma</a></li>\n<li><a href=\"/wiki/Nevus_sebaceous\" title=\"Nevus sebaceous\">nevus sebaceous</a></li>\n<li><a href=\"/wiki/Trichoepithelioma\" title=\"Trichoepithelioma\">trichoepithelioma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Pigmented</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Freckle\" title=\"Freckle\">Freckles</a></li>\n<li><a href=\"/wiki/Lentigo\" title=\"Lentigo\">lentigo</a></li>\n<li><a href=\"/wiki/Melasma\" title=\"Melasma\">melasma</a></li>\n<li><a href=\"/wiki/Nevus\" title=\"Nevus\">nevus</a></li>\n<li><a class=\"mw-selflink selflink\">melanoma</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Dermis\" title=\"Dermis\">Dermal</a> and<br />subcutaneous</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Epidermoid_cyst\" title=\"Epidermoid cyst\">epidermal inclusion cyst</a></li>\n<li><a href=\"/wiki/Hemangioma\" title=\"Hemangioma\">hemangioma</a></li>\n<li><a href=\"/wiki/Benign_fibrous_histiocytoma\" title=\"Benign fibrous histiocytoma\">dermatofibroma (benign fibrous histiocytoma)</a></li>\n<li><a href=\"/wiki/Keloid\" title=\"Keloid\">keloid</a></li>\n<li><a href=\"/wiki/Lipoma\" title=\"Lipoma\">lipoma</a></li>\n<li><a href=\"/wiki/Neurofibroma\" title=\"Neurofibroma\">neurofibroma</a></li>\n<li><a href=\"/wiki/Xanthoma\" title=\"Xanthoma\">xanthoma</a></li>\n<li><a href=\"/wiki/Kaposi%27s_sarcoma\" title=\"Kaposi&#39;s sarcoma\">Kaposi's sarcoma</a></li>\n<li><a href=\"/wiki/Infantile_digital_fibromatosis\" title=\"Infantile digital fibromatosis\">infantile digital fibromatosis</a></li>\n<li><a href=\"/wiki/Granular_cell_tumor\" title=\"Granular cell tumor\">granular cell tumor</a></li>\n<li><a href=\"/wiki/Leiomyoma\" title=\"Leiomyoma\">leiomyoma</a></li>\n<li><a href=\"/wiki/Lymphangioma_circumscriptum\" title=\"Lymphangioma circumscriptum\">lymphangioma circumscriptum</a></li>\n<li><a href=\"/wiki/Myxoid_cyst\" title=\"Myxoid cyst\">myxoid cyst</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Rash\" title=\"Rash\">Rashes</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">With<br /> epidermal<br /> involvement</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Eczematous</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Contact_dermatitis\" title=\"Contact dermatitis\">contact dermatitis</a></li>\n<li><a href=\"/wiki/Atopic_dermatitis\" title=\"Atopic dermatitis\">atopic dermatitis</a></li>\n<li><a href=\"/wiki/Seborrhoeic_dermatitis\" title=\"Seborrhoeic dermatitis\">seborrheic dermatitis</a></li>\n<li><a href=\"/wiki/Stasis_dermatitis\" title=\"Stasis dermatitis\">stasis dermatitis</a></li>\n<li><a href=\"/wiki/Lichen_simplex_chronicus\" title=\"Lichen simplex chronicus\">lichen simplex chronicus</a></li>\n<li><a href=\"/wiki/Darier%27s_disease\" title=\"Darier&#39;s disease\">Darier's disease</a></li>\n<li><a href=\"/wiki/Glucagonoma_syndrome\" class=\"mw-redirect\" title=\"Glucagonoma syndrome\">glucagonoma syndrome</a></li>\n<li><a href=\"/wiki/Langerhans_cell_histiocytosis\" title=\"Langerhans cell histiocytosis\">langerhans cell histiocytosis</a></li>\n<li><a href=\"/wiki/Lichen_sclerosus\" title=\"Lichen sclerosus\">lichen sclerosus</a></li>\n<li><a href=\"/wiki/Pemphigus\" title=\"Pemphigus\">pemphigus foliaceus</a></li>\n<li><a href=\"/wiki/Wiskott%E2%80%93Aldrich_syndrome\" title=\"Wiskott\u2013Aldrich syndrome\">Wiskott\u2013Aldrich syndrome</a></li>\n<li><a href=\"/wiki/Zinc_deficiency\" title=\"Zinc deficiency\">Zinc deficiency</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Scale_(dermatology)\" class=\"mw-redirect\" title=\"Scale (dermatology)\">Scaling</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Psoriasis\" title=\"Psoriasis\">psoriasis</a></li>\n<li>tinea (<a href=\"/wiki/Tinea_corporis\" title=\"Tinea corporis\">corporis</a></li>\n<li><a href=\"/wiki/Tinea_cruris\" title=\"Tinea cruris\">cruris</a></li>\n<li><a href=\"/wiki/Athlete%27s_foot\" title=\"Athlete&#39;s foot\">pedis</a></li>\n<li><a href=\"/wiki/Tinea_manuum\" title=\"Tinea manuum\">manuum</a></li>\n<li><a href=\"/wiki/Tinea_faciei\" title=\"Tinea faciei\">faciei</a>)</li>\n<li><a href=\"/wiki/Pityriasis_rosea\" title=\"Pityriasis rosea\">pityriasis rosea</a></li>\n<li><a href=\"/wiki/Syphilis\" title=\"Syphilis\">secondary syphilis</a></li>\n<li><a href=\"/wiki/Mycosis_fungoides\" title=\"Mycosis fungoides\">mycosis fungoides</a></li>\n<li><a href=\"/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">systemic lupus erythematosus</a></li>\n<li><a href=\"/wiki/Pityriasis_rubra_pilaris\" title=\"Pityriasis rubra pilaris\">pityriasis rubra pilaris</a></li>\n<li><a href=\"/wiki/Parapsoriasis\" title=\"Parapsoriasis\">parapsoriasis</a></li>\n<li><a href=\"/wiki/Ichthyosis\" title=\"Ichthyosis\">ichthyosis</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Blister\" title=\"Blister\">Blistering</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Herpes_simplex\" title=\"Herpes simplex\">herpes simplex</a></li>\n<li><a href=\"/wiki/Herpes_zoster\" class=\"mw-redirect\" title=\"Herpes zoster\">herpes zoster</a></li>\n<li><a href=\"/wiki/Chickenpox\" title=\"Chickenpox\">varicella</a></li>\n<li><a href=\"/wiki/Impetigo\" title=\"Impetigo\">bullous impetigo</a></li>\n<li><a href=\"/wiki/Contact_dermatitis\" title=\"Contact dermatitis\">acute contact dermatitis</a></li>\n<li><a href=\"/wiki/Pemphigus_vulgaris\" title=\"Pemphigus vulgaris\">pemphigus vulgaris</a></li>\n<li><a href=\"/wiki/Bullous_pemphigoid\" title=\"Bullous pemphigoid\">bullous pemphigoid</a></li>\n<li><a href=\"/wiki/Dermatitis_herpetiformis\" title=\"Dermatitis herpetiformis\">dermatitis herpetiformis</a></li>\n<li><a href=\"/wiki/Porphyria_cutanea_tarda\" title=\"Porphyria cutanea tarda\">porphyria cutanea tarda</a></li>\n<li><a href=\"/wiki/Epidermolysis_bullosa_simplex\" title=\"Epidermolysis bullosa simplex\">epidermolysis bullosa simplex</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Papule\" title=\"Papule\">Papular</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Scabies\" title=\"Scabies\">scabies</a></li>\n<li><a href=\"/wiki/Insect_bites_and_stings\" title=\"Insect bites and stings\">insect bite reactions</a></li>\n<li><a href=\"/wiki/Lichen_planus\" title=\"Lichen planus\">lichen planus</a></li>\n<li><a href=\"/wiki/Miliaria\" title=\"Miliaria\">miliaria</a></li>\n<li><a href=\"/wiki/Keratosis_pilaris\" title=\"Keratosis pilaris\">keratosis pilaris</a></li>\n<li><a href=\"/wiki/Lichen_spinulosus\" title=\"Lichen spinulosus\">lichen spinulosus</a></li>\n<li><a href=\"/wiki/Transient_acantholytic_dermatosis\" title=\"Transient acantholytic dermatosis\">transient acantholytic dermatosis</a></li>\n<li><a href=\"/wiki/Lichen_nitidus\" title=\"Lichen nitidus\">lichen nitidus</a></li>\n<li><a href=\"/wiki/Pityriasis_lichenoides_et_varioliformis_acuta\" title=\"Pityriasis lichenoides et varioliformis acuta\">pityriasis lichenoides et varioliformis acuta</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pustule\" class=\"mw-redirect\" title=\"Pustule\">Pustular</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Acne_vulgaris\" class=\"mw-redirect\" title=\"Acne vulgaris\">acne vulgaris</a></li>\n<li><a href=\"/wiki/Acne_rosacea\" class=\"mw-redirect\" title=\"Acne rosacea\">acne rosacea</a></li>\n<li><a href=\"/wiki/Folliculitis\" title=\"Folliculitis\">folliculitis</a></li>\n<li><a href=\"/wiki/Impetigo\" title=\"Impetigo\">impetigo</a></li>\n<li><a href=\"/wiki/Candidiasis\" title=\"Candidiasis\">candidiasis</a></li>\n<li><a href=\"/wiki/Neisseria_gonorrhoeae\" title=\"Neisseria gonorrhoeae\">gonococcemia</a></li>\n<li><a href=\"/wiki/Dermatophyte\" title=\"Dermatophyte\">dermatophyte</a></li>\n<li><a href=\"/wiki/Coccidioidomycosis\" title=\"Coccidioidomycosis\">coccidioidomycosis</a></li>\n<li><a href=\"/wiki/Subcorneal_pustular_dermatosis\" class=\"mw-redirect\" title=\"Subcorneal pustular dermatosis\">subcorneal pustular dermatosis</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Hypopigmented</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Tinea_versicolor\" title=\"Tinea versicolor\">tinea versicolor</a></li>\n<li><a href=\"/wiki/Vitiligo\" title=\"Vitiligo\">vitiligo</a></li>\n<li><a href=\"/wiki/Pityriasis_alba\" title=\"Pityriasis alba\">pityriasis alba</a></li>\n<li><a href=\"/wiki/Postinflammatory_hyperpigmentation\" class=\"mw-redirect\" title=\"Postinflammatory hyperpigmentation\">postinflammatory hyperpigmentation</a></li>\n<li><a href=\"/wiki/Tuberous_sclerosis\" title=\"Tuberous sclerosis\">tuberous sclerosis</a></li>\n<li><a href=\"/wiki/Idiopathic_guttate_hypomelanosis\" title=\"Idiopathic guttate hypomelanosis\">idiopathic guttate hypomelanosis</a></li>\n<li><a href=\"/wiki/Leprosy\" title=\"Leprosy\">leprosy</a></li>\n<li><a href=\"/wiki/Mycosis_fungoides\" title=\"Mycosis fungoides\">hypopigmented mycosis fungoides</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Without<br /> epidermal<br /> involvement</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Red\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Red</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Blanchable<br /> <a href=\"/wiki/Erythema\" title=\"Erythema\">Erythema</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Generalized</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Drug_eruption\" title=\"Drug eruption\">drug eruptions</a></li>\n<li><a href=\"/wiki/Exanthem\" title=\"Exanthem\">viral exanthems</a></li>\n<li><a href=\"/wiki/Erythema_toxicum_neonatorum\" title=\"Erythema toxicum neonatorum\">toxic erythema</a></li>\n<li><a href=\"/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">systemic lupus erythematosus</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Localized</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cellulitis\" title=\"Cellulitis\">cellulitis</a></li>\n<li><a href=\"/wiki/Abscess\" title=\"Abscess\">abscess</a></li>\n<li><a href=\"/wiki/Boil\" title=\"Boil\">boil</a></li>\n<li><a href=\"/wiki/Erythema_nodosum\" title=\"Erythema nodosum\">erythema nodosum</a></li>\n<li><a href=\"/wiki/Carcinoid_syndrome\" title=\"Carcinoid syndrome\">carcinoid syndrome</a></li>\n<li><a href=\"/wiki/Fixed_drug_eruption\" class=\"mw-redirect\" title=\"Fixed drug eruption\">fixed drug eruption</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Specialized</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Urticaria\" class=\"mw-redirect\" title=\"Urticaria\">urticaria</a></li>\n<li>erythema (<a href=\"/wiki/Erythema_multiforme\" title=\"Erythema multiforme\">multiforme</a></li>\n<li><a href=\"/wiki/Erythema_chronicum_migrans\" class=\"mw-redirect\" title=\"Erythema chronicum migrans\">migrans</a></li>\n<li><a href=\"/wiki/Erythema_gyratum_repens\" title=\"Erythema gyratum repens\">gyratum repens</a></li>\n<li><a href=\"/wiki/Erythema_annulare_centrifugum\" title=\"Erythema annulare centrifugum\">annulare centrifugum</a></li>\n<li><a href=\"/wiki/Erythema_ab_igne\" title=\"Erythema ab igne\">ab igne</a>)</li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Nonblanchable<br /> Purpura</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Macular</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Thrombocytopenic_purpura\" title=\"Thrombocytopenic purpura\">thrombocytopenic purpura</a></li>\n<li><a href=\"/wiki/Solar_purpura\" title=\"Solar purpura\">actinic/solar purpura</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Papular</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Disseminated_intravascular_coagulation\" title=\"Disseminated intravascular coagulation\">disseminated intravascular coagulation</a></li>\n<li><a href=\"/wiki/Vasculitis\" title=\"Vasculitis\">vasculitis</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Indurated</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Scleroderma\" title=\"Scleroderma\">scleroderma</a>/<a href=\"/wiki/Morphea\" title=\"Morphea\">morphea</a></li>\n<li><a href=\"/wiki/Granuloma_annulare\" title=\"Granuloma annulare\">granuloma annulare</a></li>\n<li><a href=\"/wiki/Lichen_sclerosus\" title=\"Lichen sclerosus\">lichen sclerosis et atrophicus</a></li>\n<li><a href=\"/wiki/Necrobiosis_lipoidica\" title=\"Necrobiosis lipoidica\">necrobiosis lipoidica</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Miscellaneous<br /> disorders</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Ulcer_(dermatology)\" title=\"Ulcer (dermatology)\">Ulcers</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li class=\"mw-empty-elt\"></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Hair</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Telogen_effluvium\" title=\"Telogen effluvium\">telogen effluvium</a></li>\n<li><a href=\"/wiki/Androgenic_alopecia\" class=\"mw-redirect\" title=\"Androgenic alopecia\">androgenic alopecia</a></li>\n<li><a href=\"/wiki/Alopecia_areata\" title=\"Alopecia areata\">alopecia areata</a></li>\n<li><a href=\"/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">systemic lupus erythematosus</a></li>\n<li><a href=\"/wiki/Tinea_capitis\" title=\"Tinea capitis\">tinea capitis</a></li>\n<li><a href=\"/wiki/Loose_anagen_syndrome\" title=\"Loose anagen syndrome\">loose anagen syndrome</a></li>\n<li><a href=\"/wiki/Lichen_planopilaris\" class=\"mw-redirect\" title=\"Lichen planopilaris\">lichen planopilaris</a></li>\n<li><a href=\"/wiki/Folliculitis_decalvans\" title=\"Folliculitis decalvans\">folliculitis decalvans</a></li>\n<li><a href=\"/wiki/Pseudofolliculitis_barbae\" title=\"Pseudofolliculitis barbae\">acne keloidalis nuchae</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Nail_(anatomy)\" title=\"Nail (anatomy)\">Nail</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Onychomycosis\" title=\"Onychomycosis\">onychomycosis</a></li>\n<li><a href=\"/wiki/Psoriasis\" title=\"Psoriasis\">psoriasis</a></li>\n<li><a href=\"/wiki/Paronychia\" title=\"Paronychia\">paronychia</a></li>\n<li><a href=\"/wiki/Ingrown_nail\" title=\"Ingrown nail\">ingrown nail</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Mucous_membrane\" title=\"Mucous membrane\">Mucous<br /> membrane</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Aphthous_stomatitis\" title=\"Aphthous stomatitis\">Aphthous stomatitis</a></li>\n<li><a href=\"/wiki/Oral_candidiasis\" title=\"Oral candidiasis\">oral candidiasis</a></li>\n<li><a href=\"/wiki/Lichen_planus\" title=\"Lichen planus\">lichen planus</a></li>\n<li><a href=\"/wiki/Leukoplakia\" title=\"Leukoplakia\">leukoplakia</a></li>\n<li><a href=\"/wiki/Pemphigus\" title=\"Pemphigus\">pemphigus vulgaris</a></li>\n<li><a href=\"/wiki/Mucous_membrane_pemphigoid\" class=\"mw-redirect\" title=\"Mucous membrane pemphigoid\">mucous membrane pemphigoid</a></li>\n<li><a href=\"/wiki/Cicatricial_pemphigoid\" title=\"Cicatricial pemphigoid\">cicatricial pemphigoid</a></li>\n<li><a href=\"/wiki/Herpesviridae\" title=\"Herpesviridae\">herpesvirus</a></li>\n<li><a href=\"/wiki/Coxsackievirus\" title=\"Coxsackievirus\">coxsackievirus</a></li>\n<li><a href=\"/wiki/Syphilis\" title=\"Syphilis\">syphilis</a></li>\n<li><a href=\"/wiki/Histoplasmosis\" title=\"Histoplasmosis\">systemic histoplasmosis</a></li>\n<li><a href=\"/wiki/Squamous-cell_carcinoma\" class=\"mw-redirect\" title=\"Squamous-cell carcinoma\">squamous-cell carcinoma</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Tumors:_Skin_neoplasm,_nevi_and_melanomas_(C43/D22,_172/216,_ICD-O_8720-8799)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Skin_tumors,_nevi_and_melanomas\" title=\"Template:Skin tumors, nevi and melanomas\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Skin_tumors,_nevi_and_melanomas\" title=\"Template talk:Skin tumors, nevi and melanomas\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Skin_tumors,_nevi_and_melanomas&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Tumors:_Skin_neoplasm,_nevi_and_melanomas_(C43/D22,_172/216,_ICD-O_8720-8799)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Neoplasm\" title=\"Neoplasm\">Tumors</a>: <a href=\"/wiki/Skin_cancer\" title=\"Skin cancer\">Skin neoplasm</a>, <a href=\"/wiki/Nevi_and_melanomas\" title=\"Nevi and melanomas\">nevi and melanomas</a> (<a href=\"/wiki/ICD-10_Chapter_II:_Neoplasms#(C43\u2013C44)_Malignant_neoplasms,_skin\" title=\"ICD-10 Chapter II: Neoplasms\">C43/D22</a>, <a href=\"/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_bone,_connective_tissue,_skin,_and_breast_(170\u2013175)\" title=\"List of ICD-9 codes 140\u2013239: neoplasms\">172/216</a>, <a href=\"/wiki/International_Classification_of_Diseases_for_Oncology\" title=\"International Classification of Diseases for Oncology\">ICD-O</a> 8720-8799)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a class=\"mw-selflink selflink\">Melanoma</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Mucosal_melanoma\" title=\"Mucosal melanoma\">Mucosal melanoma</a></li>\n<li><a href=\"/wiki/Superficial_spreading_melanoma\" title=\"Superficial spreading melanoma\">Superficial spreading melanoma</a></li>\n<li><a href=\"/wiki/Nodular_melanoma\" title=\"Nodular melanoma\">Nodular melanoma</a></li>\n<li><i><a href=\"/wiki/Lentigo\" title=\"Lentigo\">lentigo</a></i>\n<ul><li><a href=\"/wiki/Lentigo_maligna\" title=\"Lentigo maligna\">Lentigo maligna</a>/<a href=\"/wiki/Lentigo_maligna_melanoma\" title=\"Lentigo maligna melanoma\">Lentigo maligna melanoma</a></li>\n<li><a href=\"/wiki/Acral_lentiginous_melanoma\" title=\"Acral lentiginous melanoma\">Acral lentiginous melanoma</a></li></ul></li>\n<li><a href=\"/wiki/Amelanotic_melanoma\" title=\"Amelanotic melanoma\">Amelanotic melanoma</a></li>\n<li><a href=\"/wiki/Desmoplastic_melanoma\" title=\"Desmoplastic melanoma\">Desmoplastic melanoma</a></li>\n<li><a href=\"/wiki/Melanoma_with_features_of_a_Spitz_nevus\" title=\"Melanoma with features of a Spitz nevus\">Melanoma with features of a Spitz nevus</a></li>\n<li><a href=\"/wiki/Small-cell_melanoma\" title=\"Small-cell melanoma\">Melanoma with small nevus-like cells</a></li>\n<li><a href=\"/wiki/Polypoid_melanoma\" title=\"Polypoid melanoma\">Polypoid melanoma</a></li>\n<li><a href=\"/wiki/Nevoid_melanoma\" title=\"Nevoid melanoma\">Nevoid melanoma</a></li>\n<li><a href=\"/wiki/Melanocytic_tumors_of_uncertain_malignant_potential\" title=\"Melanocytic tumors of uncertain malignant potential\">Melanocytic tumors of uncertain malignant potential</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Nevus\" title=\"Nevus\">Nevus</a>/<br /><a href=\"/wiki/Melanocytic_nevus\" title=\"Melanocytic nevus\">melanocytic nevus</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><td colspan=\"2\" class=\"navbox-list navbox-even\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Nevus_of_Ito\" title=\"Nevus of Ito\">Nevus of Ito</a>/<a href=\"/wiki/Nevus_of_Ota\" title=\"Nevus of Ota\">Nevus of Ota</a></li>\n<li><a href=\"/wiki/Compound_nevus\" title=\"Compound nevus\">Compound nevus</a></li>\n<li><a href=\"/wiki/Spitz_nevus\" title=\"Spitz nevus\">Spitz nevus</a>\n<ul><li><a href=\"/wiki/Pigmented_spindle_cell_nevus\" title=\"Pigmented spindle cell nevus\">Pigmented spindle cell nevus</a></li></ul></li>\n<li><a href=\"/wiki/Halo_nevus\" title=\"Halo nevus\">Halo nevus</a></li>\n<li><a href=\"/wiki/Junctional_nevus\" title=\"Junctional nevus\">Junctional nevus</a></li>\n<li><a href=\"/wiki/Pseudomelanoma\" title=\"Pseudomelanoma\">Pseudomelanoma</a></li></ul>\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Blue_nevus\" title=\"Blue nevus\">Blue nevus</a>\n<ul><li><a href=\"/wiki/Blue_nevus_of_Jadassohn%E2%80%93Ti%C3%A8che\" class=\"mw-redirect\" title=\"Blue nevus of Jadassohn\u2013Ti\u00e8che\">of Jadassohn\u2013Ti\u00e8che</a></li>\n<li><a href=\"/wiki/Cellular_blue_nevus\" class=\"mw-redirect\" title=\"Cellular blue nevus\">Cellular</a></li>\n<li><a href=\"/wiki/Epithelioid_blue_nevus\" class=\"mw-redirect\" title=\"Epithelioid blue nevus\">Epithelioid</a></li>\n<li><a href=\"/wiki/Deep_penetrating_nevus\" class=\"mw-redirect\" title=\"Deep penetrating nevus\">Deep penetrating</a></li>\n<li><a href=\"/wiki/Amelanotic_blue_nevus\" class=\"mw-redirect\" title=\"Amelanotic blue nevus\">Amelanotic</a></li>\n<li><a href=\"/wiki/Malignant_blue_nevus\" class=\"mw-redirect\" title=\"Malignant blue nevus\">Malignant</a></li></ul></li></ul>\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-even\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Congenital_melanocytic_nevus\" title=\"Congenital melanocytic nevus\">Congenital melanocytic nevus</a> (<a href=\"/wiki/Giant_pigmented_nevus\" class=\"mw-redirect\" title=\"Giant pigmented nevus\">Giant</a></li>\n<li><a href=\"/wiki/Medium-sized_congenital_nevocytic_nevus\" class=\"mw-redirect\" title=\"Medium-sized congenital nevocytic nevus\">Medium-sized</a></li>\n<li><a href=\"/wiki/Small-sized_congenital_nevocytic_nevus\" class=\"mw-redirect\" title=\"Small-sized congenital nevocytic nevus\">Small-sized</a>)</li></ul>\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-odd\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Balloon_cell_nevus\" title=\"Balloon cell nevus\">Balloon cell nevus</a></li>\n<li><a href=\"/wiki/Dysplastic_nevus\" title=\"Dysplastic nevus\">Dysplastic nevus</a>/<a href=\"/wiki/Dysplastic_nevus_syndrome\" title=\"Dysplastic nevus syndrome\">Dysplastic nevus syndrome</a></li></ul>\n</div></td></tr><tr><td colspan=\"2\" class=\"navbox-list navbox-even\" style=\"width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Acral_nevus\" title=\"Acral nevus\">Acral nevus</a></li>\n<li><a href=\"/wiki/Becker%27s_nevus\" title=\"Becker&#39;s nevus\">Becker's nevus</a></li>\n<li><a href=\"/wiki/Benign_melanocytic_nevus\" title=\"Benign melanocytic nevus\">Benign melanocytic nevus</a></li>\n<li><a href=\"/wiki/Nevus_spilus\" title=\"Nevus spilus\">Nevus spilus</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q180614&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q180614&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q180614\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"><a href=\"/wiki/Integrated_Authority_File\" title=\"Integrated Authority File\">GND</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://d-nb.info/gnd/4074707-4\">4074707-4</a></span></span></li>\n<li><span class=\"nowrap\"><a href=\"/wiki/Library_of_Congress_Control_Number\" title=\"Library of Congress Control Number\">LCCN</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"http://id.loc.gov/authorities/subjects/sh85083381\">sh85083381</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2174\nCached time: 20180921220327\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 2.036 seconds\nReal time usage: 2.202 seconds\nPreprocessor visited node count: 9392/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 462864/2097152 bytes\nTemplate argument size: 6125/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 242169/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 1.142/10.000 seconds\nLua memory usage: 10.58 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 1789.616      1 -total\n 72.59% 1299.135      1 Template:Reflist\n 44.99%  805.101    103 Template:Cite_journal\n 10.59%  189.459      2 Template:Infobox\n  8.47%  151.552      1 Template:Infobox_medical_condition_(new)\n  5.90%  105.554     17 Template:Cite_web\n  4.56%   81.570     11 Template:Navbox\n  3.32%   59.411      1 Template:Medical_condition_classification_and_resources\n  3.23%   57.795      9 Template:Cite_book\n  2.77%   49.657     10 Template:Cite_news\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:716631-0!canonical and timestamp 20180921220325 and revision id 859587171\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%88%D8%B1%D9%85_%D9%85%D9%8A%D9%84%D8%A7%D9%86%D9%8A%D9%86%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0648\u0631\u0645 \u0645\u064a\u0644\u0627\u0646\u064a\u0646\u064a"},{"lang":"ast","url":"https://ast.wikipedia.org/wiki/Melanoma","langname":"Asturian","autonym":"asturianu","*":"Melanoma"},{"lang":"be","url":"https://be.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Belarusian","autonym":"\u0431\u0435\u043b\u0430\u0440\u0443\u0441\u043a\u0430\u044f","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"be-x-old","url":"https://be-x-old.wikipedia.org/wiki/%D0%9C%D1%8D%D0%BB%D1%8F%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Belarusian (Tara\u0161kievica orthography)","autonym":"\u0431\u0435\u043b\u0430\u0440\u0443\u0441\u043a\u0430\u044f (\u0442\u0430\u0440\u0430\u0448\u043a\u0435\u0432\u0456\u0446\u0430)\u200e","*":"\u041c\u044d\u043b\u044f\u043d\u043e\u043c\u0430"},{"lang":"bg","url":"https://bg.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Bulgarian","autonym":"\u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"bs","url":"https://bs.wikipedia.org/wiki/Melanom","langname":"Bosnian","autonym":"bosanski","*":"Melanom"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Melanoma","langname":"Catalan","autonym":"catal\u00e0","*":"Melanoma"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Melanom","langname":"Czech","autonym":"\u010de\u0161tina","*":"Melanom"},{"lang":"cy","url":"https://cy.wikipedia.org/wiki/Melanoma","langname":"Welsh","autonym":"Cymraeg","*":"Melanoma"},{"lang":"da","url":"https://da.wikipedia.org/wiki/Moderm%C3%A6rkekr%C3%A6ft","langname":"Danish","autonym":"dansk","*":"Moderm\u00e6rkekr\u00e6ft"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Malignes_Melanom","langname":"German","autonym":"Deutsch","*":"Malignes Melanom"},{"lang":"dv","url":"https://dv.wikipedia.org/wiki/%DE%89%DE%AC%DE%8D%DE%A8%DE%8E%DE%B0%DE%82%DE%A6%DE%82%DE%B0%DE%93%DE%B0_%DE%89%DE%AC%DE%8D%DE%A6%DE%82%DE%AF%DE%89%DE%A7","langname":"Divehi","autonym":"\u078b\u07a8\u0788\u07ac\u0780\u07a8\u0784\u07a6\u0790\u07b0","*":"\u0789\u07ac\u078d\u07a8\u078e\u07b0\u0782\u07a6\u0782\u07b0\u0793\u07b0 \u0789\u07ac\u078d\u07a6\u0782\u07af\u0789\u07a7"},{"lang":"et","url":"https://et.wikipedia.org/wiki/Melanoom","langname":"Estonian","autonym":"eesti","*":"Melanoom"},{"lang":"el","url":"https://el.wikipedia.org/wiki/%CE%9C%CE%B5%CE%BB%CE%AC%CE%BD%CF%89%CE%BC%CE%B1","langname":"Greek","autonym":"\u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","*":"\u039c\u03b5\u03bb\u03ac\u03bd\u03c9\u03bc\u03b1"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Melanoma","langname":"Spanish","autonym":"espa\u00f1ol","*":"Melanoma"},{"lang":"eo","url":"https://eo.wikipedia.org/wiki/Melanomo","langname":"Esperanto","autonym":"Esperanto","*":"Melanomo"},{"lang":"eu","url":"https://eu.wikipedia.org/wiki/Melanoma","langname":"Basque","autonym":"euskara","*":"Melanoma"},{"lang":"fa","url":"https://fa.wikipedia.org/wiki/%D9%85%D9%84%D8%A7%D9%86%D9%88%D9%85%D8%A7","langname":"Persian","autonym":"\u0641\u0627\u0631\u0633\u06cc","*":"\u0645\u0644\u0627\u0646\u0648\u0645\u0627"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/M%C3%A9lanome","langname":"French","autonym":"fran\u00e7ais","*":"M\u00e9lanome"},{"lang":"ga","url":"https://ga.wikipedia.org/wiki/Meilean%C3%B3ma","langname":"Irish","autonym":"Gaeilge","*":"Meilean\u00f3ma"},{"lang":"gl","url":"https://gl.wikipedia.org/wiki/Melanoma_maligno","langname":"Galician","autonym":"galego","*":"Melanoma maligno"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%ED%9D%91%EC%83%89%EC%A2%85","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ud751\uc0c9\uc885"},{"lang":"hy","url":"https://hy.wikipedia.org/wiki/%D5%84%D5%A5%D5%AC%D5%A1%D5%B6%D5%B8%D5%B4%D5%A1","langname":"Armenian","autonym":"\u0570\u0561\u0575\u0565\u0580\u0565\u0576","*":"\u0544\u0565\u056c\u0561\u0576\u0578\u0574\u0561"},{"lang":"hr","url":"https://hr.wikipedia.org/wiki/Melanom","langname":"Croatian","autonym":"hrvatski","*":"Melanom"},{"lang":"id","url":"https://id.wikipedia.org/wiki/Melanoma","langname":"Indonesian","autonym":"Bahasa Indonesia","*":"Melanoma"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Melanoma","langname":"Italian","autonym":"italiano","*":"Melanoma"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%9E%D7%9C%D7%A0%D7%95%D7%9E%D7%94","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05de\u05dc\u05e0\u05d5\u05de\u05d4"},{"lang":"kk","url":"https://kk.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Kazakh","autonym":"\u049b\u0430\u0437\u0430\u049b\u0448\u0430","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"ky","url":"https://ky.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Kyrgyz","autonym":"\u041a\u044b\u0440\u0433\u044b\u0437\u0447\u0430","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"la","url":"https://la.wikipedia.org/wiki/Melanoma_malignum","langname":"Latin","autonym":"Latina","*":"Melanoma malignum"},{"lang":"lv","url":"https://lv.wikipedia.org/wiki/Melanoma","langname":"Latvian","autonym":"latvie\u0161u","*":"Melanoma"},{"lang":"lt","url":"https://lt.wikipedia.org/wiki/Melanoma","langname":"Lithuanian","autonym":"lietuvi\u0173","*":"Melanoma"},{"lang":"hu","url":"https://hu.wikipedia.org/wiki/Melan%C3%B3ma","langname":"Hungarian","autonym":"magyar","*":"Melan\u00f3ma"},{"lang":"mk","url":"https://mk.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC","langname":"Macedonian","autonym":"\u043c\u0430\u043a\u0435\u0434\u043e\u043d\u0441\u043a\u0438","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c"},{"lang":"ms","url":"https://ms.wikipedia.org/wiki/Melanoma","langname":"Malay","autonym":"Bahasa Melayu","*":"Melanoma"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Melanoom","langname":"Dutch","autonym":"Nederlands","*":"Melanoom"},{"lang":"new","url":"https://new.wikipedia.org/wiki/%E0%A4%AE%E0%A5%87%E0%A4%B2%E0%A4%BE%E0%A4%A8%E0%A5%8B%E0%A4%AE%E0%A4%BE","langname":"Newari","autonym":"\u0928\u0947\u092a\u093e\u0932 \u092d\u093e\u0937\u093e","*":"\u092e\u0947\u0932\u093e\u0928\u094b\u092e\u093e"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E6%82%AA%E6%80%A7%E9%BB%92%E8%89%B2%E8%85%AB","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u60aa\u6027\u9ed2\u8272\u816b"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Malignt_melanom","langname":"Norwegian","autonym":"norsk","*":"Malignt melanom"},{"lang":"or","url":"https://or.wikipedia.org/wiki/%E0%AC%AE%E0%AD%87%E0%AC%B2%E0%AC%BE%E0%AC%A8%E0%AD%8B%E0%AC%AE%E0%AC%BE","langname":"Odia","autonym":"\u0b13\u0b21\u0b3c\u0b3f\u0b06","*":"\u0b2e\u0b47\u0b32\u0b3e\u0b28\u0b4b\u0b2e\u0b3e"},{"lang":"uz","url":"https://uz.wikipedia.org/wiki/Melanoma","langname":"Uzbek","autonym":"o\u02bbzbekcha/\u045e\u0437\u0431\u0435\u043a\u0447\u0430","*":"Melanoma"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Czerniak_(nowotw%C3%B3r)","langname":"Polish","autonym":"polski","*":"Czerniak (nowotw\u00f3r)"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Melanoma","langname":"Portuguese","autonym":"portugu\u00eas","*":"Melanoma"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"sco","url":"https://sco.wikipedia.org/wiki/Melanoma","langname":"Scots","autonym":"Scots","*":"Melanoma"},{"lang":"simple","url":"https://simple.wikipedia.org/wiki/Melanoma","langname":"Simple English","autonym":"Simple English","*":"Melanoma"},{"lang":"sl","url":"https://sl.wikipedia.org/wiki/Melanom","langname":"Slovenian","autonym":"sloven\u0161\u010dina","*":"Melanom"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Melanom","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Melanom"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Melanooma","langname":"Finnish","autonym":"suomi","*":"Melanooma"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Malignt_melanom","langname":"Swedish","autonym":"svenska","*":"Malignt melanom"},{"lang":"ta","url":"https://ta.wikipedia.org/wiki/%E0%AE%95%E0%AE%B0%E0%AF%81%E0%AE%AE%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D","langname":"Tamil","autonym":"\u0ba4\u0bae\u0bbf\u0bb4\u0bcd","*":"\u0b95\u0bb0\u0bc1\u0bae\u0bcd\u0baa\u0bc1\u0bb1\u0bcd\u0bb1\u0bc1\u0ba8\u0bcb\u0baf\u0bcd"},{"lang":"te","url":"https://te.wikipedia.org/wiki/%E0%B0%AE%E0%B1%86%E0%B0%B2%E0%B0%A8%E0%B1%8B%E0%B0%AE%E0%B0%BE","langname":"Telugu","autonym":"\u0c24\u0c46\u0c32\u0c41\u0c17\u0c41","*":"\u0c2e\u0c46\u0c32\u0c28\u0c4b\u0c2e\u0c3e"},{"lang":"th","url":"https://th.wikipedia.org/wiki/%E0%B9%80%E0%B8%A1%E0%B8%A5%E0%B8%B2%E0%B9%82%E0%B8%99%E0%B8%A1%E0%B8%B2","langname":"Thai","autonym":"\u0e44\u0e17\u0e22","*":"\u0e40\u0e21\u0e25\u0e32\u0e42\u0e19\u0e21\u0e32"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/Melanom","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"Melanom"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%9C%D0%B5%D0%BB%D0%B0%D0%BD%D0%BE%D0%BC%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u041c\u0435\u043b\u0430\u043d\u043e\u043c\u0430"},{"lang":"ur","url":"https://ur.wikipedia.org/wiki/%D8%A7%D8%B3%D9%88%D8%AF%DB%8C%D9%86%D9%88%D9%85%DB%81","langname":"Urdu","autonym":"\u0627\u0631\u062f\u0648","*":"\u0627\u0633\u0648\u062f\u06cc\u0646\u0648\u0645\u06c1"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E9%BB%91%E8%89%B2%E7%B4%A0%E7%98%A4","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u9ed1\u8272\u7d20\u7624"}],"categories":[{"sortkey":"","hidden":"","*":"Pages_with_DOIs_inactive_since_2018"},{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","hidden":"","*":"Articles_with_hAudio_microformats"},{"sortkey":"","hidden":"","*":"Articles_including_recorded_pronunciations_(English)"},{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_May_2013"},{"sortkey":"","hidden":"","*":"Articles_with_Curlie_links"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_GND_identifiers"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_LCCN_identifiers"},{"sortkey":"","*":"Melanoma"},{"sortkey":"","hidden":"","*":"RTT"},{"sortkey":"","*":"Cancer"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from May 2013"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with GND identifiers"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with LCCN identifiers"},{"ns":0,"exists":"","*":"Paywall"},{"ns":0,"exists":"","*":"8-oxoguanine"},{"ns":0,"exists":"","*":"ABIM Foundation"},{"ns":0,"exists":"","*":"Abscess"},{"ns":0,"exists":"","*":"Acne rosacea"},{"ns":0,"exists":"","*":"Acne vulgaris"},{"ns":0,"exists":"","*":"Acral lentiginous melanoma"},{"ns":0,"exists":"","*":"Acral nevus"},{"ns":0,"exists":"","*":"Acrochordon"},{"ns":0,"exists":"","*":"Actinic keratosis"},{"ns":0,"exists":"","*":"Adjuvant therapy"},{"ns":0,"exists":"","*":"Adoptive cell transfer"},{"ns":0,"exists":"","*":"Age adjustment"},{"ns":0,"exists":"","*":"Alopecia areata"},{"ns":0,"exists":"","*":"Amelanotic blue nevus"},{"ns":0,"exists":"","*":"Amelanotic melanoma"},{"ns":0,"exists":"","*":"Amelanotic melanomas"},{"ns":0,"exists":"","*":"American Academy of Dermatology"},{"ns":0,"exists":"","*":"American Society of Clinical Oncology"},{"ns":0,"exists":"","*":"Ancient Greek"},{"ns":0,"exists":"","*":"Androgenic alopecia"},{"ns":0,"exists":"","*":"Aphthous stomatitis"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Athlete's foot"},{"ns":0,"exists":"","*":"Atopic dermatitis"},{"ns":0,"exists":"","*":"Australia"},{"ns":0,"exists":"","*":"Avobenzone"},{"ns":0,"exists":"","*":"BRAF (gene)"},{"ns":0,"exists":"","*":"BRAF inhibitor"},{"ns":0,"exists":"","*":"Balloon cell nevus"},{"ns":0,"exists":"","*":"Basal-cell carcinoma"},{"ns":0,"exists":"","*":"Becker's nevus"},{"ns":0,"exists":"","*":"Benign fibrous histiocytoma"},{"ns":0,"exists":"","*":"Benign melanocytic nevus"},{"ns":0,"exists":"","*":"Biologic therapy"},{"ns":0,"exists":"","*":"Biopsy"},{"ns":0,"exists":"","*":"Blister"},{"ns":0,"exists":"","*":"Blue nevus"},{"ns":0,"exists":"","*":"Blue nevus of Jadassohn\u2013Ti\u00e8che"},{"ns":0,"exists":"","*":"Boil"},{"ns":0,"exists":"","*":"Brain metastasis"},{"ns":0,"exists":"","*":"Bread loafing"},{"ns":0,"exists":"","*":"Breslow's depth"},{"ns":0,"exists":"","*":"Breslow's thickness"},{"ns":0,"exists":"","*":"Bristol-Myers Squibb"},{"ns":0,"exists":"","*":"British Association of Dermatologists"},{"ns":0,"exists":"","*":"Bullous pemphigoid"},{"ns":0,"exists":"","*":"CCPDMA"},{"ns":0,"exists":"","*":"CDK4"},{"ns":0,"exists":"","*":"Callus"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Cancer immunotherapy"},{"ns":0,"exists":"","*":"Cancer staging"},{"ns":0,"exists":"","*":"Cancer stem cells"},{"ns":0,"exists":"","*":"Cancer vaccine"},{"ns":0,"exists":"","*":"Candidiasis"},{"ns":0,"exists":"","*":"Carcinoid syndrome"},{"ns":0,"exists":"","*":"Cell division"},{"ns":0,"exists":"","*":"Cell nucleus"},{"ns":0,"exists":"","*":"Cellular blue nevus"},{"ns":0,"exists":"","*":"Cellulitis"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Chickenpox"},{"ns":0,"exists":"","*":"Choosing Wisely"},{"ns":0,"exists":"","*":"Chromosomal translocation"},{"ns":0,"exists":"","*":"Chromosome"},{"ns":0,"exists":"","*":"Chromosome 9 (human)"},{"ns":0,"exists":"","*":"Cicatricial pemphigoid"},{"ns":0,"exists":"","*":"CiteSeerX"},{"ns":0,"exists":"","*":"Clark level"},{"ns":0,"exists":"","*":"Classical compound"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Coccidioidomycosis"},{"ns":0,"exists":"","*":"Compound nevus"},{"ns":0,"exists":"","*":"Computed tomography"},{"ns":0,"exists":"","*":"Congenital melanocytic nevi"},{"ns":0,"exists":"","*":"Congenital melanocytic nevus"},{"ns":0,"exists":"","*":"Contact dermatitis"},{"ns":0,"exists":"","*":"Coxsackievirus"},{"ns":0,"exists":"","*":"Cyclin"},{"ns":0,"exists":"","*":"Cyclin-dependent kinase"},{"ns":0,"exists":"","*":"Cytosine"},{"ns":0,"exists":"","*":"DMOZ"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"DNA damage"},{"ns":0,"exists":"","*":"Dabrafenib"},{"ns":0,"exists":"","*":"Dacarbazine"},{"ns":0,"exists":"","*":"Darier's disease"},{"ns":0,"exists":"","*":"Deep penetrating nevus"},{"ns":0,"exists":"","*":"Dendritic cells"},{"ns":0,"exists":"","*":"Dermatitis herpetiformis"},{"ns":0,"exists":"","*":"Dermatofibroma"},{"ns":0,"exists":"","*":"Dermatology"},{"ns":0,"exists":"","*":"Dermatophyte"},{"ns":0,"exists":"","*":"Dermatoscope"},{"ns":0,"exists":"","*":"Dermatoscopy"},{"ns":0,"exists":"","*":"Dermis"},{"ns":0,"exists":"","*":"Desmoplastic melanoma"},{"ns":0,"exists":"","*":"Diagnostic method"},{"ns":0,"exists":"","*":"Differential diagnosis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Direct DNA damage"},{"ns":0,"exists":"","*":"Diseases Database"},{"ns":0,"exists":"","*":"Disseminated intravascular coagulation"},{"ns":0,"exists":"","*":"Drug eruption"},{"ns":0,"exists":"","*":"Dye"},{"ns":0,"exists":"","*":"Dysplastic"},{"ns":0,"exists":"","*":"Dysplastic nevus"},{"ns":0,"exists":"","*":"Dysplastic nevus syndrome"},{"ns":0,"exists":"","*":"EMedicine"},{"ns":0,"exists":"","*":"EPH receptor A2"},{"ns":0,"exists":"","*":"Elsevier"},{"ns":0,"exists":"","*":"Epidermis"},{"ns":0,"exists":"","*":"Epidermis (skin)"},{"ns":0,"exists":"","*":"Epidermoid cyst"},{"ns":0,"exists":"","*":"Epidermolysis bullosa simplex"},{"ns":0,"exists":"","*":"Epithelioid blue nevus"},{"ns":0,"exists":"","*":"Erythema"},{"ns":0,"exists":"","*":"Erythema ab igne"},{"ns":0,"exists":"","*":"Erythema annulare centrifugum"},{"ns":0,"exists":"","*":"Erythema chronicum migrans"},{"ns":0,"exists":"","*":"Erythema gyratum repens"},{"ns":0,"exists":"","*":"Erythema multiforme"},{"ns":0,"exists":"","*":"Erythema nodosum"},{"ns":0,"exists":"","*":"Erythema toxicum neonatorum"},{"ns":0,"exists":"","*":"Exanthem"},{"ns":0,"exists":"","*":"False alarm"},{"ns":0,"exists":"","*":"Fibrate"},{"ns":0,"exists":"","*":"Fine-needle aspiration"},{"ns":0,"exists":"","*":"Five-year survival rates"},{"ns":0,"exists":"","*":"Fixed drug eruption"},{"ns":0,"exists":"","*":"Folliculitis"},{"ns":0,"exists":"","*":"Folliculitis decalvans"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration (United States)"},{"ns":0,"exists":"","*":"Fort Washington, Pennsylvania"},{"ns":0,"exists":"","*":"Freckle"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"Gene therapy"},{"ns":0,"exists":"","*":"Genes"},{"ns":0,"exists":"","*":"Genetic testing"},{"ns":0,"exists":"","*":"Giant pigmented nevus"},{"ns":0,"exists":"","*":"Glucagonoma syndrome"},{"ns":0,"exists":"","*":"Granular cell tumor"},{"ns":0,"exists":"","*":"Granuloma annulare"},{"ns":0,"exists":"","*":"Greek language"},{"ns":0,"exists":"","*":"H&E stain"},{"ns":0,"exists":"","*":"HMB-45"},{"ns":0,"exists":"","*":"Halo nevus"},{"ns":0,"exists":"","*":"Hemangioma"},{"ns":0,"exists":"","*":"Herpes simplex"},{"ns":0,"exists":"","*":"Herpes zoster"},{"ns":0,"exists":"","*":"Herpesviridae"},{"ns":0,"exists":"","*":"Histological"},{"ns":0,"exists":"","*":"Histoplasmosis"},{"ns":0,"exists":"","*":"Human skin color"},{"ns":0,"exists":"","*":"Hunterian and Wellcome Museums"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"ICD-10 Chapter II: Neoplasms"},{"ns":0,"exists":"","*":"Ichthyosis"},{"ns":0,"exists":"","*":"Idiopathic guttate hypomelanosis"},{"ns":0,"exists":"","*":"Imiquimod"},{"ns":0,"exists":"","*":"Immunoperoxidase"},{"ns":0,"exists":"","*":"Immunosuppression"},{"ns":0,"exists":"","*":"Impetigo"},{"ns":0,"exists":"","*":"In vivo"},{"ns":0,"exists":"","*":"Inch"},{"ns":0,"exists":"","*":"Incidence (epidemiology)"},{"ns":0,"exists":"","*":"Infantile digital fibromatosis"},{"ns":0,"exists":"","*":"Ingrown nail"},{"ns":0,"exists":"","*":"Insect bites and stings"},{"ns":0,"exists":"","*":"Integrated Authority File"},{"ns":0,"exists":"","*":"Interferon"},{"ns":0,"exists":"","*":"Interleukin-2"},{"ns":0,"exists":"","*":"International Agency for Research on Cancer"},{"ns":0,"exists":"","*":"International Classification of Diseases for Oncology"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"Intestines"},{"ns":0,"exists":"","*":"Ipilimumab"},{"ns":0,"exists":"","*":"Itch"},{"ns":0,"exists":"","*":"John Hunter (surgeon)"},{"ns":0,"exists":"","*":"Junctional nevus"},{"ns":0,"exists":"","*":"Kaposi's sarcoma"},{"ns":0,"exists":"","*":"Keloid"},{"ns":0,"exists":"","*":"Keratosis pilaris"},{"ns":0,"exists":"","*":"Kinase"},{"ns":0,"exists":"","*":"Lactate dehydrogenase"},{"ns":0,"exists":"","*":"Langerhans cell histiocytosis"},{"ns":0,"exists":"","*":"Leiomyoma"},{"ns":0,"exists":"","*":"Lentigo"},{"ns":0,"exists":"","*":"Lentigo maligna"},{"ns":0,"exists":"","*":"Lentigo maligna melanoma"},{"ns":0,"exists":"","*":"Leprosy"},{"ns":0,"exists":"","*":"Leukoplakia"},{"ns":0,"exists":"","*":"Library of Congress Control Number"},{"ns":0,"exists":"","*":"Lichen nitidus"},{"ns":0,"exists":"","*":"Lichen planopilaris"},{"ns":0,"exists":"","*":"Lichen planus"},{"ns":0,"exists":"","*":"Lichen sclerosus"},{"ns":0,"exists":"","*":"Lichen simplex chronicus"},{"ns":0,"exists":"","*":"Lichen spinulosus"},{"ns":0,"exists":"","*":"Lipoma"},{"ns":0,"exists":"","*":"List of ICD-9 codes"},{"ns":0,"exists":"","*":"List of ICD-9 codes 140\u2013239: neoplasms"},{"ns":0,"exists":"","*":"Local anesthesia"},{"ns":0,"exists":"","*":"Loose anagen syndrome"},{"ns":0,"exists":"","*":"Lung cancer"},{"ns":0,"exists":"","*":"Lymph node"},{"ns":0,"exists":"","*":"Lymph nodes"},{"ns":0,"exists":"","*":"Lymph vessels"},{"ns":0,"exists":"","*":"Lymphadenectomy"},{"ns":0,"exists":"","*":"Lymphangioma circumscriptum"},{"ns":0,"exists":"","*":"Lymphocyte"},{"ns":0,"exists":"","*":"Lymphoscintigraphy"},{"ns":0,"exists":"","*":"MAP kinase"},{"ns":0,"exists":"","*":"MC1R"},{"ns":0,"exists":"","*":"MCM6"},{"ns":0,"exists":"","*":"MDM2"},{"ns":0,"exists":"","*":"MEK inhibitor"},{"ns":0,"exists":"","*":"MLANA"},{"ns":0,"exists":"","*":"MRI"},{"ns":0,"exists":"","*":"Malignant blue nevus"},{"ns":0,"exists":"","*":"Medical Subject Headings"},{"ns":0,"exists":"","*":"Medium-sized congenital nevocytic nevus"},{"ns":0,"exists":"","*":"MedlinePlus"},{"ns":0,"exists":"","*":"Melanin"},{"ns":0,"exists":"","*":"Melanocortin 1 receptor"},{"ns":0,"exists":"","*":"Melanocyte"},{"ns":0,"exists":"","*":"Melanocytes"},{"ns":0,"exists":"","*":"Melanocytic nevus"},{"ns":0,"exists":"","*":"Melanocytic tumor"},{"ns":0,"exists":"","*":"Melanocytic tumors of uncertain malignant potential"},{"ns":0,"exists":"","*":"Melanoma with features of a Spitz nevus"},{"ns":0,"exists":"","*":"Melanoma with small nevus-like cells"},{"ns":0,"exists":"","*":"Melanosis"},{"ns":0,"exists":"","*":"Melasma"},{"ns":0,"exists":"","*":"Merkel-cell carcinoma"},{"ns":0,"exists":"","*":"Merriam-Webster"},{"ns":0,"exists":"","*":"Metastasis"},{"ns":0,"exists":"","*":"Miliaria"},{"ns":0,"exists":"","*":"Missense mutation"},{"ns":0,"exists":"","*":"Mitosis"},{"ns":0,"exists":"","*":"Mohs surgery"},{"ns":0,"exists":"","*":"Mole (skin marking)"},{"ns":0,"exists":"","*":"Molecular weight"},{"ns":0,"exists":"","*":"Molluscum contagiosum"},{"ns":0,"exists":"","*":"Morbidity"},{"ns":0,"exists":"","*":"Morphea"},{"ns":0,"exists":"","*":"Mucosal melanoma"},{"ns":0,"exists":"","*":"Mucous membrane"},{"ns":0,"exists":"","*":"Mucous membrane pemphigoid"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"Mycosis fungoides"},{"ns":0,"exists":"","*":"Myxoid cyst"},{"ns":0,"exists":"","*":"Nail (anatomy)"},{"ns":0,"exists":"","*":"National Cancer Institute"},{"ns":0,"exists":"","*":"Nausea"},{"ns":0,"exists":"","*":"Necrobiosis lipoidica"},{"ns":0,"exists":"","*":"Neisseria gonorrhoeae"},{"ns":0,"exists":"","*":"Neoplasm"},{"ns":0,"exists":"","*":"Neurofibroma"},{"ns":0,"exists":"","*":"Nevi"},{"ns":0,"exists":"","*":"Nevi and melanomas"},{"ns":0,"exists":"","*":"Nevoid melanoma"},{"ns":0,"exists":"","*":"Nevus"},{"ns":0,"exists":"","*":"Nevus of Ito"},{"ns":0,"exists":"","*":"Nevus of Ota"},{"ns":0,"exists":"","*":"Nevus sebaceous"},{"ns":0,"exists":"","*":"Nevus spilus"},{"ns":0,"exists":"","*":"New Latin"},{"ns":0,"exists":"","*":"Nivolumab"},{"ns":0,"exists":"","*":"Nodular melanoma"},{"ns":0,"exists":"","*":"Nonsense mutation"},{"ns":0,"exists":"","*":"Northern Europe"},{"ns":0,"exists":"","*":"OMIM"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"Oncolytic viruses"},{"ns":0,"exists":"","*":"Onychomycosis"},{"ns":0,"exists":"","*":"Oral candidiasis"},{"ns":0,"exists":"","*":"P16 (gene)"},{"ns":0,"exists":"","*":"P53"},{"ns":0,"exists":"","*":"PMEL (gene)"},{"ns":0,"exists":"","*":"Palliative care"},{"ns":0,"exists":"","*":"Papillary dermis"},{"ns":0,"exists":"","*":"Papule"},{"ns":0,"exists":"","*":"Paraneoplastic syndrome"},{"ns":0,"exists":"","*":"Parapsoriasis"},{"ns":0,"exists":"","*":"Paronychia"},{"ns":0,"exists":"","*":"Pathogenesis"},{"ns":0,"exists":"","*":"Pathology"},{"ns":0,"exists":"","*":"Pembrolizumab"},{"ns":0,"exists":"","*":"Pemphigus"},{"ns":0,"exists":"","*":"Pemphigus vulgaris"},{"ns":0,"exists":"","*":"Perineural invasion"},{"ns":0,"exists":"","*":"Peru"},{"ns":0,"exists":"","*":"Pigmented spindle cell nevus"},{"ns":0,"exists":"","*":"Pityriasis alba"},{"ns":0,"exists":"","*":"Pityriasis lichenoides et varioliformis acuta"},{"ns":0,"exists":"","*":"Pityriasis rosea"},{"ns":0,"exists":"","*":"Pityriasis rubra pilaris"},{"ns":0,"exists":"","*":"Podosome"},{"ns":0,"exists":"","*":"Polymerase chain reaction"},{"ns":0,"exists":"","*":"Polypoid melanoma"},{"ns":0,"exists":"","*":"Porphyria cutanea tarda"},{"ns":0,"exists":"","*":"Positron emission tomography"},{"ns":0,"exists":"","*":"Postinflammatory hyperpigmentation"},{"ns":0,"exists":"","*":"Prognosis"},{"ns":0,"exists":"","*":"Progression-free survival"},{"ns":0,"exists":"","*":"Proleukin"},{"ns":0,"exists":"","*":"Protein"},{"ns":0,"exists":"","*":"Protein dimer"},{"ns":0,"exists":"","*":"Protooncogene"},{"ns":0,"exists":"","*":"Pseudofolliculitis barbae"},{"ns":0,"exists":"","*":"Pseudomelanoma"},{"ns":0,"exists":"","*":"Psoriasis"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Purine"},{"ns":0,"exists":"","*":"Pustule"},{"ns":0,"exists":"","*":"Pyrimidine"},{"ns":0,"exists":"","*":"Pyrimidine dimers"},{"ns":0,"exists":"","*":"Pyrimidines"},{"ns":0,"exists":"","*":"Quality of life"},{"ns":0,"exists":"","*":"Radiation therapy"},{"ns":0,"exists":"","*":"Radiocarbon"},{"ns":0,"exists":"","*":"Radioimmunotherapy"},{"ns":0,"exists":"","*":"Rash"},{"ns":0,"exists":"","*":"Reactive oxygen species"},{"ns":0,"exists":"","*":"Reading frame"},{"ns":0,"exists":"","*":"Ren\u00e9 Laennec"},{"ns":0,"exists":"","*":"Risk factor"},{"ns":0,"exists":"","*":"Royal College of Surgeons of England"},{"ns":0,"exists":"","*":"S-100 protein"},{"ns":0,"exists":"","*":"Samuel Cooper (surgeon)"},{"ns":0,"exists":"","*":"Scabies"},{"ns":0,"exists":"","*":"Scale (dermatology)"},{"ns":0,"exists":"","*":"Scleroderma"},{"ns":0,"exists":"","*":"Seborrheic keratosis"},{"ns":0,"exists":"","*":"Seborrhoeic dermatitis"},{"ns":0,"exists":"","*":"Sentinel lymph node"},{"ns":0,"exists":"","*":"Skin biopsy"},{"ns":0,"exists":"","*":"Skin cancer"},{"ns":0,"exists":"","*":"Skin pigmentation"},{"ns":0,"exists":"","*":"Small-cell melanoma"},{"ns":0,"exists":"","*":"Small-sized congenital nevocytic nevus"},{"ns":0,"exists":"","*":"Solar purpura"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Spitz nevus"},{"ns":0,"exists":"","*":"Splice site mutation"},{"ns":0,"exists":"","*":"Squamous-cell carcinoma"},{"ns":0,"exists":"","*":"Squamous cell carcinoma"},{"ns":0,"exists":"","*":"Stasis dermatitis"},{"ns":0,"exists":"","*":"Statin"},{"ns":0,"exists":"","*":"Subcorneal pustular dermatosis"},{"ns":0,"exists":"","*":"Sun protective clothing"},{"ns":0,"exists":"","*":"Sunbed"},{"ns":0,"exists":"","*":"Sunburn"},{"ns":0,"exists":"","*":"Sunscreen"},{"ns":0,"exists":"","*":"Superficial spreading melanoma"},{"ns":0,"exists":"","*":"Surgical margin"},{"ns":0,"exists":"","*":"Syphilis"},{"ns":0,"exists":"","*":"Systemic lupus erythematosus"},{"ns":0,"exists":"","*":"TNM staging system"},{"ns":0,"exists":"","*":"T cell receptor"},{"ns":0,"exists":"","*":"T cells"},{"ns":0,"exists":"","*":"Tanning lamp"},{"ns":0,"exists":"","*":"Telogen effluvium"},{"ns":0,"exists":"","*":"Temozolomide"},{"ns":0,"exists":"","*":"The Lancet Oncology"},{"ns":0,"exists":"","*":"The New York Times"},{"ns":0,"exists":"","*":"Thrombocytopenic purpura"},{"ns":0,"exists":"","*":"Thymine"},{"ns":0,"exists":"","*":"Timeless (gene)"},{"ns":0,"exists":"","*":"Timeline of melanoma"},{"ns":0,"exists":"","*":"Tinea capitis"},{"ns":0,"exists":"","*":"Tinea corporis"},{"ns":0,"exists":"","*":"Tinea cruris"},{"ns":0,"exists":"","*":"Tinea faciei"},{"ns":0,"exists":"","*":"Tinea manuum"},{"ns":0,"exists":"","*":"Tinea versicolor"},{"ns":0,"exists":"","*":"Tissue biopsy"},{"ns":0,"exists":"","*":"Titanium dioxide"},{"ns":0,"exists":"","*":"Trametinib"},{"ns":0,"exists":"","*":"Transcription factor"},{"ns":0,"exists":"","*":"Transient acantholytic dermatosis"},{"ns":0,"exists":"","*":"Transition (genetics)"},{"ns":0,"exists":"","*":"Translesion synthesis"},{"ns":0,"exists":"","*":"Trichoepithelioma"},{"ns":0,"exists":"","*":"Tuberous sclerosis"},{"ns":0,"exists":"","*":"Tumor"},{"ns":0,"exists":"","*":"Tumor infiltrating lymphocyte"},{"ns":0,"exists":"","*":"Tumor suppressor gene"},{"ns":0,"exists":"","*":"Tyrosinase"},{"ns":0,"exists":"","*":"UVB"},{"ns":0,"exists":"","*":"Ulcer (dermatology)"},{"ns":0,"exists":"","*":"Ultraviolet"},{"ns":0,"exists":"","*":"Ultraviolet light"},{"ns":0,"exists":"","*":"Unnecessary health care"},{"ns":0,"exists":"","*":"Urticaria"},{"ns":0,"exists":"","*":"Uveal melanoma"},{"ns":0,"exists":"","*":"Vaginal melanoma"},{"ns":0,"exists":"","*":"Vasculitis"},{"ns":0,"exists":"","*":"Vemurafenib"},{"ns":0,"exists":"","*":"Virotherapy"},{"ns":0,"exists":"","*":"Vitamin D"},{"ns":0,"exists":"","*":"Vitiligo"},{"ns":0,"exists":"","*":"WIPI1"},{"ns":0,"exists":"","*":"Wart"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"White people"},{"ns":0,"exists":"","*":"Wide local excision"},{"ns":0,"exists":"","*":"Wiskott\u2013Aldrich syndrome"},{"ns":0,"exists":"","*":"Word sense"},{"ns":0,"exists":"","*":"Xanthoma"},{"ns":0,"exists":"","*":"Xeroderma pigmentosum"},{"ns":0,"exists":"","*":"Zinc deficiency"},{"ns":0,"exists":"","*":"Zinc oxide"},{"ns":0,"*":"GLOBOCAN"},{"ns":6,"*":"File:Melanoma-pronunciation.ogg"},{"ns":10,"exists":"","*":"Template:Diseases of the skin and appendages by morphology"},{"ns":10,"exists":"","*":"Template:Skin tumors, nevi and melanomas"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":11,"exists":"","*":"Template talk:Diseases of the skin and appendages by morphology"},{"ns":11,"exists":"","*":"Template talk:Skin tumors, nevi and melanomas"},{"ns":12,"exists":"","*":"Help:Authority control"},{"ns":12,"exists":"","*":"Help:IPA/English"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Convert"},{"ns":10,"exists":"","*":"Template:IPAc-en"},{"ns":10,"exists":"","*":"Template:IPA audio link"},{"ns":10,"exists":"","*":"Template:Audio"},{"ns":10,"exists":"","*":"Template:Ubl"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Refbegin"},{"ns":10,"exists":"","*":"Template:Refbegin/styles.css"},{"ns":10,"exists":"","*":"Template:Column-count"},{"ns":10,"exists":"","*":"Template:Legend"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Refend"},{"ns":10,"exists":"","*":"Template:See also"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Google books"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Closed access"},{"ns":10,"exists":"","*":"Template:Cite press release"},{"ns":10,"exists":"","*":"Template:Medical condition classification and resources"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD10"},{"ns":10,"exists":"","*":"Template:ICD9"},{"ns":10,"exists":"","*":"Template:ICDO"},{"ns":10,"exists":"","*":"Template:EMedicine2"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":10,"exists":"","*":"Template:Wiktionary"},{"ns":10,"exists":"","*":"Template:Sister project"},{"ns":10,"exists":"","*":"Template:Side box"},{"ns":10,"exists":"","*":"Template:Commons category"},{"ns":10,"exists":"","*":"Template:Commons"},{"ns":10,"exists":"","*":"Template:DMOZ"},{"ns":10,"exists":"","*":"Template:Curlie"},{"ns":10,"exists":"","*":"Template:Diseases of the skin and appendages by morphology"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Skin tumors, nevi and melanomas"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Convert"},{"ns":828,"exists":"","*":"Module:Convert/data"},{"ns":828,"exists":"","*":"Module:Convert/text"},{"ns":828,"exists":"","*":"Module:IPAc-en"},{"ns":828,"exists":"","*":"Module:IPAc-en/data"},{"ns":828,"exists":"","*":"Module:IPAc-en/pronunciation"},{"ns":828,"exists":"","*":"Module:IPAc-en/phonemes"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Labelled list hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Side box"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"}],"images":["Melanoma-pronunciation.ogg","Lock-green.svg","Closed_Access_logo_alternative.svg","Melanoma.jpg","Loudspeaker.svg","Diagram_showing_where_melanoma_is_most_likely_to_develop_CRUK_383.svg","Metastatic_Melanoma_Cells_Nci-vol-9872-300.jpg","Melanoma_vs_normal_mole_ABCD_rule_NCI_Visuals_Online.jpg","Dermatoscope1.JPG","Malignant_melanoma_(1)_at_thigh_Case_01.jpg","Lymph_node_with_almost_complete_replacement_by_metastatic_melanoma.jpg","Anal_Melanoma.JPG","Diagram_showing_the_T_stages_of_melanoma_CRUK_373.svg","Malignes_Melanom.jpg","Malignant_melanoma_on_chest.jpg","Diagram_showing_the_most_common_places_for_melanoma_to_spread_to_CRUK_312.svg","5YearSurvival2008to14.jpg","Worldwide_Melanoma_of_Skin_Cancer_Incidence_-_2008_Globocan.svg","Melanoma_and_other_skin_cancers_world_map-Deaths_per_million_persons-WHO2012.svg","Wiktionary-logo-en-v2.svg","Commons-logo.svg","Blue_pencil.svg"],"externallinks":["http://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq","https://web.archive.org/web/20150704213842/http://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq","https://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf","https://web.archive.org/web/20140530232406/http://www.iarc.fr/en/publications/pdfs-online/wcr/2003/WorldCancerReport.pdf","//www.ncbi.nlm.nih.gov/pubmed/11310650","http://seer.cancer.gov/statfacts/html/melan.html","https://web.archive.org/web/20140706134347/http://seer.cancer.gov/statfacts/html/melan.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577","//doi.org/10.1016/S0140-6736(16)31678-6","//www.ncbi.nlm.nih.gov/pubmed/27733282","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903","//doi.org/10.1016/s0140-6736(16)31012-1","//www.ncbi.nlm.nih.gov/pubmed/27733281","http://linkinghub.elsevier.com/retrieve/pii/S1085-5629(11)00130-1","//doi.org/10.1016/j.sder.2011.08.003","//www.ncbi.nlm.nih.gov/pubmed/22123420","//doi.org/10.1016/j.suc.2014.07.013","//www.ncbi.nlm.nih.gov/pubmed/25245960","http://linkinghub.elsevier.com/retrieve/pii/S1470204517306071","//doi.org/10.1016/s1470-2045(17)30607-1","//www.ncbi.nlm.nih.gov/pubmed/29208439","https://web.archive.org/web/20150801214405/http://melanomawarningsigns.com/","http://www.melanomawarningsigns.com/","//doi.org/10.1177/107327489500200503","//www.ncbi.nlm.nih.gov/pubmed/10862180","http://www.mayoclinic.org/diseases-conditions/melanoma/basics/risk-factors/con-20026009","https://web.archive.org/web/20170410133759/http://www.mayoclinic.org/diseases-conditions/melanoma/basics/risk-factors/con-20026009","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3404185","//doi.org/10.1136/bmj.e4757","//www.ncbi.nlm.nih.gov/pubmed/22833605","//doi.org/10.1016/S1470-2045(09)70213-X","//www.ncbi.nlm.nih.gov/pubmed/19655431","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4482339","//doi.org/10.1001/jamadermatol.2014.1077","//www.ncbi.nlm.nih.gov/pubmed/25188246","//doi.org/10.1039/c1pp05232b","//www.ncbi.nlm.nih.gov/pubmed/22005748","//doi.org/10.1067/mjd.2001.114594","//www.ncbi.nlm.nih.gov/pubmed/11312434","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2082713","//doi.org/10.1136/adc.2005.086918","//www.ncbi.nlm.nih.gov/pubmed/16326797","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2010319","//doi.org/10.1038/bjc.1980.138","//www.ncbi.nlm.nih.gov/pubmed/7426301","//doi.org/10.1002/1097-0142(19950115)75:2","//www.ncbi.nlm.nih.gov/pubmed/7804988","http://www.who.int/mediacentre/news/notes/2005/np07/en/","https://web.archive.org/web/20090616124844/http://www.who.int/mediacentre/news/notes/2005/np07/en/","//www.ncbi.nlm.nih.gov/pubmed/1632422","//doi.org/10.1002/(SICI)1097-0142(19991201)86:11","//www.ncbi.nlm.nih.gov/pubmed/10630172","//doi.org/10.1097/00001622-200103000-00008","//www.ncbi.nlm.nih.gov/pubmed/11224711","https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=full_report&list_uids=1029","https://web.archive.org/web/20041117054925/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3881546","//doi.org/10.1158/1078-0432.CCR-08-2678","//www.ncbi.nlm.nih.gov/pubmed/19318491","//doi.org/10.1002/ijc.2910620402","//www.ncbi.nlm.nih.gov/pubmed/7635560","//doi.org/10.1056/NEJMra052166","//www.ncbi.nlm.nih.gov/pubmed/16822996","//doi.org/10.1001/jama.258.21.3146","//www.ncbi.nlm.nih.gov/pubmed/3312689","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3018069","//doi.org/10.1155/2010/260267","//www.ncbi.nlm.nih.gov/pubmed/21234353","http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=34439","https://web.archive.org/web/20110725021007/http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=34439","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3169242","//doi.org/10.1038/onc.2010.323","//www.ncbi.nlm.nih.gov/pubmed/20697348","http://www.intechopen.com/books/new-research-directions-in-dna-repair/dna-damage-dna-repair-and-cancer","//doi.org/10.1039/c1pp05219e","//www.ncbi.nlm.nih.gov/pubmed/21901217","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3565312","//doi.org/10.3390/ijms14011132","//www.ncbi.nlm.nih.gov/pubmed/23303275","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3367798","//doi.org/10.1038/nature11071","//www.ncbi.nlm.nih.gov/pubmed/22622578","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037280","//doi.org/10.1126/science.1186802","//www.ncbi.nlm.nih.gov/pubmed/20220176","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3483378","//doi.org/10.1038/ng.2418","//www.ncbi.nlm.nih.gov/pubmed/23001126","https://www.proteinatlas.org/humanpathology/melanoma","http://science.sciencemag.org/content/357/6352/eaan2507","//doi.org/10.1126/science.aan2507","//www.ncbi.nlm.nih.gov/pubmed/28818916","//doi.org/10.1002/jcb.20296","//www.ncbi.nlm.nih.gov/pubmed/15523674","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2427333","//doi.org/10.1074/jbc.M802030200","//www.ncbi.nlm.nih.gov/pubmed/18397884","//www.ncbi.nlm.nih.gov/pmc/articles/PMC384722","//doi.org/10.1073/pnas.0400195101","//www.ncbi.nlm.nih.gov/pubmed/15010535","//doi.org/10.1002/bies.20734","//www.ncbi.nlm.nih.gov/pubmed/18348191","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2265711","//doi.org/10.1186/1750-2187-3-3","//www.ncbi.nlm.nih.gov/pubmed/18269766","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4810118","//doi.org/10.3390/cancers8030034","//www.ncbi.nlm.nih.gov/pubmed/26978405","https://web.archive.org/web/20101019035021/http://australianprescriber.com/magazine/33/5/150/5","http://www.australianprescriber.com/magazine/33/5/150/5","https://web.archive.org/web/20030423111111/http://melanomafoundation.org/prevention/abcd.htm","http://www.melanomafoundation.org/prevention/abcd.htm","//doi.org/10.3322/canjclin.35.3.130","//www.ncbi.nlm.nih.gov/pubmed/3921200","//doi.org/10.1001/archderm.134.11.1484","//www.ncbi.nlm.nih.gov/pubmed/9828892","http://dermnetnz.org/doctors/dermoscopy-course/introduction.html","https://web.archive.org/web/20090507183545/http://dermnetnz.org/doctors/dermoscopy-course/introduction.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628830","//www.ncbi.nlm.nih.gov/pubmed/19155361","//doi.org/10.1111/ajd.12333","//www.ncbi.nlm.nih.gov/pubmed/25827527","//doi.org/10.1111/j.1524-4725.2012.02384.x","//www.ncbi.nlm.nih.gov/pubmed/22471244","//doi.org/10.1016/j.amjsurg.2005.08.020","//www.ncbi.nlm.nih.gov/pubmed/16307945","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961608","//doi.org/10.5999/aps.2014.41.2.122","//www.ncbi.nlm.nih.gov/pubmed/24665419","https://web.archive.org/web/20100718150647/http://chorus.rad.mcw.edu/doc/00955.html","http://chorus.rad.mcw.edu/doc/00955.html","http://www.jco.org/cgi/content/full/19/16/3635","//citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.475.6560","//doi.org/10.1200/JCO.2001.19.16.3635","//www.ncbi.nlm.nih.gov/pubmed/11504745","https://web.archive.org/web/20060305151011/http://www.jco.org/cgi/content/full/19/16/3635","//doi.org/10.1586/14737140.5.5.821","//www.ncbi.nlm.nih.gov/pubmed/16221052","//doi.org/10.1007/s10552-008-9129-6","//www.ncbi.nlm.nih.gov/pubmed/18273687","http://www.cancerepidemiology.net/article/S1877-7821(15)00002-8/fulltext","//doi.org/10.1016/j.canep.2014.12.014","//www.ncbi.nlm.nih.gov/pubmed/26096748","http://www.cancer.org/docroot/cri/content/cri_2_4_2x_can_melanoma_be_prevented_50.asp","https://web.archive.org/web/20060627025413/http://www.cancer.org/docroot/cri/content/cri_2_4_2x_can_melanoma_be_prevented_50.asp","//doi.org/10.1111/j.1600-0781.2011.00557.x","//www.ncbi.nlm.nih.gov/pubmed/21392107","http://www.jabfm.org/content/24/6/735","//doi.org/10.3122/jabfm.2011.06.100178","//www.ncbi.nlm.nih.gov/pubmed/22086817","https://web.archive.org/web/20140810061440/http://www.jabfm.org/content/24/6/735","http://www.cochrane.org/CD003697/SKIN_currently-there-is-no-clear-evidence-that-cholesterol-drugs-reduce-melanoma-risk.","//doi.org/10.1002/14651858.CD003697.pub2","//www.worldcat.org/issn/1465-1858","//www.ncbi.nlm.nih.gov/pubmed/16235336","//doi.org/10.1093/jnci/djj412","//www.ncbi.nlm.nih.gov/pubmed/17077356","https://web.archive.org/web/20120711150413/http://www.malignant-melanoma.org/sentinel-node-biopsy/sentinel-node-biopsy-false-positivity/","http://www.malignant-melanoma.org/sentinel-node-biopsy/sentinel-node-biopsy-false-positivity/","https://www.cochrane.org/CD010307/SKIN_lymph-node-biopsy-followed-lymph-node-dissection-localised-skin-cancer","//doi.org/10.1002/14651858.CD010307.pub2","//www.ncbi.nlm.nih.gov/pubmed/25978975","//doi.org/10.1177/107327480801500304","//www.ncbi.nlm.nih.gov/pubmed/18596673","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1242959","//doi.org/10.1097/00000658-199309000-00005","//www.ncbi.nlm.nih.gov/pubmed/8373269","http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802011000100014","//doi.org/10.1002/14651858.CD004835.pub2","//www.ncbi.nlm.nih.gov/pubmed/19821334","https://books.google.com/books?id=8j9sAAAAMAAJ","https://web.archive.org/web/20160107215207/https://books.google.com/books?id=8j9sAAAAMAAJ","http://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1076-0512&date=2008&volume=34&issue=5&spage=660","//doi.org/10.1111/j.1524-4725.2007.34124.x","//www.ncbi.nlm.nih.gov/pubmed/18261099","https://web.archive.org/web/20090106181514/http://www.malignant-melanoma.org/surgery/lymph-node-dissection-surgery/","http://www.malignant-melanoma.org/surgery/lymph-node-dissection-surgery/","//www.ncbi.nlm.nih.gov/pubmed/24005142","//doi.org/10.1016/j.clindermatol.2012.08.004","//www.ncbi.nlm.nih.gov/pubmed/23608449","http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-dermatology/","https://web.archive.org/web/20131201171621/http://www.choosingwisely.org/doctor-patient-lists/american-academy-of-dermatology/","//doi.org/10.1016/j.jaad.2011.04.031","//www.ncbi.nlm.nih.gov/pubmed/21868127","https://web.archive.org/web/20131228154542/https://subscriptions.nccn.org/gl_login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf","https://subscriptions.nccn.org/gl_login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf","//www.ncbi.nlm.nih.gov/pmc/articles/PMC6094595","//doi.org/10.2217/mmt.14.23","//www.ncbi.nlm.nih.gov/pubmed/30190820","//doi.org/10.1007/s00432-012-1322-z","//www.ncbi.nlm.nih.gov/pubmed/23052696","//doi.org/10.1016/S0733-8635(02)00025-6","//www.ncbi.nlm.nih.gov/pubmed/12380054","//doi.org/10.1200/JCO.1996.14.1.7","//www.ncbi.nlm.nih.gov/pubmed/8558223","http://as.wiley.com/WileyCDA/WileyTitle/productCd-1444335529,descCd-buy.html","http://www.cochrane.org/CD008955/SKIN_interferon-treatment-melanoma-patients-after-surgical-removal-their-tumour","//doi.org/10.1002/14651858.CD008955.pub2","//www.ncbi.nlm.nih.gov/pubmed/23775773","http://ascopubs.org/doi/abs/10.1200/jco.2007.25.18_suppl.8526","//doi.org/10.1200/jco.2007.25.18_suppl.8526","//doi.org/10.1200/JCO.2000.18.12.2444","//www.ncbi.nlm.nih.gov/pubmed/10856105","//doi.org/10.1016/S0140-6736(02)08001-7","//www.ncbi.nlm.nih.gov/pubmed/11918944","//doi.org/10.1364/OL.31.002998","//www.ncbi.nlm.nih.gov/pubmed/17001379","//doi.org/10.1053/sonc.2002.35238","//www.ncbi.nlm.nih.gov/pubmed/12407508","//www.ncbi.nlm.nih.gov/pubmed/15609471","//doi.org/10.2340/00015555-2035","//www.ncbi.nlm.nih.gov/pubmed/25520039","//doi.org/10.2165/00003495-200565060-00002","//www.ncbi.nlm.nih.gov/pubmed/15819587","http://www.cancernetwork.com/display/article/10165/1413720","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2737459","//www.ncbi.nlm.nih.gov/pubmed/19544689","https://web.archive.org/web/20090530081051/http://www.cancernetwork.com/display/article/10165/1413720","https://www.cochrane.org/CD011123/SKIN_systemic-treatments-tablets-or-injections-taken-metastatic-melanoma-expanded-its-starting-point","//doi.org/10.1002/14651858.CD011123.pub2","//www.ncbi.nlm.nih.gov/pubmed/29405038","//doi.org/10.1126/science.aaa4967","//www.ncbi.nlm.nih.gov/pubmed/25838374","http://www.medscimonit.com/download/index/idArt/890496","//doi.org/10.12659/MSM.890496","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4063985","//www.ncbi.nlm.nih.gov/pubmed/24912947","https://web.archive.org/web/20170629085737/http://medscimonit.com/download/index/idArt/890496","//doi.org/10.1007/s00262-014-1558-3","//www.ncbi.nlm.nih.gov/pubmed/24878889","http://www.cochrane.org/CD010308/SKIN_interventions-treatment-melanoma-situ-including-lentigo-maligna","//doi.org/10.1002/14651858.CD010308.pub2","//www.ncbi.nlm.nih.gov/pubmed/25526608","http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(97)70114-2","//doi.org/10.1016/S0190-9622(97)70114-2","//www.ncbi.nlm.nih.gov/pubmed/9366823","//doi.org/10.1088/0031-9155/59/6/r183","//www.ncbi.nlm.nih.gov/pubmed/24584183","//doi.org/10.1016/j.ctrv.2004.09.005","//www.ncbi.nlm.nih.gov/pubmed/15707701","https://wayback.archive-it.org/all/20080216112052/https://www.moffitt.usf.edu/pubs/ccj/v12n4/pdf/223.pdf","//doi.org/10.1177/107327480501200403","//www.ncbi.nlm.nih.gov/pubmed/16258493","https://www.moffitt.usf.edu/pubs/ccj/v12n4/pdf/223.pdf","//doi.org/10.1016/j.jaad.2014.09.029","//www.ncbi.nlm.nih.gov/pubmed/25440435","http://www-dep.iarc.fr/","https://web.archive.org/web/20120217163455/http://www-dep.iarc.fr/","//doi.org/10.2741/1877","//www.ncbi.nlm.nih.gov/pubmed/16368510","http://aihw.gov.au/cancer/cancer-in-australia-overview-2012/","https://web.archive.org/web/20140602195619/http://aihw.gov.au/cancer/cancer-in-australia-overview-2012/","https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4584771","//www.ncbi.nlm.nih.gov/pubmed/26042651","https://web.archive.org/web/20170531141344/https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm","https://www.cdc.gov/cancer/skin/statistics/","https://web.archive.org/web/20170410214142/https://www.cdc.gov/cancer/skin/statistics/","https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html","https://web.archive.org/web/20170410135926/https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html","//doi.org/10.1002/1097-0142(196605)19:5%3C607::AID-CNCR2820190502%3E3.0.CO;2-8","//www.ncbi.nlm.nih.gov/pubmed/5326247","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2312310","//www.ncbi.nlm.nih.gov/pubmed/5698493","https://books.google.com/books?id=hgE0AQAAMAAJ","http://unabridged.merriam-webster.com/collegiate/","http://www.perseus.tufts.edu/hopper/text?doc=Perseus:text:1999.04.0057:entry%3Dme/las","https://web.archive.org/web/20110605183904/http://www.perseus.tufts.edu/hopper/text?doc=Perseus:text:1999.04.0057:entry%3Dme/las","http://dorlands.com/","https://ahdictionary.com/","http://adisonline.com/pharmaceuticalmedicine/Abstract/2012/26030/Drugs_in_Clinical_Development_for_Melanoma__.4.aspx","//doi.org/10.1007/BF03262391","//doi.org/10.1177/107327480200900106","//www.ncbi.nlm.nih.gov/pubmed/11907465","http://jco.ascopubs.org/content/26/32/5233.full","//doi.org/10.1200/JCO.2008.16.5449","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652090","//www.ncbi.nlm.nih.gov/pubmed/18809613","https://web.archive.org/web/20150210005932/http://jco.ascopubs.org/content/26/32/5233.full","http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=20406835","//doi.org/10.1158/1078-0432.CCR-10-0041","//www.ncbi.nlm.nih.gov/pubmed/20406835","http://www.nih.gov/news/pr/aug2006/nci-31b.htm","https://web.archive.org/web/20060928214625/http://www.nih.gov/news/pr/aug2006/nci-31b.htm","http://www.cbsnews.com/stories/2009/05/30/health/main5050957.shtml","https://web.archive.org/web/20101029214646/http://www.cbsnews.com/stories/2009/05/30/health/main5050957.shtml","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3517182","//doi.org/10.1056/NEJMoa1012863","//www.ncbi.nlm.nih.gov/pubmed/21631324","https://www.nytimes.com/2010/02/22/health/research/22trial.html?","https://web.archive.org/web/20170210085433/http://www.nytimes.com/2010/02/22/health/research/22trial.html","https://www.nytimes.com/2011/06/06/health/research/06melanoma.html","https://web.archive.org/web/20170131105246/http://www.nytimes.com/2011/06/06/health/research/06melanoma.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549296","//doi.org/10.1056/NEJMoa1103782","//www.ncbi.nlm.nih.gov/pubmed/21639808","https://www.reuters.com/article/2013/05/30/us-glaxosmithkline-approvals-idUSBRE94S1A020130530","https://web.archive.org/web/20150924181713/http://www.reuters.com/article/2013/05/30/us-glaxosmithkline-approvals-idUSBRE94S1A020130530","http://www.news-medical.net/news/20121001/Combination-of-dabrafenib-and-trametinib-delays-development-of-treatment-resistance-in-MM-patients.aspx?page=2","https://web.archive.org/web/20130514034005/http://www.news-medical.net/news/20121001/Combination-of-dabrafenib-and-trametinib-delays-development-of-treatment-resistance-in-MM-patients.aspx?page=2","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3549295","//doi.org/10.1056/NEJMoa1210093","//www.ncbi.nlm.nih.gov/pubmed/23020132","http://www.onclive.com/web-exclusives/FDA-Approves-First-Ever-Combination-for-Metastatic-Melanoma","https://web.archive.org/web/20140125190539/http://www.onclive.com/web-exclusives/FDA-Approves-First-Ever-Combination-for-Metastatic-Melanoma","http://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/counteracting-drug-resistance-melanoma","https://web.archive.org/web/20150204044952/http://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/counteracting-drug-resistance-melanoma","https://www.reuters.com/article/idUSN0218461520100605","https://web.archive.org/web/20101109095301/http://www.reuters.com/article/idUSN0218461520100605","https://web.archive.org/web/20110315041905/http://blogs.forbes.com/sciencebiz/2010/06/06/the-risk-for-bristol/","https://blogs.forbes.com/sciencebiz/2010/06/the-risk-for-bristol/","http://www.news-medical.net/news/20100609/Phase-3-clinical-study-Ipilimumab-boosts-sustains-immune-system-responses-against-melanoma-tumors.aspx","https://web.archive.org/web/20121019003945/http://www.news-medical.net/news/20100609/Phase-3-clinical-study-Ipilimumab-boosts-sustains-immune-system-responses-against-melanoma-tumors.aspx","http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm","https://web.archive.org/web/20110327063147/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm","https://www.nytimes.com/2011/03/26/business/26drug.html","https://web.archive.org/web/20110401011816/http://www.nytimes.com/2011/03/26/business/26drug.html","https://www.drugs.com/yervoy.html","https://web.archive.org/web/20110809231412/http://www.drugs.com/yervoy.html","//doi.org/10.1056/NEJMoa1104621","//www.ncbi.nlm.nih.gov/pubmed/21639810","http://www.jco.org/cgi/pmidlookup?view=long&pmid=20065175","//doi.org/10.1200/JCO.2009.25.7428","//www.ncbi.nlm.nih.gov/pubmed/20065175","https://web.archive.org/web/20111014181613/http://www.malignant-melanoma.org/sunmel/","http://www.malignant-melanoma.org/sunmel","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3778850","//doi.org/10.3389/fgene.2013.00184","//www.ncbi.nlm.nih.gov/pubmed/24062768","//doi.org/10.1200/JCO.2014.58.3377","//www.ncbi.nlm.nih.gov/pubmed/26014293","https://www.wikidata.org/wiki/Q180614","http://apps.who.int/classifications/icd10/browse/2016/en#/C43","http://www.icd9data.com/getICD9Code.ashx?icd9=172.9","https://progenetix.org/subsets/?term_id=icdom:8720_3","https://omim.org/entry/155600","https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&term=D008545","http://www.diseasesdatabase.com/ddb7947.htm","https://www.nlm.nih.gov/medlineplus/ency/article/000850.htm","http://www.emedicine.com/derm/topic257.htm","http://www.emedicine.com/med/topic1386.htm#","http://www.emedicine.com/ent/topic27.htm#","http://www.emedicine.com/plastic/topic456.htm#","https://www.cancer.gov//cancertopics/types/melanoma","https://curlie.org/Health/Conditions_and_Diseases/Cancer/Melanoma/","https://d-nb.info/gnd/4074707-4","http://id.loc.gov/authorities/subjects/sh85083381"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"Melanoma","byteoffset":7595,"anchor":"Signs_and_symptoms"},{"toclevel":1,"level":"2","line":"Cause","number":"2","index":"2","fromtitle":"Melanoma","byteoffset":9289,"anchor":"Cause"},{"toclevel":2,"level":"3","line":"UV radiation","number":"2.1","index":"3","fromtitle":"Melanoma","byteoffset":10009,"anchor":"UV_radiation"},{"toclevel":2,"level":"3","line":"Genetics","number":"2.2","index":"4","fromtitle":"Melanoma","byteoffset":16166,"anchor":"Genetics"},{"toclevel":1,"level":"2","line":"Pathophysiology","number":"3","index":"5","fromtitle":"Melanoma","byteoffset":21551,"anchor":"Pathophysiology"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"4","index":"6","fromtitle":"Melanoma","byteoffset":32386,"anchor":"Diagnosis"},{"toclevel":2,"level":"3","line":"ABCDE","number":"4.1","index":"7","fromtitle":"Melanoma","byteoffset":34733,"anchor":"ABCDE"},{"toclevel":2,"level":"3","line":"Ugly duckling","number":"4.2","index":"8","fromtitle":"Melanoma","byteoffset":36259,"anchor":"Ugly_duckling"},{"toclevel":2,"level":"3","line":"Biopsy","number":"4.3","index":"9","fromtitle":"Melanoma","byteoffset":38315,"anchor":"Biopsy"},{"toclevel":2,"level":"3","line":"Classification","number":"4.4","index":"10","fromtitle":"Melanoma","byteoffset":41301,"anchor":"Classification"},{"toclevel":2,"level":"3","line":"Laboratory","number":"4.5","index":"11","fromtitle":"Melanoma","byteoffset":42214,"anchor":"Laboratory"},{"toclevel":2,"level":"3","line":"Staging","number":"4.6","index":"12","fromtitle":"Melanoma","byteoffset":43730,"anchor":"Staging"},{"toclevel":1,"level":"2","line":"Prevention","number":"5","index":"13","fromtitle":"Melanoma","byteoffset":45947,"anchor":"Prevention"},{"toclevel":2,"level":"3","line":"Avoiding ultraviolet radiation","number":"5.1","index":"14","fromtitle":"Melanoma","byteoffset":45963,"anchor":"Avoiding_ultraviolet_radiation"},{"toclevel":2,"level":"3","line":"Sunscreen","number":"5.2","index":"15","fromtitle":"Melanoma","byteoffset":47859,"anchor":"Sunscreen"},{"toclevel":2,"level":"3","line":"Medications","number":"5.3","index":"16","fromtitle":"Melanoma","byteoffset":49816,"anchor":"Medications"},{"toclevel":1,"level":"2","line":"Treatment","number":"6","index":"17","fromtitle":"Melanoma","byteoffset":51018,"anchor":"Treatment"},{"toclevel":2,"level":"3","line":"Surgery","number":"6.1","index":"18","fromtitle":"Melanoma","byteoffset":52650,"anchor":"Surgery"},{"toclevel":2,"level":"3","line":"Add on treatment","number":"6.2","index":"19","fromtitle":"Melanoma","byteoffset":64275,"anchor":"Add_on_treatment"},{"toclevel":2,"level":"3","line":"Chemotherapy and immunotherapy","number":"6.3","index":"20","fromtitle":"Melanoma","byteoffset":68063,"anchor":"Chemotherapy_and_immunotherapy"},{"toclevel":2,"level":"3","line":"Lentigo maligna","number":"6.4","index":"21","fromtitle":"Melanoma","byteoffset":73659,"anchor":"Lentigo_maligna"},{"toclevel":2,"level":"3","line":"Radiation therapy","number":"6.5","index":"22","fromtitle":"Melanoma","byteoffset":76554,"anchor":"Radiation_therapy"},{"toclevel":1,"level":"2","line":"Prognosis","number":"7","index":"23","fromtitle":"Melanoma","byteoffset":77889,"anchor":"Prognosis"},{"toclevel":1,"level":"2","line":"Epidemiology","number":"8","index":"24","fromtitle":"Melanoma","byteoffset":83828,"anchor":"Epidemiology"},{"toclevel":2,"level":"3","line":"Australia","number":"8.1","index":"25","fromtitle":"Melanoma","byteoffset":85918,"anchor":"Australia"},{"toclevel":2,"level":"3","line":"United States","number":"8.2","index":"26","fromtitle":"Melanoma","byteoffset":87577,"anchor":"United_States"},{"toclevel":1,"level":"2","line":"History","number":"9","index":"27","fromtitle":"Melanoma","byteoffset":89822,"anchor":"History"},{"toclevel":2,"level":"3","line":"Terminology","number":"9.1","index":"28","fromtitle":"Melanoma","byteoffset":93320,"anchor":"Terminology"},{"toclevel":1,"level":"2","line":"Research","number":"10","index":"29","fromtitle":"Melanoma","byteoffset":95372,"anchor":"Research"},{"toclevel":2,"level":"3","line":"Targeted therapies","number":"10.1","index":"30","fromtitle":"Melanoma","byteoffset":95801,"anchor":"Targeted_therapies"},{"toclevel":2,"level":"3","line":"BRAF inhibitors","number":"10.2","index":"31","fromtitle":"Melanoma","byteoffset":100517,"anchor":"BRAF_inhibitors"},{"toclevel":2,"level":"3","line":"Ipilimumab","number":"10.3","index":"32","fromtitle":"Melanoma","byteoffset":105878,"anchor":"Ipilimumab"},{"toclevel":2,"level":"3","line":"Surveillance methods","number":"10.4","index":"33","fromtitle":"Melanoma","byteoffset":110113,"anchor":"Surveillance_methods"},{"toclevel":2,"level":"3","line":"Oncolytic virotherapy","number":"10.5","index":"34","fromtitle":"Melanoma","byteoffset":111048,"anchor":"Oncolytic_virotherapy"},{"toclevel":1,"level":"2","line":"References","number":"11","index":"35","fromtitle":"Melanoma","byteoffset":112494,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"12","index":"36","fromtitle":"Melanoma","byteoffset":112522,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Melanoma","iwlinks":[{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/melano-","*":"wikt:melano-"},{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/-oma","*":"wikt:-oma"},{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/%CE%BC%CE%AD%CE%BB%CE%B1%CF%82","*":"wikt:\u03bc\u03ad\u03bb\u03b1\u03c2"},{"prefix":"wikt","url":"https://en.wiktionary.org/wiki/-%CF%89%CE%BC%CE%B1","*":"wikt:-\u03c9\u03bc\u03b1"},{"prefix":"d","url":"https://www.wikidata.org/wiki/Q180614","*":"d:Q180614"},{"prefix":"wiktionary","url":"https://en.wiktionary.org/wiki/melanoma","*":"wiktionary:melanoma"},{"prefix":"commons","url":"https://commons.wikimedia.org/wiki/Category:Melanoma","*":"commons:Category:Melanoma"}],"properties":[{"name":"wikibase_item","*":"Q180614"}]}}